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ortho-Quinone methides (o-QMs) are highly reactive intermediates with various 
applications in chemical and biological sciences.  In the last decade, chemists have 
utilized o-QM reactivity to develop numerous synthetic transformations that provide 
access to biologically relevant scaffolds, such as chromanes.  However, enantioselective 
functionalization of o-QM is still a challenge.  Presented herein are functionalization 
reactions of o-QMs with a chiral Pd-catalyst to provide biologically relevant chromane 
and bis-arylmethane scaffolds in excellent enantioselectivity.  These studies are followed 
by development of hydrofunctionalization of vinyl phenols and vinyl indoles to provide 
the corresponding bis-arylmethanes.  
 In the first study, a unique approach to alkene difunctionalization was taken based 
on a mechanistic hypothesis of a quinone methide intermediate in a related reaction.  
Substrates containing an alkene adjacent to an ortho-phenol and a tethered nucleophile 
were prepared, allowing for the regioselective addition of two distinct nucleophiles.  The 
reaction was applied to the dialkoxylation of alkenes, resulting in the enantioselective 
formation of heterocyclic compounds bearing two adjacent chiral centers.   
In the second study, a Pd-catalyzed enantioselective reaction of indoles with o-
QMs was developed, using a similar strategy as above, to provide bis-arylmethanes.  
Since many biologically active compounds contain bis-arylmethane functionality, several 
of the newly synthesized compounds were screened against breast cancer cell lines.  Two 
of newly synthesized bis-arylmethanes, 69 and 72, demonstrated micromolar anti-cancer 
activity against breast cancer cell lines with different phenotypes. 
 Inspired by promising biological activity of bis-arylmethanes, a unique 
hydrofunctionalization reaction of vinyl phenol with heteroaromatics was developed to 
provide analogous structures.  The key development in this process is use of alkyl 
chloride as a sacrificial hydride source to provide the requisite Pd-hydride.   
 Finally, acid-catalyzed hydrofunctionalization of vinyl indoles with 
heteroaromatics was developed.  This process provides unsymmetrical bis-
indolylmethanes in high yields.  The biological studies of newly synthesized compounds 
demonstrated anti-cancer activity against breast cancer cell lines.  One of the newly 
synthesized compound, 149, demonstrated excellent deferential activity between wild-
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RECENT DEVELOPMENTS IN THE SYNTHESIS AND  
APPLICATIONS OF ORTHO-QUINONE  
METHIDE INTERMEDIATES  
Introduction 
Quinone methide (QM) intermediates are ubiquitous in various areas of chemical 
and biological research.1-6   There are three possible regioisomers of QM, namely ortho-
QM (o-QM), meta-QM (m-QM) and para-QM (p-QM).  From these, the o-QM and p-
QM are the most studied and are of broad synthetic interest.  The parent o-QM, 1, is a 
molecule having a cyclohexadiene core with a carbonyl group and a methylene unit 
attached.  It is related to o-quinone, 2, which has two carbonyl groups, and to o-quinone 
dimethide, 3, which has two methylene units.  Unlike intermediates 2 and 3, which have 
two identical groups, o-quinone methides are highly polarized and, therefore, quite 
reactive.  This reactivity can be rationalized by considering the resonance hybrid of two 
principal canonical forms 4, which is aromatic and exhibits charge separation, and 1, 
which is nonaromatic (Figure 1.1). From these canonical forms, the reactivity of QM 
intermediates is understood, wherein nucleophiles reacts at the C-center and electrophiles 
at the O- center.  Generation of the aromatic ring, which results from this reactivity, 
provides a the life-time of QM intermediates in solution is generally very short and thus 








Quinone methides are useful intermediates with wide applications in organic 
synthesis,1-2 materials chemistry,5 and biology.5,7  The o-QM intermediates are known to 
undergo 1,4-conjugate addition reactions with nucleophiles and Diels-Alder reactions 
with various dienophiles (Figure 1.2).  Additionally, the biological activity of vitamins E 
and K, as well as the anti-cancer effects of drugs like anthracyclin antibiotic are 
purportedly due to o-QM formation (Figure 1.3).8-10  Because of their extensive 
applicability, various methods are available for their synthesis under thermal, acidic, 
basic, and neutral conditions.6  In this chapter, recent developments regarding the 























Evidence for o-QM Existence 
  In 1907, Fries first suggested the existence of o-QM intermediates based on his 
observations and isolation of dimers and trimers of o-QMs.11  Subsequently, various 
indirect evidence (such as observed reactivity with enol ethers) supported the existence of 
o-QMs as reactive intermediates in a variety of reactions.  In 1963, Gardner and 
coworkers were the first to analyze the o-QM intermediate spectroscopically at -100 °C, 
which provided solid evidence of their existence.12-15  Since then a number of o-QMs 
with bulky substituents and/or extended conjugation have been isolated and 
characterized.   
In 1998, Amouri and coworkers reported the first example of a transition metal 
complex of the simplest o-QM (1) with Ir.  The complex was characterized by X-ray to 
provide tangible evidence of its existence (vide infra).1,16-18   
Synthetic Preparation and Utility 
The major issue with reactions of o-QMs is formation of its dimers and trimers.  
Nature overcomes this problem by producing highly reactive o-QMs in low 
concentrations and in the vicinity of a reactive site, which makes these undesired 
reactions less likely.  In the laboratory setting such control is difficult to achieve.  
However, side product formation can be reduced by using a large excess of the 
subsequent reaction partner.  In order to more effectively direct the reactivity of o-QM, 
biologically inspired methods for in situ o-QM generation have been reported, including 
1) thermolysis, 2) tautomerization, 3) acid catalysis, 4) base catalysis, 5) oxidation and 6) 
photolysis (Figure 1.4).6  Some of these methods require forcing conditions, and thus, are 
















form o-QMs in situ.  Below, some of the key developments in the last decade are 
discussed in detail.  
Metal Free o-QM Formation and Utility 
In 1995, Mitchell and coworkers reported a reaction of dicarbonate 5 with NaBH4 
to give the ketone reduction product monoprotected resorcinol 6 (Figure 1.5).19  This 
unique route to monoprotected resorcinol derivatives is proposed to proceed by the 
mechanism shown in Figure 1.6.  The reaction of NaBH4 with 5 leads to the formation of 
intermediate A, which then undergoes carbonate migration to give an intermediate B.  
This decomposes to give o-QM C, which further reacts with the hydride reagent, 
followed by protonation to yield the desired product 6.   
Inspired by these results, Pettus and coworkers developed a unique method to 
generate o-QM intermediates under relatively mild conditions, where the reaction of O-
Boc protected phenol with organolithium or Grignard reagents leads to the formation of 
dialkylated phenols in an excellent yield (Figure 1.7).20-23  This three component reaction 
allows for the addition of two different Grignard and/or organolithium reagents.  The 
proposed mechanism is similar to that described in Figure 1.6, except the reaction is 
initiated by addition of RM (organometallic reagents) instead of hydride (Figure 1.8).  
The reaction of 5 with the first R1M gives intermediate A, which undergoes Boc 
migration to give intermediate B.  This decomposes to an o-QM with elimination of an 


























More recently, Pettus and coworkers extended this method to include enol ethers 
as the exogeneous nucleophile (Figure 1.9).24-25  Enol ethers are known to undergo an 
inverse electron demand [4+2] cycloaddition reaction with o-QMs to give chromane 
frameworks.  Chromanes are important substructures found in many natural products and 
pharmacophores that displays various biological activities such as anti-cancer and anti-
HIV effects.2,26-32  Pettus and coworkers also utilized their base-triggered synthesis of o-
QMs for the synthesis of various natural products.33-37  One representative example is 
shown in Figure 1.10.37  In this elegant synthesis of berkelic acid via a cycloaddition 
reaction, an o-QM precursor was used to synthesize the core of berkelic acid, which 
allowed for subsequent functionalization of the chromane core.  
 





Figure 1.10. Key step towards berkelic acid synthesis. Data from Pettus and coworkers. 
In 2003, Ohwada and coworkers reported a unique method to generate 4H-1,2-
benzoxazines.38  In this report, they showcased 7 as an excellent precursor for the 
generation of o-QM at relatively lower temperatures (Figure 1.11).  Later in 2007, the 
authors extended this study to incorporate various classes of nucleophiles that react with 
benzoxazine derived o-QM.39-40  The reaction proceeded smoothly to provide chromanes 
in good to excellent yield with various dienophiles.  Of particular note, highly electron 
deficient o-QMs, which were thought to be unreactive prior to this report, reacted under 
these conditions.  Additionally, in situ generated o-QMs reacted with relatively electron 
poor imines to yield either 3,4-dihydro-1,3-benzoxazines or benzylic amines. 
In 1997, Rokita and coworkers reported a novel method to generate o-QMs from 
the corresponding silyl phenol.41-42  A distinctive use of this method recently came from 
Scheidt and coworkers for the reaction of o-QM with acyl anions to give α-aryl ketones 
























Figure 1.13. Proposed mechanism of in situ generation of both reactive intermediate. 








fluoride as the common initiator.  Hanson and coworkers also utilized a similar approach 
to generate eight-membered sultams via a formal [4+4] cyclization of o-QM (Figure 
1.14).44   
o-QM with Transition Metals 
 
Os- and Ir-Mediated o-QM Generation 
 
In 1994, Hermann and coworkers reported the first metal complex of an o-QM.45  
The Os-complex was generated via reaction of an Os-complex of p-cresol with excess of 
crotonaldehyde (Figure 1.15).  The complex 8 was characterized by NMR spectroscopy 
 
Figure 1.14. Generation of eight-membered sultams via a formal [4+4] cyclization of o-







   
Figure 1.15. Os-complex of o-QM. Data from Hermann and coworkers. 
 
Later, in 1998 Amouri and coworkers reported the first example of an Ir-complex 
of a simple o-QM, i.e. an o-QM not bearing substituents on the exocyclic double bond.1,16  
Previously, the parent o-QM was only observed via NMR spectroscopy at -100 °C.  The 
treatment of the oxo-η5-dienyl iridium complexes 9 with NaOMe/methanol or t-
BuOK/CH2Cl2 for several hours at room temperature and subsequent reaction workup 
afforded a yellow microcrystalline η4-o-quinone methide complex 10 (Figure 1.16).  This 
complex was characterized by X-ray to give the first concrete evidence of the existence 
and structure of an o-QM.  Interestingly, o-QM complex 10 showed umpulong reactivity 
i.e. o-QM in complex 10 has nucleophilic character and reacted with electrophiles. For 
example, when complex 10 was treated with I2, it gave complex 11 as the major product. 
Pd-Catalyzed o-QM Generation and Its Reactions 
In 1971, Chapman and coworkers were the first to suggest the formation of o-
QMs from vinyl phenols using stoichiometric Pd(OAc)2 (Figure 1.17).46  They used this 
method for the oxidative coupling of a vinyl phenol to form the natural product 
carpanone via dimerization of o-QM.  In 2006, Sigman and Schultz reported a unique Pd-























 addition of two alcohol molecules across the double bond, when vinyl phenol 12 was 
treated with MeOH and Pd(MeCN)2Cl2 as the catalyst.  The scope of this reaction was 
limited to the use of simple alcohols.  Furthermore, the alcohol was used as the solvent.  
This reaction was proposed to proceed via a unique mechanism involving an o-QM 
intermediate, where the coordination of the alkene with Pd followed by an intermolecular 
nucleopalladation resulted in Pd-alkyl intermediate A (Figure1.19).  The Pd-alkyl A 
decomposes to an o-QM with concomitant reduction of Pd.  Then, the o-QM intermediate 
B reacts with a second equivalent of nucleophilic solvent to give the desired product. 
The proposed mechanism was supported by the following experiments: reaction of 
protected phenol substrate 13 did not yield difunctionalized product instead a mixture of 
regioisomeric Wacker products were obtained via hydrolysis of the acetals upon workup, 
supporting the essential role of phenol (Figure 1.20).  Second, a deuterium labeling study 
was performed in which substrate 12 was submitted to the dialkoxylation reaction in 
CD3OD.  No deuterium incorporation into the alkyl chain of the product was observed.   
Furthermore, exposure of the isotopically labeled substrate 14 to the reaction conditions 
resulted in no deuterium transfer within the product (Figure 1.20).  These experiments 
suggest that no β-hydride elimination of substrate or nucleophile occurred during the 
reaction. 
Interestingly, when EtOH rather than MeOH was used as the solvent and (─)-
sparteine was used as a ligand, the authors observed the hydroalkoxylation product 15 as 
the major product (Figure 1.21).48  Under optimized conditions, various alcohols can be 























Figure 1.21. Effect of solvent in Pd-catalyzed alkene functionalization of vinyl phenols.  




The major limitation of this reaction is utilization of the nucleophilic alcohol as 
solvent, which clearly prohibits the use of precious alcohols or alcohols in the solid state.  
Later, the authors expanded the scope of this transformation to include sec-phenyl ethyl 
alcohol as a sacrificial alcohol, which allowed for the use of other solvents and more 
precious alcohols as nucleophiles (Figure 1.22).49   
 A Pd-catalyzed alcohol oxidation is proposed to be the source of Pd-hydride A, 
which reacts with alkene to give Pd-alkyl intermediate B (Figure 1.23).  Pd-alkyl B 
decomposes to give o-QM, which reacts with an equivalent of the solvent to give the 






Figure 1.22. Scope of Pd-catalyzed hydrofunctionalization of vinyl phenols using a 











observations: 1) the use of PhCD(OH)CH3 as the sacrificial alcohol results in two 
isotopomers 16 and 17 in a 2.5:1 ratio, consistent with the proton incorporated into the 
product being derived from the oxidation of sec-phenethyl alcohol, 2) the reaction of 18 
with an enol ether gave chromane 19 in 19% yield, which provides strong evidence for 
the intermediacy of an o-quinone methide under the hydroalkoxylation reaction 
conditions (Figure 1.24). 
Asymmetric Reactions of o-QM 
 Pettus and coworkers were the first to demonstrate substrate-controlled 
asymmetric reactions of o-QMs.25  Using their three component coupling method with 
chiral (non-racemic) enol ethers, the desired chromanes were produced with excellent 
diastereoselectivity (Figure 1.25).  The major limitations of this method were 1) 
availability of chiral enol ethers, and 2) chiral enol ethers were used as a source of 
chirality hence, only chiral (non racemic) chromanes can be obtained using this method. 
 In 2009, Lectka and coworkers reported a catalytic, asymmetric cycloaddition of 
an o-QM with a ketene enolate.50  Chiral cinchona alkaloid-derived tetra-alkyl 
ammonium fluoride 21 was used as a pre-catalyst to generate the ketene enolate in situ 
(Figure 1.26).  Unfortunately, the scope of the reaction was limited to only 20 as the o-
QM.  The proposed mechanism, shown in Figure 1.27 is initiated by ﬂuoride ion-
promoted desilylation of the ketene acetal 22, forming chiral ion-paired ketene enolate A.  
The resultant ketene enolate regioselectively alkylates the o-QM at the methide carbon to 
give intermediate B.  Subsequently, B undergoes lactonization to form the desired 






















Figure 1.25. Diastereoselective reaction of chiral enol ethers with o-QM. Data from 




Figure 1.26. Enantioselective reaction of o-QM with ketene enolate using chiral 





Figure 1.27. Proposed mechanism. Data from Lectka and coworkers. 
24 
 
In 2007, Sigman and coworkers reported an enantioselective Pd-catalyzed alkene 
difunctionalization reaction, which purportedly reacts via o-QM, with a relatively broad 
substrate scope of alcohols (Figure 1.28).51  The use of (S)-iPr-Quinox as a chiral ligand 
leads to the dialkoxylation product in excellent enantioselectivity and good 
diastereoselectivity.  The major limitations of this process were the addition of identical 
nucleophiles across the alkene and the use of the nucleophile as the solvent.  
Conclusion 
Since its initial discovery, the chemistry of o-QM intermediates has made 
significant progress.  Major advancements have been achieved in the characterization and 
synthesis of o-QM intermediates under mild conditions.  o-QMs can be generated under 
acidic, basic as well as neutral conditions to react with various nucleophiles.  This 
process has allowed for the efficient and rapid synthesis of phenol-containing natural 
products and chromane derivatives.  Despite such advances, the reports of 
enantioselective functionalization of o-QM are only a handful, and this area holds 
potential for further 
  
 
Figure 1.28. Enantioselective Pd-catalyzed dialkoxylation of vinyl phenols. Data from 





development.  This limitation and our discovery of a Pd-catalyst, which affords alkene 
difunctionalized products in excellent enantioselectivity provided the impetus to further 
pursue enantioselective alkene difunctionalization via the formation of an o-QM 
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PALLADIUM-CATALYZED ENANTIOSELECTIVE  
DIFUNCTIONALIZATION OF SUBSTITUTED 
 VINYLPHENOLS WITH ALCOHOLS AS  
EXOGENOUS NUCLEOPHILES 
Introduction 
Palladium(0)-catalyzed reactions have been widely used to successfully 
synthesize carbon-carbon and carbon–heteroatom bonds.1-3  In recent years, substantial 
attention has been paid to oxidative palladium catalysis, which includes a wide variety of 
olefin functionalization reactions, such as the Wacker cyclization4-8 and the oxidative 
Heck reaction.9-10  These olefin functionalization reactions are proposed to proceed via 
nucleopalladation of an alkene with subsequent β-hydride elimination to give mono-
functionalized product as shown in Figure 2.1.  Though these reactions are useful, one of 
the limitations of mono-functionalization of alkenes is loss of chiral information during 
the β-hydride elimination step.  However, in the case of alkene difunctionalization 
reaction such loss can be avoided, which makes development of a difunctionalization 
reaction very attractive.11 
To achieve an enantioselective olefin difunctionalization reaction, several issues  








by using an appropriate chiral ligand.  More importantly, β-hydride elimination should be 
prevented to preserve the chiral information and allow for functionalization of the 
resulting Pd-alkyl intermediate.  Therefore, it is necessary to develop a system in which 
the rate of the second functionalization step is greater than that of β-hydride elimination.  
This could potentially be achieved by either stabilizing the Pd-alkyl species (such as 
through Pd-π-allyl/benzyl stabilization) or by rapidly transforming the Pd-alkyl species 
into an intermediate suitable for further functionalization (such as oxidation of PdII to 







Stabilization of Pd-alkyl Intermediate 
via Pd-π–allyl/benzyl Formation 
The most commonly used substrates for preventing β–hydride elimination via 
formation of Pd-allyl intermediates are conjugated alkenes, such as dienes and styrenes.  
The Pd-alkyl species from dienes and styrenes form relatively stable Pd-π-allyl or Pd-π-
benzyl complexes, respectively, thereby circumventing β-hydride elimination. 
Bäckvall and coworkers have made significant contributions toward Pd-catalyzed 
diene difunctionalization reactions.11-19  In 1981, they reported a noteworthy example of 
Pd-catalyzed diene diacetoxylation reaction, where either cis or trans difunctionalized 
products can be obtained (Figure 2.2).13  Prior to this report such stereochemical control 
was difficult to achieve.  It is proposed that coordination of PdII to the diene followed by 
anti-oxypalladation, results in formation of a Pd-π-allyl intermediate B.  Nucleophilic 
attack of B by a second equivalent of acetate results in product formation with 
concomitant reduction of Pd.  Benzoquinone is used as a terminal oxidant to regenerate 
PdII from Pd0.  Interestingly, the diastereoselectivity of the resultant product can be 
controlled based on chloride ion concentration.  High [Cl-] prevents pre-coordination of 
acetate to Pd, which results in intermolecular attack by acetate on B from the face 
opposite to palladium, leading to cis-24.  In contrast, with low [Cl-], intramolecular attack 
by a coordinated acetate occurs to form trans-25. 
Later, Bäckvall and coworkers expanded the scope of this transformation to 
intramolecular processes, such as alkoxyacetoxylation, aminoacetoxylation, and 









reaction, a complete reversal in product stereochemistry was observed by using a 
catalytic amount of LiCl (Figure 2.3, compare reaction B and C).  These reactions 
generally proceed with excellent diastereoselectivity and good yields.   
Another elegant use of the Pd-π-allyl stabilization for difuctionalization of dienes 
was demonstrated by Booker-Milburn and coworkers (Figure 2.4).20  Using this mode of 
Pd-alkyl stabilization, the authors were able to promote the diamination of various dienes 
in good yields.  This reaction is proposed to proceed via nucleophilic attack of urea on 
the Pd-coordinated diene to yield the Pd-π-allyl intermediate A, which on subsequent 





Figure 2.3.  Pd-catalyzed intramolecular diene alkoxyacetoxylation, aminoacetoxylation, 









Recently, our group has reported Pd-catalyzed hydrofunctionalization and 
difunctionalization of styrenes with aryl stananes.21  The reactions are likely proceeding 
through the Pd-π-benzyl intermediate, which is proposed to undergo transmetalation and 
reductive elimination to give the desired product (e.g., Figure 2.5).  Later, the scope of 
the difunctionalization reaction was expanded to incorporate simple terminal alkenes as a 
substrate to give 1,1-difunctionalized products.22  The proposed mechanism for 1,1-
diarylation is shown in Figure 2.6, where initial transmetalation followed by insertion 
gives intermediate A.  The intermediate A undergoes sequential β-hydride elimination 
and reinsertion to give Pd-π-benyl intermediate B, which proceeds to the observed 
product via a second transmetalation followed by reductive elimination.  
Palladium-Catalyzed Alkene Difunctionalization  
Involving PdII to PdIV Oxidation 
 In recent years the use of high oxidation state Pd catalysis (PdII/PdIV) has grown 
significantly.23-25  This increase in use of PdIV as a means to functionalize alkenes has 
several advantages over conventional PdII/Pd0 catalysis: 1) PdIV species are often resistant 
to β-H elimination processes, allowing diverse transformations of PdIV intermediates; 2) 
PdIV species undergo reductive elimination under relatively mild conditions; 3) In some 
cases, PdII/PdIV catalysis realizes transformations that are difficult to achieve by PdII/Pd0 
catalyzed reactions. 
A general catalytic cycle for PdII/PdIV catalysis is shown in Figure 2.7.  The 
coordination of PdII with an alkene followed by nucleophilic attack of a suitable 














undergoes oxidation to PdIV-alkyl intermediate C, which subsequently reacts with an 
equivalent of nucleophile to give the difunctionalized product.  The second 
functionalization can proceed through two possible pathways: 1) reductive elimination of 
C-Nu from PdIV, resulting in retention of stereochemistry, or 2) nucleophilic attack of an 









In 2005, Sorenson and coworkers reported an intramolecular aminoacetoxylation 
of alkenes using PdII/PdIV catalysis (Figure 2.8a). 26  They used PhI(OAc)2 as an oxidant 
to oxidized the PdII-alkyl species to the PdIV-alkyl intermediate.  Soon after, Muñiz and 
coworkers reported the use of PdII/PdIV catalysis for intramolecular diamination of 
unactivated alkenes using o-alkenyl-substituted ureas as substrates (Figure 2.8b).27-29  In 
addition, Stahl and co-workers reported the diastereoselective intermolecular 
aminoacetoxylation of terminal alkenes with phthalimide as the nitrogen nucleophile 
(Figure 2.8c).30  Sanford and co-workers utilized a similar strategy for the 
diastereoselective construction of substituted tetrahydrofurans through aminooxygenation 








Another elegant use of PdII/PdIV catalysis was reported by Song and Dong for 
diacetoxylation of alkenes (Figure 2.9).32  In this chemistry, the authors used PhI(OAc)2 
as the preferred oxidant to give a diacetoxylation product 26 in good yield and excellent 
diastereoselectivity.  However, recently Gade and coworkers reported that the TfOH, 
generated from the first catalytic turnover, is the active catalyst in this transformation.33  
Later, Jiang and coworkers reported a diacetoxylation of alkenes using O2 as the sole 








presence of peracetic acid and acetic anhydride to produce diacetates in good yields and 
diastereoselectivity.35 
 Electrophilic fluorinating reagents like N-ﬂuorobenzenesulfonimide (NFSI) can 
effectively oxidize the PdII-alkyl intermediates to PdIV-alkyl intermediates (Figure 2.10).  
Michael and coworkers reported the use of NFSI for Pd-catalyzed diamination of simple 
alkenes. 36-37  NFSI acts as both the oxidant and nitrogen source in the alkene diamination 
reaction.36  Interestingly, when aromatic solvents are used, the aminoarylation was 
observed predominantly (Figure 2.10b).  This is proposed via attack of an aromatic group  
39 
 
to the electrophilic PdIV-species through the electrophilic aromatic substitution 
mechanism.37  Recently, Liu and coworkers utilized NFSI as an effective oxidant in their 
intermolecular flouroamination of alkenes.  Here, NFSI acts as the source of both fluorine 
anion and nitrogen nucleophile (Figure 2.10c).38   
As described in Chapter 1, our group has developed a distinctive method for the 
difunctionalization of vinyl phenols via conversion of a Pd-alkyl intermediate to an o-QM 
as a latent electrophile.  Though these reactions are mechanistically intriguing, they have 
limited substrate scope.  Recently, we have reported highly enantioselective 
difunctionalization of vinyl phenols with alcohols as nucleophiles.39  The major limitation 
of this approach is the addition of identical nucleophiles across an alkene.  To overcome 
this, we envisioned a difunctionalization reaction, where one of the nucleophiles is  
 
Figure 2.10. Alkene difunctionalization using NFSI as an oxidant. 
40 
 
incorporated into the starting material as shown in Figure 2.11.  We hypothesized that 
this class of substrates would first undergo nucleopalladation in an intramolecular fashion 
to give the palladium alkyl species A.  This would subsequently undergo quinone 
methide formation B, followed by attack of an external nucleophile, to yield product.  
These proposed substrates would allow us to functionalize substituted vinyl phenols with 
two distinct nucleophiles to give substituted heterocycles, which are prominent structures 
in pharmaceutically interesting compounds and natural products.  The remainder of this 
chapter is devoted to a detailed discussion of our findings.   
Reaction Development and Optimization 
To test our hypothesis, we synthesized substrates containing alcohols that can act 
as intramolecular nucleophiles.  Our strategy for preparing these substrates can be  
 





divided into two general routes as shown in Figure 2.12.  The Wittig salt 27 was 
synthesized by the reaction of commercially available ethyl-4-bromobutanoate with 
triphenylphosphine.  Wittig salt 27 was then subjected to the reaction with 
salicylaldehyde 28, in the presence of potassium tert-butoxide as base to yield alkene 29.  
This was subsequently treated with either MeMgBr or LiAlH4 to give products 30 and 31, 
respectively.  Vinyl phenols 36 and 39 were synthesized using a Sonogashira coupling 
route.  The Sonogashira coupling between aryl iodide 32 and alkyne 33 gave compound 
34 in excellent yield.  Alkyne 34 was then converted to the alkene 35 via a Pd-catalyzed 
hydrogenation reaction and subsequently deprotected to give compound 36.   
Optimization of reaction conditions and evaluation of substrate scope were 
conducted in collaboration with former graduate student Dr. Katrina Jensen.  Initial 
evaluation of 30 under conditions similar to the intermolecular dialkoxylation gave the 
desired product in good enantioselectivity but in very low yield and with a significant 
number of unidentified side products (Table 2.1, entry 1).  During the optimization of the 
intermolecular dialkoxylation reaction, it was observed that a catalytic amount of CuCl2 
accelerates this transformation and generally leads to better chemoselectivity.  
Unfortunately, during this study Dr. Yang Zhang also observed decreased 
enantioselectivity with an increased copper loading (Table 2.2).39  We believe this 
decrease in enantioselectivity is due to the ligand exchange between copper and 
palladium.  Therefore, a pre-formed copper complex was used in order to prevent ligand 
exchange and resulting decrease in enantioselectivity.  Excitingly, an increase in product 
















Table 2.2.  Detrimental effect of copper on enantioselectivity in the Pd-catalyzed 







enantioselectivity (Table 2.1, entry 2).  Reduced catalyst loading resulted in lower yield 
(Table 2.1, entry 3), while removal of molecular sieves resulted in an unexpected increase 
in product yield. (In the case of intermolecular dialkoxylation, molecular sieves were 
beneficial) (Table 2.1, compare entries 3 and 4).  By changing the base from KOtBu to 
NaHCO3, we were able to recover the yield loss that resulted from lowering CuCl2 
loading (Table 1.1, compare entries 5 and 6).  With the virtue of using a common solvent 
for all nucleophiles, other solvents were tested with 50 equivalents of MeOH as a 
nucleophile.  Enantioselectivity and selectivity of product formation were found to be 
greatly solvent dependent.  As a crude measure of this selectivity, GC product peak area 
was compared to all other peak areas (besides starting material).  After this systematic 
screening of solvents, THF and toluene were found to give better enantioselectivity and 
chemoselectivity (Table 2.3).  Thus, these solvents were chosen for further pursuits.  
Toluene, THF or a 1:1 mixture of toluene:THF each allowed for product formation with 
high enantioselectivity, short reaction times, and good yield (Table 2.4, entries 1-3)  
Furthermore, in situ-formed complexes gave results similar to those from the preformed 
complexes under these reaction conditions.  Employment of CuI in place of CuII resulted 
in shorter reactions times, likely due to an effect of overall [Cl-] (Table 2.4, entry 4). 
Evaluation of Substrate Scope 
 Having optimized conditions in hand, the scope of the sequential intra- and 
intermolecular dialkoxylation reaction was evaluated.  The scope of this reaction is 











Table 2.4.  Final optimization. 




 As discussed above, since the 1:1 toluene:THF mixture and toluene alone were 
found to provide good yield and excellent enantioselectivity of the desired product, both 
solvent systems were tested for alcohol nucleophiles (Table 2.5).  In addition to 
methanol, other simple alcohols also provided the desired difunctionalized product in 
good yield and excellent enantioselectivity.  This is noteworthy because primary alcohols 
containing a β-hydrogen are known to undergo palladium-catalyzed alcohol oxidation 
much more readily than methanol.  Thus, it was important to confirm that primary 
alcohols can be used as exogenous nucleophiles under these conditions.  In some cases, 
the use of toluene as solvent was found to give slightly improved yields.  Ethers, with the 
potential for deprotection, are formed using benzyl alcohol and trimethylsilylethanol, 
with the latter giving an excellent er of 99:1 (47). A relatively complex chiral alcohol, 
(─)-myrtenol, was employed successfully (48), demonstrating the potential to couple two 
chiral partners.   
When more polar nucleophiles like H2O and ethylene glycol (EG) were subjected 
to the optimized conditions, they did not provide any desired product.  This was proposed 
to be because of low miscibility of these nucleophiles in nonpolar solvents.  To improve 
the solubility of these nucleophiles, hindered alcohols such as t-BuOH and t-AmylOH 
were evaluated as solvents.  In both solvents, using 50 equivalent of H2O as the 
nucleophile, product formation was observed in good yield with excellent 
enantioselectivity.  However, because t-BuOH solidifies at 24 °C, t-AmylOH was chosen 














1:1 THF:toluene, 3 h 
97:3 er; 10:1 dr 
44 
53% yield 
1:1 THF:toluene,12 h 
97:3 er; 9:1 dr 
4 mol% Pd(MeCNhCI2, 
8 mol% CuCI 
14 mol% (S)-iPr-Quinox, 
40 mol% KHC03 
• 




toluene, 12 h 
96:4 er; 5:1 dr 
45 
60% yield 
toluene, 12 h 
94:6 er; 5:1 dr 
43 
57% yield 
toluene, 12 h 
96:4 er; 4: 1 dr 
46 
51% yield 
1:1 THF:toluene, 16 h 




toluene, 16 h 
99:1 er; 6:1 dr 
55% yield" 
toluene, 12 h 
10:1 dr 
Isolated yield on 0.50 mmol scale. er for major diastereomer. 
"25 equiv. of NuH. 
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the desired product with excellent enantioselectivity (Table 2.6).  Moreover, NaN3 was 
also found to be an effective nucleophile, demonstrating that an exogenous nitrogen 
nucleophile is viable.  While low diastereoselectivity is observed, the diastereomers of 51 
are readily separated.  No improvement in product yield or enantioselectivity was 
observed by changing the azide anion source to tetra-butylammonium azide (TBAA) or 
TMSN3.  Other nucleophiles that did not lead to the difunctionalized products are shown 
in Figure 2.13. 
As discussed in Chapter 1, o-QMs are known to undergo inverse electron demand 
Diels-Alder reactions with electron rich enol ethers.  Thus, to evaluate the compatibility 
of enol ethers as nucleophiles in our difunctionalization method, we (in collaboration 
with Dr. Katrina Jensen ) subjected enol ether 52 to reaction conditions with a standard 
substrate 30 (Figure 2.14).  To our delight, chromane 53 was obtained in good yield and 
excellent enantioselectivity and diastereoselectivity.  The primary alcohol substrate 31 
also gave product 54 with excellent stereoselectivity.  It should be noted that in the above 





Figure 2.13. Nucleophiles that failed to yield the desired product. 
 
 




mentioned  reaction, three new bonds with four contiguous chiral centers were 
constructed in a single step.  This clearly demonstrates the power of this method to 
construct relatively complex frameworks from a simple substrate, in a single step.   
Intramolecular Nucleophiles 
 In examining other ring systems that could be accessed, it was found that five and 
six membered rings could be successfully formed from tethered alcohol nucleophiles 
(Table 2.7).  In addition to the tertiary alcohol substrates, the primary alcohols 31 and 36  
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also cyclized to the corresponding tetrahydrofuran 55 and tetrahydropyrane 56 with high  
enantio- and diastereoselectivity.  A 1,4-dioxane can also be accessed  in modest yield 
and good enantioselectivity. 
Product Derivatization 
 While the phenol moiety is a mechanistic requirement for o-QM formation, it also 
provides a handle for further derivatization of products.  We envisioned that oxidation of 
the phenol to a carboxylic acid would provide the basic building block for further 
functionalization.  However, when compound 55 was treated with ozone (O3), no desired 
product formation was observed.  Ru-catalyzed oxidation of arenes to carboxylic acids is 
well documented in the literature,40-41 thus it was examined for oxidation of 55.  After 
significant optimization of the reaction conditions, we arrived at these optimal conditions: 
10 mol% RuCl3 and 10 mol% NaIO4 in a MeCN:CCl4:H2O (2:2:3) solvent system 
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(Figure 2.15).  Under these conditions, 55 gave the desired product 58, in 43% yield with 
no deterioration of diastereoselectivity or enantioselectivity.   
Another useful method for functionalization of phenols is via dearomatization.  
This is a very powerful method to provide synthetically useful p-benzoquinone ketals.42  
Thus, compound 41 and 55 were treated with PhI(OAc)2 in MeOH to give 59 and 60 as 
the corresponding products in good yields (Figure 2.16).   
Determination of Product Stereochemistry 
The relative stereochemistry between newly formed stereocenters was determined 
by X-ray analysis of compound 41 (Figure 2.17).  Mosher ester analysis was used to 
determine the absolute stereochemistry (Figure 2.18).43-44  Product 41, which was 
obtained using water as the exogenous nucleophile was used in this analysis.  Methyl 
protection of the phenol followed by coupling with each enantiomer of Mosher’s acid 
gave the diastereomeric Mosher esters 62 and 63.  Based on chemical shift analysis and 
in combination with the crystal structure data, the absolute stereochemistry was assigned 
as (R,R). 
Conclusion 
We have developed a highly enantioselective Pd-catalyzed alkene 
difunctionalization reaction involving the addition of two distinct nucleophiles.45  This  
 






































process allows for the formation of complex chiral molecules from relatively simple 
starting materials.  A key step in the optimization of the reaction conditions was the use 
of a ligated copper complex as a co-catalyst, which drastically improved reaction rate and 
yield, with no detrimental effect on enantioselectivity.  Furthermore, the optimized 
conditions allowed for the use of exogenous nucleophiles other than solvent.  In 
evaluating the scope of the reaction, alcohols, water, and sodium azide were found to add 
successfully as exogenous nucleophiles.  
Experimental 
General Considerations 
 Unless otherwise noted, all reactions were performed under a nitrogen atmosphere 
with stirring.  Toluene, CH2Cl2, dichloroethane and THF were dried before use by 
passing through a column of activated alumina.  Methanol was distilled from magnesium 
methoxide.  Et3N was distilled from CaH2.  3Å molecular sieves were powdered and 
activated by flame heating under vacuum (ca. 3 min).  n-Butanol, n-Butenol and 
etheleneglycol monomethylether were purified by distillation from MgSO4.  All other 
reagents were purchased from commercial sources and used without further purification.  
Yields were calculated for material judged homogeneous by thin-layer chromatography 
and NMR.  Thin-layer chromatography was performed with EMD silica gel 60 F254 
plates eluting with the solvents indicated, visualized by a 254 nm UV lamp, or stained 
either with potassium permanganate, p-anisaldehyde, phosphomolybdic acid, or 
ninhydrin.  Flash column chromatography was performed with EcoChrom MP Silitech 
32-63D 60Å silica gel, slurry packed with solvents indicated in glass columns.  Nuclear 
magnetic resonance spectra were acquired at 300, 400, or 500 MHz for 1H, and 75, 100, 
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or 125 MHz for 13C.  Chemical shifts for proton nuclear magnetic resonance (1H NMR) 
spectra are reported in parts per million downfield relative to the line of CHCl3 singlet at 
7.26 ppm.  Chemical shifts for carbon nuclear magnetic resonance (13C NMR) spectra are 
reported in parts per million downfield relative to the center-line of the CDCl3 triplet at 
77.23 ppm.  The abbreviations s, d, t, dd, td, ddd, and m stand for the resonance 
multiplicities singlet, doublet, triplet, doublet of doublets, triplet of doublets, doublet of 
doublets of doublets, and multiplet, respectively.  Optical rotations were obtained (Na D 
line) using a Perkin Elmer Model 343 Polarimeter fitted with a micro cell with a 1 dm 
path length;  concentrations are reported in g/100 mL.  IR spectra were recorded using a 
Nicolate FTIR instrument.  GC (gas chromatography) analysis was performed using a 
Hewlett Packard HP 6890 Series GC system fitted with a HP-Chiral permethylated β-
cyclodextrin column.  HPLC (high pressure liquid chromatography) analysis was 
performed using a Hewlett Packard Series 1100 instrument fitted with a chiral stationary 
phase (as indicated).  SFC (supercritical fluid chromatography) analysis was performed at 
40 °C, using a Thar instrument fitted with a chiral stationary phase (as indicated).  HRMS 
(high resolution mass spectrometry) analysis was performed using Waters LCP Premier 
XE.  Glassware for all reactions was oven-dried at 110 oC and cooled under N2 
atmosphere prior to use.  Known compounds 28, (S)-iPr-Quinox, Pd(PPh3 )2Cl2, 62, 63, 
71, and were prepared according to literature procedures.   
Synthesis of Substrates 
Preparation of 29 
 To an oven-dried 500 mL round bottom flask equipped with a stir bar were added 
23.4 g of 27 (51.0 mmol, 2.30 equiv.) and 200 mL toluene.  To this was added a solution 
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of 5.80 g KOtBu (51.2 mmol, 2.33 equiv.) in 40 mL of THF dropwise via cannulation.  
The reaction mixture slowly turned a deep red color over 4 h.  The mixture was cooled to 
–78 °C and 2.70 g of salicylaldehyde 28 (22.2 mmol, 1.00 equiv.), dissolved in 20 mL of 
toluene was added dropwise via cannulation.  The mixture was allowed to slowly warm 
to ambient temperature and stirred 48 hours then quenched with 50 mL of saturated 
NH4Cl solution.  The mixture was diluted with 100 mL of Et2O and washed with 100 mL 
(2 x 50 mL) of water and 60 mL of brine.  The organic layer was dried over MgSO4, 
filtered, and the solvent removed in vacuo.  The crude mixture was purified by flash 
silica-gel column chromatography with 10%-20% EtOAc/hexanes as eluent to give 4.15 
g (85% yield, average of two reactions).  Isomeric ratio Z:E = 10:1, major isomer: Rf = 
0.52 with 33% EtOAc/hexanes, colorless oil, 1H-NMR (300 MHz, CDCl3) δ = 7.02-7.28 
(m, 2 H), 6.85-6.95 (m, 2 H), 6.38-6.48 (d, J = 11.2 Hz, 2 H), 5.89 (s, 1 H), 5.74-5.86 (m, 
1 H), 4.08-4.16 (m, 2 H), 2.37-2.48 (m, 4 H), 1.18-1.29 (m, 3 H). 13C-NMR (75 MHz, 
CDCl3) δ = 173.3, 153.1, 134.4, 129.9, 128.8, 125.1, 123.8, 120.5, 116.1, 60.9, 33.9, 
24.3, 14.3.  IR: 3392, 2981, 1705, 1450, 1269, 1195, 1154, 754 cm-1.  HRMS C13H16O3 
(M+Na)+ calcd. 243.0997, obsvd. 243.0996. 
Preparation of 30  
 To an oven dried 500 mL round bottom flask equipped with a stir bar were added 
4.10 g of 29 (18.6 mmol, 1.00 equiv.) in 180 mL THF.  To this was slowly added a 
solution of 3.0 M MeMgBr (130 mmol, 7.00 equiv.) at 0 °C.  The reaction mixture was 
then allowed to warm to rt and was stirred for 12 h.  The reaction was quenched by the 
slow addition of 20 mL of 1 M HCl solution.  The mixture was diluted with 50 mL of 
Et2O and washed with 100 mL (2 x 50 mL) of water and 60 mL of brine.  The organic 
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extract was dried over MgSO4, filtered, and the solvent was removed in vacuo.  The 
crude mixture was purified by flash silica-gel column chromatography with 1:1 
EtOAc:hexanes as eluent to give 3.34 g of 30 in 87% yield.  Isomeric ratio Z:E = 10:1, 
major isomer:  Rf = 0.32 with 33% EtOAc/hexanes, colorless solid.  mp = 74-75 °C.  1H-
NMR (400 MHz, CDCl3) δ = 7.28-7.07 (m, 2 H), 6.95-6.87 (m, 2 H), 6.40-6.37 (d, J = 
10.9 Hz), 5.95-5.88 (m, 1 H), 5.34 (s, 1 H), 2.28-2.19 (m, 2 H), 1.67-1.57 (m, 2 H), 1.19 
(s, 6 H). 13C-NMR (100 MHz, CDCl3) δ = 152.9, 137.0, 129.8, 128.8, 123.9, 123.4, 
120.4, 115.5, 71.3, 43.3, 29.4, 24.1.  IR: 3410, 3013, 2971, 1604, 1448, 1377, 1261, 
1210, 1147, 1131, 904, 755 cm-1.  HRMS C13H18O2 (M+Na)+ calcd. 229.1204, obsvd. 
229.1201. 
Preparation of 31  
 To a 100 mL oven dried round bottom flask equipped with a stir bar were added 
1.6 g 29 (7.27 mmol, 1 equiv.) followed by 40 mL THF under a nitrogen atmosphere.  
The reaction mixture was cooled to 0 °C.  To this was added 544 mg LiAlH4 portion wise 
(14.5 mmol, 2 equiv.).  The reaction mixture was allowed to slowly warm to rt and stirred 
overnight.  The reaction mixture was cooled to 0 °C, and quenched by the sequential 
addition of 544 µL of water, 544 µL 15% NaOH, and 1630 µL water.  The reaction 
mixture was warmed to rt, MgSO4 was added, and the mixture was stirred for 15 min and 
then filtered.  The filtrate was concentrated in vacuo and the crude mixture was purified 
by silica gel column chromatography with 1:3 EtOAc:hexanes to give 777 mg of 53 (60% 
yield, average of two reactions).  Isomeric ratio Z:E = 10:1, major isomer: Rf = 0.20 with 
33% EtOAc/hexanes, white solid.  mp = 45-47 °C.  1H-NMR (300 MHz, CDCl3) δ = 
7.06-7.21 (m, 2 H), 6.83-6.94 (m, 2 H), 6.38-6.46 (d, J = 11.2 Hz, 1 H), 5.82-5.95 (m, 1 
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H), 3.59-3.68 (t, J = 6.4Hz, 2 H), 2.17-2.25 (m, 2 H), 1.62-1.74 (m, 2 H). 13C-NMR (75 
MHz, CDCl3) δ = 135.9, 130.0, 128.8, 124.1, 120.4, 115.6, 62.7, 32.1, 25.5. IR: 3404, 
2938, 2881, 1604, 1448, 1358, 1269, 1225, 1036, 841 cm-1.  HRMS C11H14O2 (M+Na)+ 
calcd. 201.0886, obsvd. 201.0886. 
Preparation of 34 
 To an oven-dried 100 mL Schlenk flask were added 2.10 g of 32 (8.00 mmol, 1 
equiv.) and 40 mL of Et3N.  The solution was degassed by 2 cycles of freeze-pump-thaw.  
To a second oven-dried Schlenk flask was added 1.26 g of 33 (8.96 mmol, 1.12 equiv.), 
20 mL of Et3N and 40 mL of THF.  The solution was degassed by 2 cycles of freeze-
pump-thaw.  To an oven-dried 250 mL round bottom flask equipped with stir bar was 
added 169 mg of Pd(PPh3)2Cl2 (0.240 mmol, 0.0300 equiv.) and 91.4 mg of CuI (0.480 
mmol, 0.0600 equiv.).  The solutions of 32 and 33 were sequentially transferred via 
cannula into the flask containing the catalysts.  The reaction mixture was then stirred at rt 
overnight.  The reaction mixture was diluted with 50 mL of Et2O and then 50 mL of 1 M 
HCl was added and the mixture was allowed to stir for 30 min.  The organic layer was 
washed with 50 mL of 1 M HCl (2 x 25 mL) and 20 mL of brine.  The organic extract 
was dried over MgSO4, filtered, and the solvent was removed in vacuo.  The crude 
mixture was purified by flash silica-gel column chromatography with 10% to 20% 
EtOAc/hexanes as eluent to give 2.03 g of 34 (92.3% yield, average of two reactions).  Rf 
= 0.20 with 20% EtOAc/hexanes, colorless oil, 1H-NMR (300 MHz, CDCl3) δ = 7.44 (dd, 
J = 7.6, 1.7 Hz, 1 H), 7.30 (ddd, J = 8.0, 7.6, 1.7 Hz, 1 H), 7.17 (ddd, J = 7.6, 7.6, 1.4 Hz, 
1 H), 7.05 (dd, J = 8.1, 1.4 Hz, 1 H), 4.11 (t, J = 6.5 Hz, 2 H), 2.47 (t, J = 6.9 Hz, 2 H), 
2.33 (s, 3 H), 2.06 (s, 3 H), 1.84-1.76 (m, 2 H), 1.71-1.63 (m, 2 H).  13C-NMR (75 MHz, 
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CDCl3) δ = 171.4, 169.1, 151.7, 133.3, 129.0, 126.1, 122.3, 118.0, 94.7, 76.2, 64.1, 28.0, 
25.4, 21.2, 21.1, 19.4. IR: 1761, 1733, 1487, 1366, 1237, 1207, 1180, 1037, 907, 755 
cm-1.  HRMS C16H18O4 (M+Na)+ calcd. 297.1103, obsvd. 297.1097. 
Preparation of 35 
 To an oven dried 50 mL Schlenk flask equipped with a stir bar were added 261 
mg of 5% Pd/BaSO4, 150 μL of quinoline (1.27 mmol, 0.42 equiv.) and 5 mL of MeOH.  
A three-way joint fitted with a balloon of H2 was attached and the flask.  To a separate, 
oven-dried 50 mL round bottom flask was added 823 mg of 34 (3.00 mmol) and 10 mL 
MeOH.  The solution of 34 is transferred via cannula to the Schlenk flask.  An additional 
5 mL of MeOH was used for rinsing.  The Schlenk flask was evacuated and refilled with 
H2 three times.  Upon completion as determined by TLC (four days), the reaction mixture 
was filtered through plug of celite® using 50 mL of MeOH.  The filtrate was concentrated 
in vacuo and dissolved in 100 mL of CH2Cl2, washed with 100 mL 0.2 M HCl (2 x 50 
mL) and 50 mL brine, dried over Na2SO4, filtered, and the solvent was removed in vacuo.  
The crude mixture was purified by flash silica-gel column chromatography with 1:4 
EtOAc:hexanes as eluent to give 576 mg of 35 as a 10:1 mixture of alkene isomers (75% 
yield, average of 2 reactions).  Rf = 0.60 with 2:3 EtOAc:hexanes, colorless oil.  Major 
isomer:  1H-NMR (300 MHz, CDCl3) δ = 7.30-7.15 (m, 3 H), 7.08-6.98 (m, 1 H), 6.30 (d, 
J = 11.5 Hz, 1H), 5.72 (ddd, J = 14.7, 11.5, 7.3 Hz, 1 H), 4.03 (t, J = 6.6 Hz, 2 H), 2.27 
(s, 3 H), 2.21 (ddd, J = 14.7, 7.4, 1.7 Hz, 2 H), 2.06 (s, 3 H), 1.68-1.40 (m, 4 H). 13C-
NMR (75 MHz, CDCl3) δ = 171.4, 169.4, 148.6, 134.4, 130.6, 130.5, 128.2, 125.9, 123.9, 
122.4, 64.5, 28.4, 28.3, 26.2, 21.2, 21.1.  IR: 1762, 1733, 1483, 1448, 1367, 1237, 1197, 
60 
 
1170, 1037, 1010, 912, 760 cm-1.  HRMS C12H16O2 (M+Na)+ calcd. 299.1254, obsvd. 
299.1257. 
Preparation of 36 
 To a 50 mL round bottom flask equipped with stir bar were added 300 mg of 35 
(1.09 mmol, 1 equiv.), 300 mg of K2CO3 (2.18 mmol, 2.00 equiv.) and 5 mL of MeOH.  
The reaction mixture was allowed to stir for 10 h.  Upon completion by TLC analysis, the 
reaction mixture was diluted with 20 mL of CH2Cl2 and washed with 20 mL of 1 M HCl, 
20 mL of water, and 20 mL of brine, dried over Na2SO4, filtered, and the solvent was 
removed in vacuo.  The crude mixture was purified by flash silica-gel column 
chromatography with 2:3 EtOAc:hexanes as eluent to give 188 mg of 36 as a 10:1 
mixture of alkene isomers (83% yield, average of two reactions).  Rf = 0.45 with 1:1 
EtOAc:hexanes, pale yellow oil, major isomer:  1H-NMR (300 MHz, CDCl3) δ = 7.18-
7.08 (m, 2 H), 6.93-6.84 (m, 2 H), 6.41 (d, J = 11.3 Hz, 1H), 5.86 (dddd, J = 11.3, 7.3, 
7.3, 1.1 Hz, 1 H), 5.71 (bs, 1 H), 3.59 (t, J = 6.3 Hz, 2 H), 2.15 (ddd, J = 14.6, 7.3, 1.6 
Hz, 2 H), 1.85 (bs, 1 H), 1.64-1.36 (m, 4 H).  13C-NMR (75 MHz, CDCl3) δ = 153.0, 
136.1, 129.9, 128.7, 124.1, 123.8, 120.3, 115.4, 62.8, 32.2, 28.4, 25.7.  IR: 3303, 2934, 
2859, 1604, 1451, 1228, 1037, 753 cm-1.  HRMS C12H16O2 (M+Na)+ calcd. 215.1043, 
obsvd. 215.1058. 
Preparation of 38 
 To an oven-dried 100 mL round bottom flask were added 2.90 g of 32 (11.1 
mmol, 1 equiv.), 10 mL of THF, and 10 mL of Et3N.  The solution was degassed by 2 
cycles of freeze-pump-thaw.  To a second dried round bottom flask was added 1.24 g of 
37 (12.4 mmol, 1.12 equiv.), 10 mL of THF, and 10 mL of Et3N.  The solution was 
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degassed by 2 cycles of freeze-pump-thaw.  To an oven-dried round bottom flask 
equipped with stir bar was added 233 mg of Pd(PPh3)2Cl2 (0.332 mmol, 0.0300 equiv.) 
and 127 mg of CuI (0.664 mmol, 0.0600 equiv.).  Solutions of 32 and 37 were 
sequentially transferred via cannula into the flask containing the catalysts.  The reaction 
mixture was stirred at rt for 1 h.  The reaction mixture was diluted with 50 mL of CH2Cl2 
and washed with 100 mL (2 x 50 mL) of 1 M HCl, 50 mL of saturated NH4Cl, and 50 mL 
of brine.  The organic phase was dried over Na2SO4, filtered, and the solvent was 
removed in vacuo.  The crude mixture was purified by flash silica-gel column 
chromatography with 1:2 EtOAc:hexanes to 1:1 EtOAc:hexanes as eluent to give 1.85 g 
of 72 (71.3% yield, average of two reactions).  Rf = 0.20 with 1:1 EtOAc:hexanes, 
colorless oil. 1H-NMR (300 MHz, CDCl3) δ = 7.49 (dd, J = 7.6, 1.7 Hz, 1 H), 7.36 (ddd, 
J = 7.6, 7.6, 1.7 Hz, 1 H), 7.20 (ddd, J = 7.6, 7.6, 1.2 Hz, 1 H), 7.09 (dd, J = 8.1, 1.2 Hz, 
1 H), 4.43 (s, 2 H), 3.78 (bdd, J = 9.1, 5.2 Hz, 2 H), 3.70 (m, 2 H), 2.34 (s, 3 H), 2.07 (bs, 
1 H).  13C-NMR (75 MHz, CDCl3) δ = 169.2, 151.8, 133.4, 130.0, 126.1, 122.5, 116.8, 
90.0, 81.7, 71.3, 62.0, 59.3, 21.1. IR: 3426, 2935, 1760, 1486, 1446, 1368, 1180, 1102, 
1010, 908, 756, 733 cm-1.  HRMS C13H14O4 (M+Na)+ calcd. 257.0784, obsvd. 257.0789. 
Preparation of 39   
 To an oven-dried 50 mL round bottom flask were added 300 mg of 38 (1.28 
mmol, 1 equiv.) and 5 mL THF.  The mixture is cooled to 0 °C in an ice bath.  In a 
separate oven-dried round bottom flask 1.6 mL of Red-Al solution (sodium bis(2-
methoxyethoxy)aluminum hydride, 65% by weight in toluene, 5.3 mmol, 4.0 equiv.) was 
diluted with 5 mL of THF.  The solution of Red-Al was transferred dropwise via cannula 
to the reaction mixture.  The reaction mixture was stirred at 0 °C for 1 h, and then 
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warmed to rt.  To this was slowly added 20 mL of 0.5 M HCl (gas evolution observed) 
followed by 20 mL of CH2Cl2.  The phases were separated, and the aqueous phase was 
extracted with 80 mL of CH2Cl2 (4 x 20 mL).  The combined organic phase was washed 
with brine, dried over Na2SO4, filtered, and the solvent was removed in vacuo.  The crude 
mixture was purified by flash silica-gel column chromatography with 2% MeOH/CH2Cl2 
as eluent to give 201 mg of 39 (1:1 mixture of alkene isomers) (81% yield, average of 
two reactions).  Rf = 0.40 with 10% MeOH/CH2Cl2, colorless oil. 1H-NMR (300 MHz, 
CDCl3) δ = 7.37 (dd, J = 7.6, 1.7 Hz, 1 H), 7.19 (dddd, J = 7.7, 7.4, 1.6, 0.7 Hz, 1 H), 
7.13 (ddd, J = 8.0, 7.4, 1.7 Hz, 1 H), 7.05 (ddd, J = 8.0, 1.9, 0.7 Hz, 1 H), 6.93-6.85 (m, 4 
H), 6.78 (dd, J = 8.0, 1.0 Hz, 1 H), 6.65 (d, J = 11.4 Hz, 1 H), 6.30 (dt, J = 16.1, 6.0 Hz, 1 
H), 6.07 (dt, J = 11.4, 7.1 Hz, 1 H), 5.99 (bs, 1 H), 5.61 (bs, 1 H), 4.22 (dd, J = 6.0, 1.4 
Hz, 2 H), 4.07 (dd, J = 7.1, 1.1 Hz, 2 H), 3.82-3.71 (m, 4 H), 3.64 (ddd, J = 4.3, 4.3, 1.5 
Hz, 2 H), 3.57 (ddd,  J = 3.4, 2.1, 1.5 Hz, 2 H), 2.38-2.26 (m, 2 H).  13C-NMR (75 MHz, 
CDCl3) δ = 153.4, 153.1, 130.2, 130.0, 129.4, 129.0, 128.7, 127.8, 127.7, 127.1, 124.0, 
123.0, 120.9, 120.6, 116.2, 116.2, 72.2, 72.1, 71.5, 67.7, 62.1, 61.9.  IR: 3301, 2932, 
2867, 1656, 1603, 1455, 1357, 1251, 1093, 1054, 976, 753 cm-1. HRMS C11H14O3 
(M+Na)+ calcd. 217.0835, obsvd. 217.0845. 
Optimization of Reaction Conditions 
General Procedure for Optimization 
 For optimization, four reactions were run simultaneously in separate 5/10 mL 
side-arm flasks attached to a four-neck cow fitted with a three way adaptor with a balloon 
of O2 attached.  A standard solution was prepared by the addition of 412.6 mg of the 
substrate 30 and 63.3 mg of the internal standard 2-methoxynaphthalene to a 2 mL 
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volumetric flask, followed by the addition of MeOH.  The flask was briefly sonicated to 
dissolve 30 and stirred to give a solution with [30] = 1.00 M and [2-methoxynaphthalene] 
= 0.20 M. 
 Each optimization reaction was performed as described in the following example:  
To a 5 mL side-arm round bottom flask equipped with a stir bar was added 2.6 mg 
Pd(MeCN)2Cl2 (0.010 mmol, 0.10 equiv.), 2.7 mg of CuCl2 (0.020 mmol, 0.20 equiv.), 
7.7 mg (S)-iPr-quinox (0.032 mmol, 0.32 eqiuv), 4.0 mg of KHCO3 (0.040 mmol, 0.40 
equiv.), and 900 µL of MeOH, and the flask was attached to a four-neck cow (Note: for 
reactions using co-solvents, 800 µL of solvent and 100 µL MeOH were added).  A three-
way joint fitted with a balloon of O2 was attached, and the apparatus was evacuated 
(using house vacuum) and refilled with oxygen three times.  The mixture was stirred 
vigorously for 20 min at rt.  A 100 µL portion of the standard solution of 30 (0.100 
mmol, 1 equiv.) and 2-methoxy naphthalene (0.020 mmol, 0.20 equiv.) was added 
dropwise to the reaction mixture.  Aliquots (ca. 50 µL) of the reaction were taken 
periodically via syringe.  Reaction samples were passed through a short silica plug 
eluting with 2 mL of EtOAc and analyzed by GC and referenced against a time zero 
sample containing the standard solution of 30 and 2-methoxynaphthalene diluted in 
EtOAc.  GC yields were calculated based on the ratio of product to internal standard 
corrected for the response factor.  Enantiomeric and diastereomeric ratios were 
determined using GC with a column equipped with a chiral stationary phase (see Table 
2.8 for separation conditions).   
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 For optimization of the reaction conditions for H2O, NaN3 and EG, the same 
procedure as the general procedure was followed, except reactions were run at 0.2 mmol 
scale and products were isolated to determined isolated yield and stereoselectivity.   
Preparation of 41  
 To a 100 mL Schlenk flask equipped with a stir bar were added 5.2 mg 
Pd(MeCN)2Cl2 (0.020 mmol, 0.040 equiv.), 4.0 mg of CuCl (0.040 mmol, 0.080 equiv.), 
16.8 mg of (S)-iPr-quinox (0.700 mmol, 0.140 equiv.), 20.0 mg of KHCO3 (0.200 mmol, 
0.400 equiv.), 1 mL of MeOH (25 mmol, 50 equiv.), 2 mL of THF, and 2 mL toluene.  A 
three-way joint fitted with a balloon of O2 was attached and flask was evacuated and 
refilled with O2 three times.  The mixture was stirred for 20 min at rt under an 
atmosphere of O2.  To the reaction mixture, 103 mg of 30 (0.500 mmol, 1 equiv.) was 
added.  The reaction mixture was stirred for 3 h and diluted with 10 mL of EtOAc.  The 
reaction mixture was then washed with 10 mL 1 M NH4Cl, 10 mL brine, dried over 
Na2SO4, filtered, and concentrated in vacuo.  The crude mixture was purified by flash 
silica-gel column chromatography with 2% to 10% EtOAc/hexanes as eluent to give 85.7 
mg of product (72% yield, average of two reactions).  Diastereomeric ratio:  10:1. Rf = 
0.70 with 33% EtOAc/hexanes, white solid.  mp = 81-84 °C.  [α]20D = –31.5 (c = 3.53, 
CHCl3).  Major diastereomer:  1H-NMR (400 MHz, CDCl3) δ = 8.12 (s, 1 H), 7.20 (ddd, 
J = 8.9, 7.2, 1.6, 1 H), 7.09 (dd, J = 7.6, 1.8 Hz, 1 H), 6.91-6.82 (m, 2 H), 4.42-4.32 (m, 2 
H), 3.36 (s, 3 H), 1.83 (ddd, J = 14.4 Hz, J = 7.0 Hz, J = 1.4 Hz, 2 H), 1.72-1.49 (m, 2 H), 
1.24 (s, 3 H), 1.22 (s, 3 H).  13C-NMR (100 MHz, CDCl3) δ = 155.8, 129.5, 129.3, 123.5, 
119.9, 117.7, 85.5, 82.8, 81.1, 57.9, 38.3, 28.3, 28.2, 27.9, 27.7. IR: 3285, 2869, 2930, 
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1487, 1456, 1367, 1236, 1102, 1056, 754 cm-1.  HRMS C14H20O3 (M+Na)+ calcd. 
259.1310, obsvd. 259.1308.  
Preparation of 42  
 To a 100 mL side-arm round bottom flask equipped with a stir bar were added 5.2 
mg Pd(MeCN)2Cl2 (0.020 mmol, 0.040 equiv.), 4.0 mg of CuCl (0.040 mmol, 0.080 
equiv.), 16.8 mg of (S)-iPr-quinox (0.700 mmol, 0.140 equiv.), 20 mg of KHCO3 (0.20 
mmol, 0.40 equiv.) and 2.6 mL of toluene. A three-way joint fitted with a balloon of O2 
was attached and flask was evacuated and refilled three times with O2.  The mixture was 
stirred for 20 min at rt.  To the reaction mixture, a 2.3 mL of n-butanol (25 mmol, 50 
equiv.) and 103 mg of 30 (0.500 mmol, 1.00 equiv.) were added.  The reaction mixture 
was stirred for 12 h and diluted with 10 mL of EtOAc.  The reaction mixture was then 
washed with 1 M NH4Cl (10 mL) followed by brine (10 mL).  The organic layer was 
dried over Na2SO4 and concentrated in vacuo.  The crude mixture was purified with flash 
silica-gel column chromatography with 10% EtOAc/hexanes as eluent to give 87.5 mg of 
product (63% yield, average of two reactions).  Diastereomeric ratio: 5:1, major 
diastereomer: Rf = 0.75 with 33% EtOAc/hexanes, colorless liquid.  [α]20D = –8.2 (c = 
1.0, CHCl3), 1H-NMR (500 MHz CDCl3) δ = 8.31 (s, 1 H), 7.22 (dd, J = 1.6, 8.7 Hz, 1 
H), 7.09 (dd, J = 1.6, 7.5 Hz, 1 H), 6.91-6.83 (m, 2 H), 4.43 (d, J = 4.1 Hz, 1 H), 4.3 
(ddd, J = 7.1, 4.2 Hz, 1 H), 3.47 (ddd, J = 9.3, 6.7, 1.0 Hz, 1 H), 3.37 (ddd, J = 9.3, 6.5, 
1.0 Hz, 1 H), 2.02-1.82 (m, 2 H), 1.70-1.29 (m, 6 H), 1.24 (s, 3 H), 1,21 (s, 3 H), 0.90 (t, 
J = 7.14 Hz, 3 H).  13C-NMR (100 MHz CDCl3) δ = 155.9, 129.2, 124.4, 119.7, 117.7, 
83.3, 82.8, 81.7, 70.0, 38.4, 31.9, 28.1, 28.0, 27.9, 19.5, 14.0.  IR:  3289, 2962, 2931, 
66 
 
1455, 1367, 1237, 1095 cm-1.  HRMS C17H26O3 (M+Na)+ calcd. 301.1780, obsvd. 
301.1777. 
Preparation of 43 
 The procedure described for 42 was followed except 2.9 mL toluene and 2.1 mL 
of 3-butene-1-ol (25 mmol, 50 equiv.) were used.  78.6 mg (57% yield, average of two 
reactions.  Diastereomeric ratio: 4:1, major diastereomer: Rf = 0.75 with 33% 
EtOAc/hexanes, colorless liquid, [α]20D = +11.0 (c = 0.1, CHCl3), 1H-NMR (500 MHz 
CDCl3) δ = 8.28 (s, 1 H), 7.20 (td, J = 1.8, 7.7 Hz, 1 H), 7.04 (dd, J = 1.5, 7.7 Hz, 1 H), 
6.90-6.83 (m, 2 H), 5.82 (ddd, J = 6.5, 3.3, 7.0 Hz, 1 H), 5.02-4.98 (m, 2 H), 4.44 (d, J 
=3.9, 1 H), 4.38 (ddd, J = 6.9, 4.1 Hz, 1 H), 3.52 (ddd, J = 9.2, 6.8 Hz, 1 H), 3.42 (ddd, J 
= 9.3, 6.6 Hz, 1 H), 2.38 (dd, J = 6.2, 8.2 Hz, 1 H), 2.09-1.82 (m, 2 H), 1.71-1.4 (m, 2 H), 
1.23 (s, 3 H), 1.21 (s, 3 H).  13C-NMR (125 MHz, CDCl3) δ = 155.8, 135.2, 129.3, 129.3, 
124.3, 119.7, 117.7, 116.8, 83.3, 82.9, 81.7, 69.3, 38.3, 34.4, 28.1, 28.0, 27.9.  IR:  3284, 
2971, 1733, 1652, 1558, 1487, 1054 cm-1.  HRMS C17H24O3 (M+Na)+ calcd. 299.1623, 
obsvd. 299.1615. 
Preparation of 44 
 The procedure described for 42 was followed except 1.5 mL of THF, 1.5 mL 
toluene, and 2.0 mL of 2-methoxyethanol (25 mmol, 50 equiv.) were used.  74.2 mg 
(53% yield, average of two reactions.  Diastereomeric ratio: 9:1, major diastereomer: Rf = 
0.35 with 33% EtOAc/hexanes, colorless oil, [α]20D = –35.0 (c = 0.15, CHCl3), 1H-NMR 
(400 MHz CDCl3) δ = 8.20 (s, 1 H), 7.20 (dd, J = 1.8, 6.9 Hz, 1 H), 7.11 (dd, J = 7.7 Hz, 
1 H), 6.91-6.85 (m, 2 H), 4.54 (d, J = 4.4 Hz, 1 H), 4,43 (ddd, J = 7.0, 4.3, 4.3 Hz, 1 H), 
3.65-3.51 (m, 4 H), 3.33 (s, 3 H), 2.00-1.83 (m, 2 H), 1.74-1.61 (m, 1 H), 1.56-1.49 (m, 1 
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H), 1.24 (s, 3 H), 1.20 (s, 3 H).  13C-NMR (100 MHz, CDCl3) δ = 155.9, 129.5, 129.4, 
124.3, 119.9, 118.0, 83.3, 82.9, 81.7, 72.1, 69.1, 59.2, 38.4, 28.1, 28.0, 28.0.  IR:  3266, 
2968, 2872, 1486, 1097, 753 cm-1.  HRMS C16H24O4 (M+Na)+ calcd. 303.1572, obsvd. 
303.1566. 
Preparation of 45 
 The procedure described for 42 was followed except 3.3 mL toluene and 1.7 mL 
of 2-chloroethanol (25 mmol, 50 equiv.) were used.  86.6 mg (61% yield, average of two 
reactions.  Diastereomeric ratio: 5:1, major diastereomer: [α]20D = –38.0 (c = 0.6, CHCl3) 
Rf = 0.50 with 20% EtOAc/hexanes, colorless oil, 1H-NMR (400 MHz CDCl3) δ = 8.29 
(s, 1 H), 7.22 (ddd, J = 7.5, 0.9 Hz, 1 H), 7.13-7.09 (m, 1 H), 6.93-6.85 (m, 2 H), 4.50 (d, 
J = 3.4 Hz, 1 H), 4.43 (td, J = 7.0, 3.5 Hz, 1 H), 3.76-3.55 (m, 4 H), 3.33 (s, 3 H), 2.01 
(m, 2 H), 1.74-1.58 (m, 2 H), 1.26 (s, 3 H), 1.24 (s, 3 H).  13C-NMR (100 MHz, CDCl3) δ 
= 155.7, 129.8, 129.4, 124.2, 120.0, 118.1, 83.4, 81.9, 69.7, 43.3, 38.3, 28.1, 27.9, 27.8.  
IR:  3265, 2966, 1490, 1461, 1364, 1190, 1104, 1049, 754 cm-1.  HRMS C15H21ClO3 
(M+Na)+ calcd. 307.1077, obsvd. 307.1079. 
Preparation of 46 
 The procedure described for 42 was followed except 0.7 mL of THF and 0.7 mL 
toluene (1:1) and 1.6 mL of benzylalcohol (15 mmol, 50 equiv.) were used.  47.7 mg 
(51% yield, average of two reactions.  Diastereomeric ratio: 6:1, major diastereomer: Rf = 
0.50 with 20% EtOAc/hexanes, colorless liquid, [α]20D = –49.5 (c = 0.39, CHCl3),1H-
NMR (300 MHz CDCl3) δ = 8.33 (s, 1 H), 7.36-7.29 (m, 5 H), 7.22 (td, J = 7.7, 1.4 Hz, 1 
H), 7.11 (dd, J = 7.5, 1.5 Hz, 1 H), 6.94 (dd, J = 8.0, 1.0 Hz, 1 H), 6.88 (td, J = 7.4, 1.1 
Hz, 1 H), 4.64 (d, J = 12.0 Hz, 1 H), 4.54 (d, J = 3.9 Hz, 1 H), 4.43 (td, J = 7.0, 3.9 Hz, 1 
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H), 4.34 (d, J = 12.0 Hz, 1 H), 1.99-1.88 (m, 2 H), 1.66 (dt, J = 12.0, 7.3 Hz, 1 H), 1.59-
1.51 (m, 1 H), 1.22 (s, 3 H), 1.20 (s, 3 H).  13C-NMR (75 MHz, CDCl3) δ = 155.9, 137.9, 
129.5, 129.4, 128.5, 128.1, 127.9, 124.0, 119.9, 118.0, 83.0, 81.7, 81.6, 71.2, 38.3, 28.0, 
27.9, 27.8.  IR:  3285, 2970, 2870, 1717, 1615, 1506, 1455, 1180, 1097, 1027, 756 cm-1. 
HRMS C20H24O3 (M+Na)+ calcd. 335.1623, obsvd. 335.3925. 
Preparation of 47 
 The procedure described for 42 was followed except 1.9 mL toluene and 1.1 mL 
of 2-(trimethylsilyl)ethanol (7.5 mmol, 25 equiv.) were used.  62.1 mg (64% yield, 
average of two reactions).  Diastereomeric ratio: 5:1, major diastereomer: Rf = 0.85 with 
20% EtOAc/hexanes, colorless liquid, [α]20D = –21 (c = 0.25, CHCl3),1H-NMR (300 MHz 
CDCl3) δ = 8.31 (s, 1 H), 7.18 (td, J = 7.7, 1.1 Hz, 1 H), 7.10 (dd, J = 7.5, 1.5 Hz, 1 H), 
6.89-6.84 (m, 2 H), 4.50 (d, J = 4.5 Hz, 1 H), 4.37 (td, J = 7.1, 4.6 Hz, 1 H), 3.63-3.57 
(m, 1 H), 3.50-3.45 (m, 1 H), 1.91-1.80 (m, 2 H), 1.63 (dt, J = 12.1, 7.5 Hz, 1 H), 1.46 
(ddd, J = 12.1, 8.2, 6.3 Hz, 1 H), 1.21 (s, 3 H) 1.16 (s, 3 H), 1.04 (m, 1 H), 0.92 (m, 1 H), 
-0.02 (s, 9 H).  13C-NMR (75 MHz, CDCl3) δ = 155.9, 129.1, 129.0, 124.3, 119.7, 117.6, 
82.6, 82.2, 81.5, 67.6, 38.3, 28.1, 27.8, 27.7, 18.5, 1.2.  IR: 3304, 2966, 2894, 1586, 
1486, 1384, 1248, 1096, 859, 836, 755 cm-1.  HRMS C18H30O3Si (M+Na)+ calcd. 
345.1862, obsvd. 345.1861. 
Preparation of 48 
 The procedure described for 42 was followed except 3.0 mL toluene and 2.0 mL 
of (–)-myrtenol (12.5 mmol, 25 equiv.) were used.  97.9 mg (55% yield, average of two 
reactions).  Diastereomeric ratio: 9:1, major diastereomer: [α]20D = –31.3 (c = 0.7, CHCl3) 
Rf = 0.76 with 33% EtOAc/hexanes, colorless liquid.  1H-NMR (400 MHz CDCl3) δ = 
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8.28 (s, 1 H), 7.20-7.16 (m, 1 H), 7.08 (dd, J = 7.5, 1.4 Hz, 1 H), 6.89-6.83 (m, 2 H), 5.46 
(dt, J = 2.9, 1.4 Hz, 1 H) 4.51 (d, J = 3.9 Hz, 1 H), 4.38 (td, J = 5.4, 3.2 Hz, 1 H), 3.90 
(dd, J = 12.3, 1.7 Hz, 1H), 3.75-3.72 (m, 1 H), 2.33 (dt, J = 8.6, 5.6 Hz, 1 H), 2.24 (m, 2 
H), 2.12 (t, J = 5.6 Hz, 1 H), 2.01 (m, 1 H), 1.94-1.88 (m, 2 H), 1.66-1.61 (m, 1 H) 1.54-
1.50 (m, 1 H), 1.27 (s, 3 H), 1.21 (s, 3 H), 1.19 (s, 3 H) 1.07 (d, J = 8.6 Hz, 1 H), 0.86 (s, 
3 H).  13C-NMR (100 MHz, CDCl3) δ = 155.7, 144.9, 129.1, 129.2, 129.0, 124.1, 120.1, 
119.5, 117.5, 82.6, 81.6, 81.5, 81.5, 76.7, 72.4, 43.4, 41.0, 40.8, 38.1, 37.9, 31.5, 31.3, 
31.2, 28.0, 27.7, 27.6, 26.2, 21.1, 20.9.  IR:  3303, 2969, 2914, 1615, 1486, 1381, 1282, 
1126, 1035, 887, 753 cm-1.  HRMS C23H32O3 (M+Na)+ calcd. 379.2249, obsvd. 
379.2254. 
Preparation of 49 
 To a 100 mL side-arm round bottom flask equipped with a stir bar were added 8.3 
mg Pd[(S)-iPr-quinox]Cl2 (0.020 mmol, 0.040 equiv.), 15.0 mg of Cu[(S)-iPr-quinox]Cl2 
(0.0400 mmol, 0.0800 equiv.), 1.2 mg of (S)-iPr-quinox (0.0050 mmol, 0.010 equiv.), 4.4 
mg of NaHCO3 (0.050 mmol, 0.10 equiv.) and 4.5 mL tAmylOH.  A three-way joint 
fitted with a balloon of O2 was attached and the flask was evacuated and refilled three 
times with O2.  The mixture was stirred for 20 min at rt.  To the reaction mixture, a 450 
µL of water (25 mmol, 50 equiv.) and 103 mg of 30 (0.500 mmol, 1 equiv.) were added.  
The reaction mixture was stirred for 24 h and diluted with 10 mL of EtOAc.  The reaction 
mixture was then washed with 1 M NH4Cl (10 mL) followed by brine (10 mL).  The 
organic layer was dried over Na2SO4 and concentrated in vacuo.  The crude mixture was 
purified with flash silica-gel column chromatography with EtOAc/hexanes (4% to 10%) 
as eluent to give 69.9 mg of product (63% yield, average of two reactions).  
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Diastereomeric ratio: 5:1, major diastereomer:  Rf = 0.60 with 33% EtOAc/hexanes, white 
solid.  [α]20D = –17.0 (c = 0.1, CHCl3).  1H-NMR (300 MHz, CDCl3) δ = 8.40 (s, 1 H), 
7.20 (ddd, J = 8.1, 7.4, 1.7 Hz, 1 H), 7.04 (dd, J = 7.6, 1.7 Hz, 1 H), 6.89 (dd, J = 8.1, 1.1 
Hz, 1 H), 6.84 (td, J = 7.4, 1.2 Hz, 1 H), 4.58 (d, J = 6.8 Hz, 1 H), 4.27 (apparent q, J = 
6.8 Hz, 1 H), 3.31 (bs, 1 H), 1.95-1.83 (m, 2 H), 1.81-1.75 (m, 2 H), 1.33 (s, 3 H), 1.27 (s, 
3 H).  13C-NMR (75 MHz, CDCl3) δ = 156.1, 129.7, 128.8, 124.4, 119.9, 118.0, 83.3, 
81.1, 78.9, 38.5, 29.1, 28.3, 28.2.  IR:  3297, 2968, 1237, 752 cm-1.  HRMS C13H18O3 
(M+Na)+ calcd. 245.1154, obsvd. 245.1146. 
Preaparation of 50 
 The procedure described for 49 was followed except 3.6 mL tAmylOH and 1.4 
mL of ethylene glycol (25 mmol, 50 equiv.) were used.  78.5 mg (59% yield, average of 
two reactions).  Diastereomeric ratio: 10:1, major diastereomer: Rf = 0.30 with 66% 
EtOAc/hexanes, colorless liquid.  [α]20D = –100 (c = 0.1, CHCl3).  1H-NMR (400 MHz, 
CDCl3) δ = 8.27 (s, 1 H), 7.21 (td, J = 7.7, 1.2 Hz, 1 H), 7.07 (dd, J = 7.5, 1.6 Hz, 1 H), 
6.91 (dd, J = 8.1, 0.9 Hz, 1 H), 6.87 (td, J = 7.4, 1.1 Hz, 1 H), 4.44-4.38 (m, 2 H), 3.81-
3.64 (m, 3 H), 3.58 (ddd, J = 10.7, 5.9, 3.0 Hz, 1 H), 2.89 (bs, 1 H), 1.93-1.87 (m, 2 H), 
1.75-1.65 (m, 2 H), 1.29 (s, 3 H), 1.27 (s, 3 H).  13C-NMR (100 MHz, CDCl3) δ = 155.9, 
129.8, 129.3, 124.1, 118.1, 85.1, 83.1, 81.7, 71.5, 61.9, 38.5, 28.5, 28.3, 28.0.  IR: 3263, 
2967, 2869, 1454, 1041, 754 cm-1.  HRMS C15H22O4 (M+Na)+ calcd. 289.1416, obsvd. 
289.1417. 
Preparation of 51 
 To a 100 mL side-arm round bottom flask equipped with a stir bar was added 8.3 
mg Pd[(S)-iPr-quinox]Cl2 (0.020 mmol, 0.040 equiv.), 15.0 mg of Cu[(S)-iPr-quinox]Cl2 
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(0.0400 mmol, 0.0800 equiv.), 1.2 mg of (S)-iPr-quinox (0.0050 mmol, 0.010 equiv.), 4.4 
mg of NaHCO3 (0.050 mmol, 0.10 equiv.) and 5.0 mL tAmylOH.  A three-way joint 
fitted with a balloon of O2 was attached and flask was emptied and refilled three times 
with O2.  The mixture was stirred for 20 min at rt.  To the reaction mixture, 65 mg of 
NaN3 (1.0 mmol, 2.0 equiv.) and 103 mg of 30 (0.200 mmol, 1 equiv.) were added.  The 
reaction mixture was stirred for 48 h at 30 °C and diluted with 10 mL of EtOAc.  The 
reaction mixture was then washed with 1.0 M NH4Cl (10 mL) followed by brine (10 mL).  
The organic layer was dried over Na2SO4 and concentrated in vacuo.  The product was 
purified with flash silica-gel column chromatography with 2% to 10% EtOAc/hexanes as 
eluent to give 62.9 mg of product (50% yield, average of two reactions).  [α]20D = +22.1 
(c = 0.25, CHCl3).  1H-NMR for major diastereomer (400 MHz CDCl3) δ = 8.21 (s, 1 H), 
7.28-7.23 (m, 1H), 7.18-7.15 (dd, J = 1.5, 7.5 Hz, 1 H), 7.01-6.88 (m, 2 H), 4.70-4.65 (d, 
J = 3.2 Hz, 1 H), 4.35-4.25 (td, J = 3.2, 6.7 Hz, 1 H), 1.9-1.8 (m, 2 H), 1.78-1.62 (m, 2 
H), 1.23 (s, 6 H).  13C-NMR (125 MHz, CDCl3) δ = 155.3, 130.3, 129.9, 123.3, 120.4, 
118.8, 84.3, 81.5, 66.9, 38.1, 28.4, 28.0, 27.8.  IR:  3264, 2971, 2100, 1456, 1251, 754 
cm-1.  HRMS C13H17N3O2 (M+Na)+ calcd. 270.1216, obsvd. 270.1214. 
 1H-NMR for minor diastereomer (400 MHz CDCl3) δ = 8.34 (s, 1 H), 7.28-7.23 
(m, 1 H), 7.18-7.15 (dd, J = 1.5, 7.5 Hz, 1 H), 7.01-6.88 (m, 2 H), 4.78-4.75 (d, J = 3.2, 1 
H), 4.44-4.38 (td, J = 3.2, 6.7 Hz, 1 H), 2.1-1.9 (m, 2 H), 1.78-1.62 (m, 2 H), 1.31 (s, 3 
H), 1.27 (s, 3 H).  13C-NMR (125 MHz, CDCl3) δ = 155.4, 130.6, 130.5, 120.2, 118.8, 





Preparation of 53 (DA) 
To a 250 mL side-arm round bottom flask equipped with a stir bar were added 5.2 
mg Pd(MeCN)2Cl2 (0.020 mmol, 0.040 equiv.), 4.0 mg of CuCl (0.040 mmol, 0.080 
equiv.), 16.8 mg of (S)-iPr-Quinox (0.070 mmol, 0.140 equiv.), 20.0 mg of KHCO3 
(0.200 mmol, 0.40 equiv.), and 2.2 mL toluene.  A three-way joint fitted with a balloon of 
O2 was attached, and flask was evacuated and refilled with O2 three times.  The mixture 
was stirred for 20 minutes at room temperature under an atmosphere of O2.  To the 
reaction mixture, 103.1 mg of 30 (0.5000 mmol, 1 equiv.) as a solution in 2.8 mL of ethyl 
propenyl ether (25 mmol, 50 equiv., Z:E = 10:1) was added (Note:  ethyl propenyl ether 
was purchased as a 3:1 mixture of isomers and enriched through multiple fractional 
distillations).  The reaction flask was evacuated and refilled with O2 twice more.  The 
reaction mixture was stirred for 24 h and passed through a plug of silica with 50 mL 
EtOAc and concentrated in vacuo, and then purified with flash alumina column 
chromatography with hexanes followed by 1% EtOAc/hexanes to 2% EtOAc/hexanes as 
eluent to give 104.1 mg of the product (72% yield).  Diastereomeric ratio:  33:5:1, major 
diastereomer:  Rf = 0.60 w/ 1:4 EtOAc:hexanes, clear oil.  [α]20D = –30.8° (c = 1.73, 
CHCl3), 1H-NMR (300 MHz, CDCl3) δ 7.31-7.28 (m, 1 H), 7.13 (ddd, J = 7.7 Hz, J = 7.7 
Hz, J = 1.7 Hz, 1 H), 6.87-6.81 (m, 2 H), 5.04 (d, J = 2.6 Hz, 1 H), 4.34 (ddd, J = 6.8 Hz, 
J = 6.8 Hz, J = 4.6 Hz, 1 H), 3.98 (dq, J = 9.5 Hz, J = 7.1 Hz, 1 H), 3.60 (dq, J = 9.5 Hz, 
J = 7.1 Hz, 1 H), 3.09 (dd, J = 5.0 Hz, J = 5.0 Hz, 1 H), 2.42 (qdd, J = 7.1 Hz, J = 5.5 Hz, 
J = 2.5 Hz, 1 H), 2.18-2.07 (m, 1 H), 1.71-1.50 (m, 3 H), 1.31 (s, 3 H), 1.23 (t, J = 7.1 
Hz, 3 H), 1.20 (s, 3 H), 1.07 (d, J = 7.1 Hz, 3 H). 13C-NMR {1H} (75 MHz, CDCl3) δ 
153.2, 129.4, 127.8, 123.1, 120.3, 116.6, 101.6, 79.7, 77.8, 64.6, 43.4, 39.0, 33.8, 30.7, 
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29.0, 27.3, 15.3, 10.6, IR 2969, 2879, 1581, 1487, 1454, 1376, 1365, 1222, 1149, 1093, 
1040, 978, 932, 752 cm-1.  HRMS C18H26O3 (M+Na)+ calcd. 313.1780, obsvd. 313.1775. 
Relative stereochemistry assigned by a combination of coupling constants, as compared 
to reported Diels Alder adducts with ethyl propenyl ether and a related quinone methide, 
and X-ray crystal structure analysis of the lactone derivative.  
Preparation of 54 
To a 250 mL side-arm round bottom flask equipped with a stir bar were added 5.2 
mg Pd(MeCN)2Cl2 (0.020 mmol, 0.040 equiv.), 4.0 mg of CuCl (0.040 mmol, 0.080 
equiv.), 16.8 mg of (S)-iPr-Quinox (0.070 mmol, 0.140 equiv.), 20.0 mg of KHCO3 
(0.200 mmol, 0.40 equiv.), and 2.2 mL toluene.  A three-way joint fitted with a balloon of 
O2 was attached, and flask was evacuated and refilled with O2 three times.  The mixture 
was stirred for 20 min at room temperature under an atmosphere of O2.  To the reaction 
mixture, 89.1 mg of 31 (0.5000 mmol, 1 equiv.) as a solution in 2.8 mL of ethyl propenyl 
ether (25 mmol, 50 equiv., Z:E = 10:1) was added (Note:  ethyl propenyl ether was 
purchased as a 3:1 mixture of isomers and enriched through multiple fractional 
distillations).  The reaction flask was evacuated and refilled with O2 twice more.  The 
reaction mixture was stirred for 24 h and passed through a plug of silica with 50 mL 
EtOAc and concentrated in vacuo, and then purified with flash alumina column 
chromatography with 1% EtOAc/hexanes to 2% EtOAc/hexanes as eluent to give 88.2 
mg of the product (67% yield).  Diastereomeric ratio:  33:8:1, major diastereomer:  Rf = 
0.70 w/ 1:3 EtOAc:hexanes, clear oil.  [α]20D = –36.1° (c = 0.58, CHCl3), 1H-NMR (300 
MHz, CDCl3) δ 7.26-7.22 (m, 1 H), 7.13 (ddd, J = 7.7 Hz, J = 7.7 Hz, J = 1.7 Hz, 1 H), 
6.88-6.81 (m, 2 H), 5.07 (d, J = 2.5 Hz, 1 H), 4.22 (ddd, J = 7.1 Hz, J = 7.1 Hz, J = 5.5 
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Hz, 1 H), 3.98 (dq, J = 9.6 Hz, J = 7.1 Hz, 1 H), 3.90 (ddd, J = 7.3 Hz, J = 5.3 Hz, J = 5.3 
Hz, 1 H), 3.65 (dd, J = 7.3 Hz, J = 7.1 Hz, 1 H), 3.61 (dq, J = 9.6 Hz, J = 7.1 Hz, 1 H), 
3.15 (dd, J = 5.3 Hz, J = 5.3 Hz, 1 H), 2.43 (qdd, J = 7.0 Hz, J = 5.5 Hz, J = 2.5 Hz, 1 H), 
2.13-2.03 (m, 1 H), 1.94-1.71 (m, 2 H), 1.65-1.53 (m, 1 H), 1.24 (t, J = 7.1 Hz, 3 H), 1.06 
(d, J = 7.0 Hz, 3 H). 13C-NMR {1H} (75 MHz, CDCl3) δ 153.3, 129.1, 127.9, 122.7, 
120.5, 116.7, 101.7, 79.1, 67.4, 64.7, 43.4, 33.7, 30.4, 26.7, 15.3, 10.1, IR 2977, 2875, 
1581, 1487, 1454, 1375, 1352, 1237, 1222, 1159, 1064, 1041, 981, 931, 754 cm-1.  
HRMS C16H22O3 (M+Na)+ calcd. 285.1467, obsvd. 285.1472. 
Preparation of 55 
 The procedure described for 54 was followed except 89.0 mg of 31 (0.500 mmol, 
1 equiv.) was added.  Reaction was stirred for 7 h.  Yield = 68%, average of two 
reactions.  Diastereomeric ratio: 10:1, major diastereomer:  Rf = 0.40 with 33% 
EtOAc/hexanes, white solid.  mp = 64-65 °C.  [α]20D = –62.0 (c = 0.1, CHCl3).  1H-NMR 
(400 MHz, CDCl3) δ = 8.09 (s, 1 H), 7.22 (dd, J = 1.6, 8.3 Hz, 1 H), 7.09 (dd, J = 7.5, 1.9 
Hz, 1 H), 6.94-6.84 (m, 2 H), 4.39-4.20 (m, 2 H), 3.98-3.78 (m, 2 H), 3.39 (s, 3 H), 1.89-
1.65 (m, 4 H).  13C-NMR (100 MHz, CDCl3) δ = 155.9, 129.7, 129.4, 123.0, 119.9, 
117.6, 86.2, 81.5, 69.2, 57.9, 28.2, 26.0.  IR:  3282, 2933, 2874, 1486, 1456, 1149, 1057, 
753 cm-1.  HRMS C12H16O3 (M+Na)+ calcd. 231.0997, obsvd. 231.0990. 
Preparation of 56 
 To a 100 mL side-arm round bottom flask equipped with a stir bar were added 5.2 
mg Pd(MeCN)2Cl2 (0.020 mmol, 0.040 equiv.), 4.0 mg of CuCl (0.040 mmol, 0.080 
equiv.), 16.8 mg of (S)-iPr-quinox (0.0700 mmol, 0.140 equiv.), 20.0 mg of KHCO3 
(0.200 mmol, 0.400 equiv.), 1 mL of MeOH (25 mmol, 50 equiv.), 1 mL of THF, and 2 
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mL toluene.  A three-way joint fitted with a balloon of O2 was attached, and flask was 
evacuated and refilled with O2 three times.  The mixture was stirred for 20 min at rt under 
an atmosphere of O2.  To the reaction mixture, 96.1 mg of 36 (0.500 mmol, 1 equiv.) in a 
solution in 1 mL THF were added.  The reaction mixture was stirred for 24 h and diluted 
with 10 mL of EtOAc.  The reaction mixture was then washed with 1 M NH4Cl (10 mL) 
followed by brine (10 mL).  The organic layer was dried over Na2SO4 and concentrated in 
vacuo.  The crude mixture was purified with flash silica-gel column chromatography with 
2% to 10% EtOAc/hexanes as eluent to give 55.0 mg of product (50% yield, average of 
two reactions).  Diastereomeric ratio: 6:1, major diastereomer:  Rf = 0.66 with 1:1 
EtOAc:hexanes, white solid.  mp = 98-103 °C.  [α]20D = –14.0 (c = 0.28, CHCl3).  1H-
NMR (300 MHz, CDCl3) δ = 7.97 (s, 1 H), 7.22 (ddd, J = 7.7, 7.7, 1.7 Hz, 1 H), 7.03 (dd, 
J = 7.5, 1.7 Hz, 1 H), 6.91-6.83 (m, 2 H), 4.23 (d, J = 5.6 Hz, 1 H), 4.16-4.05 (m, 1 H), 
3.75-3.68 (m, 1 H), 3.49 (ddd, J = 11.5, 11.5, 2.7 Hz, 1 H), 3.38 (s, 3H), 1.85-1.75 (m, 1 
H), 1.65-1.15 (m, 5 H).  13C-NMR (75 MHz, CDCl3) δ = 155.8, 129.9, 129.7, 122.9, 
119.9, 117.6, 87.3, 80.0, 69.1, 57.9, 28.1, 25.9, 23.1.  IR:  3326, 2937, 2855, 1506, 1457, 
1241, 1082, 756 cm-1.  HRMS C13H18O3 (M+Na)+ calcd. 245.1148, obsvd. 245.1152. 
Preparation of 57 
 To a 200 mL side-arm round bottom flask equipped with a stir bar were added 5.2 
mg Pd(MeCN)2Cl2 (0.020 mmol, 0.040 equiv.), 4.0 mg of CuCl (0.040 mmol, 0.080 
equiv.), 16.8 mg of (S)-iPr-quinox (0.0700 mmol, 0.140 equiv.), 42.0 mg of NaHCO3 
(0.500 mmol, 1.00 equiv.), 1.0 mL of MeOH (25 mmol, 50 equiv.), 1 mL of THF, and 2 
mL toluene.  A three-way joint fitted with a balloon of O2 was attached, and flask was 
evacuated and refilled with O2 three times.  The mixture was stirred for 20 min at rt.  To 
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the reaction mixture, 97.1 mg of 37 (0.500 mmol, 1 equiv.) in a solution in 1 mL THF 
were added.  The reaction mixture was stirred for 24 h and diluted with 10 mL of CH2Cl2.  
The reaction mixture was then washed with 1 M NH4Cl (10 mL) followed by brine (10 
mL).  The organic layer was dried over Na2SO4 and concentrated in vacuo.  The crude 
mixture was passed through a plug of alumina with 200 mL of 1:1 EtOAc:hexanes 
followed by 10% MeOH/EtOAc (to separate the product from ligand, which are 
inseparable by silica chromatography).  The portion eluted with 10% MeOH/EtOAc was 
concentrated in vacuo, then purified with flash silica-gel column chromatography with 
1% MeOH/CH2Cl2 as eluent to give 39.5 mg of the product (30% yield, average of two 
reactions).  Diastereomeric ratio:  6:1, major diastereomer:  Rf = 0.60 with 10% 
MeOH/CH2Cl2, clear oil.  [α]20D = –26.3 (c = 1.88, CHCl3).  1H-NMR (300 MHz, CDCl3) 
δ = 7.64 (s, 1 H), 7.23 (dd, J = 8.5, 1.5 Hz, 1 H), 6.98 (dd, J = 7.6, 1.8 Hz, 1 H), 6.93-
6.83 (m, 2 H), 4.27 (d, J = 6.0 Hz, 1 H), 3.97 (ddd, J = 9.3, 6.1, 3.4 Hz, 1 H), 3.90 (bdd, J 
= 9.9, 2.1 Hz, 1 H), 3.77 (ddd, J = 11.2, 11.2, 2.8 Hz, 1 H), 3.69 (bdd, J = 9.9, 2.8 Hz, 1 
H), 3.59 (ddd, J = 11.2, 11.2, 2.8 Hz, 1 H), 3.51-3.41 (m, 2 H), 3.39 (s, 3 H).  13C-NMR 
(75 MHz, CDCl3) δ = 155.8, 130.2, 129.2, 121.5, 120.2, 117.6, 84.3, 68.3, 67.1, 66.4, 
57.9, 29.9.  IR: 3363, 3054, 2859, 1489, 1457, 1265, 1242, 1123, 1083, 731, 702 cm-1.  
HRMS C12H16O4 (M+Na)+ calcd. 247.0941, obsvd. 247.0945. 
Preparation of Catalyst Complexes 
Preparation of Pd[(S)- iPr-Quinox]Cl2 
 To an oven dried 100 mL round bottom flask equipped with stir bar were added 
381 mg of Pd(MeCN)2Cl2 (1.47 mmol, 1.00 equiv.), 300 mg of (S)-iPr-quinox ligand 
(1.47 mmol, 1.00 equiv.) and 80 mL of DCE under a nitrogen atmosphere.  The reaction 
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mixture was heated at reflux for 10 h.  The reaction mixture was then allowed to cool to 
rt and concentrated to ca. 2 mL.  To this mixture, 3 mL of CH2Cl2 was added, and 
precipitation was observed.  The remaining solvent was removed in vacuo and dried 
overnight under vacuum to give the desired complex in quantitative yield (680 mg).  
[α]20D = –57° (c = 0.19, CHCl3), 1H-NMR (400 MHz, CDCl3) δ = 9.59 (d, J = 8.7 Hz, 1 
H), 8.39 (d, J = 8.0 Hz, 1 H), 7.83 (d, J = 8.4 Hz, 1 H), 7.71 (d, J = 8.4 Hz, 1 H), 7.56 (m, 
2 H), 5.07 (t, J = 10.6 Hz, 1 H), 4.76-4.71 (m, 2 H), 2.89-2.74 (m, 1 H), 0.95 (d, J = 6.9 
Hz, 3 H), 0.81 (d, J = 6.6 Hz, 3 H). 13C-NMR (100 MHz, CDCl3) δ = 169.9, 148.7, 145.9, 
141.6, 132.3, 131.3, 129.8, 129.5, 127.9, 120.7, 72.1, 67.7, 29.3, 18.8, 14.5. IR: 2958, 
1651, 1589, 1371, 923, 839 cm-1. 
Preparation of Cu[(S)- iPr-Quinox]Cl2 
To an oven dried 50 mL round bottom flask equipped with stir bar were added 
45.3 mg of CuCl2 (0.340 mmol, 1.00 equiv.), 81 mg of (S)-iPr-quinox ligand (0.34 mmol, 
1.0 equiv.) and 16 mL of MeOH under a nitrogen atmosphere.  The reaction mixture was 
heated at reflux for 10 h.  The reaction mixture was then allowed to cool to rt and 
concentrated to ca. 2 mL.  Approximately 3 mL of CH2Cl2 was added, and precipitation 
was observed.  The remaining solvent was removed in vacuo and dried overnight under 
vacuum to give complex in quantitative yield (126.3 mg).  [α]20D = +229 (c = 0.17, 
CHCl3), IR: 1651, 1590, 1510, 1254, 1165, 758 cm-1, HRMS C16H24O5 (M+Na)+ calcd. 






Preparation of 58 
To an oven-dried 5 mL round bottom flask equipped with a stir bar was added 
40.0 mg of 55 (0.192 mmol, 1.00 equiv.) in 550:550:820 µL (MeCN:CCl4:H2O). To the 
reaction mixture, 4.0 mg of RuCl3 (0.019 mmol, 0.100 equiv.) and 410 mg of NaIO4 
(1.92 mmol, 10.0 equiv.) were added at room temperature. After 30 min, the solution was 
diluted with IPA (500 µL), and the reaction mixture was allowed to stir for another 30 
min. The resultant salts were removed by passing the reaction mixture through a celite® 
plug and an aliquot was concentrated in vacuo. The product S1 was used without further 
purification. 
To an oven dried 5 mL round bottom flask equipped with a stir bar were added 
32.0 mg of S1 (0.20 mmol, 1.00 equiv.) in 1600:400 µL (CH2Cl2:MeOH). To the reaction 
mixture, 200 µL of TMSCHN2 (0.40 mmol, 2.0 equiv.) was added at 0 °C. After 30 min, 
the solvent was evaporated in vacuo and the mixture was purified by column 
chromatography with EtOAc/Hexanes (4% to 10%) as an eluent to give 58 in 45% yield 
with no loss of diastereomeric ratio observed.  
Compound 58  Rf = 0.4 w/ 33% EtOAc/Hexane, colorless liquid, [α]D20 = –14° (c 
= 0.14, CHCl3), 1H-NMR (500 MHz, CDCl3): 4.20 (aprant q, J = 5.25 Hz, 1 H), 3.90 
(aprant q, J = 6.5 Hz, 1 H), 3.79 (s, 3 H), 3.77-3.74 (m, 2 H), 3.44 (s, 3 H), 1.97-1.83 (m, 
4 H). 13C-NMR (125 MHz, CDCl3): 171.3, 83.2, 79.1, 69.1, 59.0, 52.1, 27.4, 26.0, IR: 
2956, 1750, 1683, 1558, 1472, 1159 cm-1.  HRMS C8H14O4 (M+Na)+ calcd. 197.0784, 
obsvd 197.0786. 
Separation conditions for enantiomers are shown in Table 2.8. 
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Table 2.8.  Separation conditions for determination of enantiopurity.  
 
entry Compound Conditions Retention time er 
OH OMe GC, llI-cyclodextrin column 
cnt- 120 ·C for 20 min, 1 increase to 140 ·C at 0.4 ·C/min 56.8 and 57.9 min 97.9:2.1 hold at 140 ·C for 2 min, 
OHO~ increase to 200 ·C at 5 ·C/min 
~ hold at 200 ·C for 8 min 2 SFC, 1% Methanol, 3 mUmin 3.9 and 4.5 min 96.4:3.6" Whelko chiral column 
OHO~ 
3 cnt- SFC, 1% Methanol, 1 mUmin Whelko chiral column 11.6 and 12.7 min 96.0:4.0· 
OH O~O, 
4 ~ SFC, 1% Methanol, 3 mUmin 4.9 and 5.7 min 97.7:2.3 5 111m Cellucoat chiral column 
OH O~CI 
5 ~ SFC, 1% Methanol, 3 mUmin 3.7 and 4.3 min 94.0:6.0" Whelko chiral column 
OH O/'-.Ph 
6 ~ SFC, 1% Methanol, 3 mUmin Whelko chiral column 7.4 and 8.1 min 96.9:3.1" 
OH O~TMS 
7 ~ HPLC, 0.5% IPAlHex, 1 mUmin 29.8 and 32.6 min 99.4:0.6b OJ-H chiral column 
OH OH 
8 ~ HPLC, 0.5% IPAlHex, 1 29.8 and 32.6 min 98.4:1.6 mLlmin OJ-H chiral column 
OH O~OH 
9 ~ SFC, 1% MeCN, 3 mLlmin 2.5 and 3.9 min 94.9:5.1 Cellucoat chiral column 
OH N3 
10 ~ HPLC, 1% IPA:Hex, 1 mL/miriO.O and 13.7 min for major91.9:8.1 OD chiral column 18.5 and 32.9 min for minor91.9:8.1 
~) Product was converted to the corresponding metho~ phenol derivative USi~ KOH and 
el. (b) Product was converted to the free alcohol via eprotection using BF3' t2• 
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Preparation of 59 
To an oven-dried 50 mL round bottom flask equipped with a stir bar were added 
240.0 mg of 55 (1.010 mmol, 1.000 equiv.) in 7.5 mL MeOH.  To the reaction mixture 
cooled to 0 °C in an ice bath, 720.0 mg of PhI(OAc)2 (2.230 mmol, 2.200 equiv.) in 5 mL 
of MeOH was added dropwise and warmed to room temperature. After stirring for 90 
min, the reaction mixture was then cooled to 0 °C, and solution of saturated Na2CO3 was 
added until precipitate was observed.  To this, 20 mL of EtOAc and 5 mL of water were 
added.  The organic layer was separated and washed with water (5 mL) followed by brine 
(10 mL). The organic layer was dried over Na2SO4 and concentrated in vacuo.  The 
product was purified with flash silica-gel column chromatography with 10% to 30% 
EtOAc/Hexanes as eluent to give 215.5 mg of product (73% yield, average of two 
reactions). 
Rf = 0.4 w/ 33% EtOAc/Hexane, colorless liquid, [α]20D = –42.3° (c = 6.3, 
CHCl3), 1H-NMR (500 MHz, CDCl3): δ 6.83 (dd, J = 3.29 Hz, 0.9 Hz, 1 H), 6.76 (dd, J = 
10.2 Hz, 3.3 Hz, 1 H), 6.23 (d, J = 10.2 Hz, 1 H), 4.24 (dd, J = 6.2, 0.8 Hz, 1 H), 3.90 (q, 
J = 6.5 Hz, 1 H), 3.35 (s, 3 H), 3.33 (s, 3 H), 3.22 (s, 3 H), 1.70 (m, 4 H), 1.20 (s, 3 H), 
1.16 (s, 3 H). 13C-NMR (125 MHz, CDCl3): δ 185.0, 143.1, 140.6, 137.8, 130.0, 93.0, 
81.6, 81.0, 79.1, 57.4, 50.5, 50.4, 38.3, 28.8, 28.2, 28.0, IR: 2967, 2936, 1678, 1644, 
1458, 1364, 1109, 1038, 962, 843 cm-1. HRMS C16H24O5 (M+Na)+ calcd. 319.1521, 
obsvd. 319.1526. 
Preparation of 60 
The procedure described for 59 was followed,  Rf = 0.45 w/ 33% EtOAc/Hexane, 
colorless liquid, [α]20D = –57.3° (c = 1.4, CHCl3),1H-NMR (500 MHz, CDCl3): δ 6.92 (dd, 
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J = 3.2 Hz, 0.8 Hz, 1 H), 6.82 (dd, J = 10.3 Hz, 3.3 Hz, 1 H), 6.27 (d, J = 10.2 Hz, 1 H), 
4.30 (dd, J = 5.1 Hz, 0.9 Hz, 1 H), 3.87 (m, 2 H), 3.35 (ddd, J = 4.2 Hz, 1 H), 3.40 (s, 3 
H), 3.37 (s, 3 H), 3.30 (s, 3 H), 1.80 (m, 4 H). 13C-NMR (125 MHz, CDCl3): δ 185.2, 
143.4, 140.5, 137.6, 130.1, 93.2, 80.9, 78.3, 68.7, 57.8, 50.7, 50.5, 27.6, 26.0, IR: 2940, 
2830, 1678, 1644, 1461, 1375, 1116, 962, 843 cm-1. HRMS C14H20O5 (M+Na)+ calcd. 
291.1208, obsvd. 291.1202. 
Preparation of Mosher Esters (Table 2.9) 
To an oven dried 5 mL round bottom flask equipped with a stir bar were added 
38.0 mg of 41 (0.170 mmol, 1.00 equiv.) in 1.7 mL THF.  To the reaction mixture, 10.0 
mg of KOH (0.170 mmol, 1.00 equiv.) and 21 μL of MeI (0.34 mmol, 2.0 equiv.) were 
added at rt.  After 2 h the solution was diluted with EtOAc and washed with water (2 x 5 
mL). The organic layer was dried over Na2SO4 and concentrated in vacuo. The product 
was used without further purification. 
Synthesis of 62 (R)-Mosher ester  
To an oven dried 5 mL round bottom flask equipped with a stir bar were added 
20.2 mg of 61 (0.0850 mmol, 2.00 equiv.) in 400 μL CH2Cl2.  To the reaction mixture, a 
19.2 mg of DCC (0.0920 mmol, 2.20 equiv.) 1.5 mg of DMAP (0.30 equiv.) and 10 mg 
of (R)-MTPA (0.043 mmol, 1.0 equiv.) was added at rt.  After 2 days, the solution was 
diluted with EtOAc and washed with solution of saturated NH4Cl (2 mL) followed by 
water (2 x 5 mL).  The organic layer was dried over Na2SO4 and concentrated in vacuo.  
The product was purified with flash silica-gel column chromatography with 
EtOAc/hexanes as eluent to give the product in 40% yield.  1H-NMR (500 MHz, CDCl3) 
δ = 7.56 (d, 2 H), 7.40-7.31 (m, 4 H), 7.05 (dd, J = 7.6, 1.6 Hz, 1 H), 6.90-6.84 (m, 2 H), 
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6.32 (d, J = 8.5 Hz, 1 H), 4.32-4.28 (m, 1 H), 3.87 (s, 3 H), 3.63 (s, 3 H), 1.83-1.67 (m, 4 
H), 1.30 (s, 3 H), 1.23 (s, 3 H). 
Synthesis of 63 (S)-Mosher ester  
 Prepared according to the procedure described above, using (S)-MTPA.  1H-NMR 
(500 MHz, CDCl3) δ = 7.56 (m, 2 H), 7.40-7.27 (m, 4 H), 6.93 (td, J = 7.5, 1.0 Hz, 1 H), 
6.89 (dd, J = 8.3, 0.9 Hz, 1 H), 6.44 (d, J = 7.3 Hz, 1 H), 4.26 (ddd, J = 7.2, 6.0 Hz, 1 H), 
3.86 (s, 3 H), 3.51 (s, 3 H), 1.82-1.57 (m, 4 H), 1.26 (s, 3 H), 1.14 (s, 3 H). 
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SYNTHESIS AND PRELIMINARY BIOLOGICAL STUDIES  
OF 3-SUBSTITUTED INDOLES ACCESSED  
BY A PALLADIUM-CATALYZED  




As discussed in Chapter 2, we have discovered a unique method for synthesizing 
o-QM intermediates and utilized it for dialkoxylation reactions of vinyl phenols with 
simple alcohols.  Because o-QMs are reactive intermediates, they give us an opportunity 
to expand the scope of this transformation beyond simple alcohol nucleophiles.  Indoles 
being one of the most commonly found nitrogen-containing heterocycle in natural 
productsH1-3H and drug moleculesH4-6H provided the impetus to evaluate them as exogenous 
nucleophiles in the alkene difunctionalization reaction (Figure 3.1).  This would allow for 
the rapid construction of molecular complexity around the biologically relevant indole 
framework.  Moreover, the product obtained can be transformed into compound 64, 
which has a tetracyclic core structure analogous to the core structure of natural products 
communesin BH7-9H and diazonamide A.H10-12H  Communesin B is of particular relevance to 
















 The indole framework represents a privileged structural motif commonly found in 
pharmaceutical drugs and natural products.  Therefore, methods for accessing unique 
indole derivatives are important for drug-lead synthesis.  For this reason, various methods 
have been developed for functionalization of the indole core.  One of the most common 
methods for functionalization of the indole core is via a Friedel-Crafts alkylation 
reaction.H13-19H  Here, the Pd-catalyzed reactions of heteroaromatics with alkenes are 
discussed. 
Pd-Catalyzed Reaction of Heteroaromatics with  
Alkenes via Electrophilic Metalation  
of Heteroaromatic C-H Bonds 
 In 1999, Fujiwara and coworkers reported a Pd-catalyzed Heck reaction between 
arenes and alkenes (Figure 3.2).H20H  They used benzoquinone (BQ) as a co-oxidant to 
oxidize Pd0 to PdII and tert-butyl hydrogen peroxide (TBHP) as a terminal oxidant.  The 
proposed mechanism is shown in Figure 3.2.  The aryl-PdII complex B is proposed to 
form via electrophilic metalation of aromatic C-H bonds.  The alkene undergoes insertion 
to complex C followed by β-hydride elimination, leading to product formation and Pd0, 
which is oxidized to PdII by BQ.  Later, Gaunt and coworkers utilized a similar concept to 
develop an intermolecular alkenylation of indoles (Figure 3.3).H21H  This work showed 
alkenylation of an indole can be directed to either the C-2 or C-3 position by simply 











Figure 3.3. Pd-catalyzed alkenylation of indoles. Data from Gaunt and coworkers. 
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Gaunt and coworkers expanded this methodology to pyrroles, where the 
protecting group had a substantial impact on alkenylation regioselectivity (Figure 3.4).H22H  
This method was the key step in an elegant synthesis of Rhazinicine (Figure 3.5).H23H  
Recently, Zhang and coworkers reported a highly regioselective Pd-catalyzed oxidative 
coupling of the indolizines and vinylarenes (Figure 3.6).H24H  Interestingly, high selectivity 
for branched products was observed with bidentate nitrogen ligands. 
 














Pd-catalyzed Reaction of Indoles with  
Pd-π-allyl Complexes 
Another powerful method for the functionalization of indoles using Pd-catalysis is 
via reaction of indoles with electrophilic Pd-π-allyl complexes.  This mode of reactivity 
has been explored by various groups to obtaine 3-allyl indoles in both racemic and 
enantiopure forms.  Selected examples of these methods are discussed in this section. 
In 2005, Tamaru and coworkers reported a Pd-catalyzed allylation of indoles with 
allyl alcohols (Figure 3.7).H25H  In this reaction, triethylborane (Et3B) was used as a 
promoter.  The scope of this transformation was found to be broad with excellent yields 
of the desired products.  Later, Trost and coworkers reported an enantioselective variant 
of this reaction (Figure 3.8),H26H wherein 3-substituted indoles were used to obtain 3,3-
disubstituted products in excellent enantioselectivity and good yield.  Using 9-
BBN(C6H11) as a promoter and 64 as a chiral ligand was found to give optimal results.  
Trost and coworkers utilized this method to synthesize the simple alkaloid (─)-



















 In the same year, Bandini and coworkers reported an enantioselective 
intramolecular allylic alkylation of indoles using similar types of chiral ligands (Figure 
3.9a).H27H  The reaction provides tetrahydro-α-carbolines and tetrahydro-γ-carbolines in 
good yields and excellent enantioselectivity, using allyl carbonates as the precursor to the 
Pd-π-allyl complex.  Rawal and coworkers also utilized allyl carbonates as a precursor to 
the Pd-π-allyl complex for allylation of 2,3-disubstituted indoles (Figure 3.9b).H28H   
 






 Recently, Trost and coworkers reported an interesting reaction of indoles and 
pyrroles with Pd-π-allyl intermediates, generated from vinyl aziridines, to give N-
substituted allyl heterocycles (Figure 3.10).H29H  The reaction is highly enantioselective 
with broad substrate scope.  However, protecting groups on the aziridine are limited to 
Bn (benzyl) and PMB (p-methoxybenzyl) groups.  This method’s utility was further 
demonstrated in the synthesis of natural products longamide B, longamide B methyl 
ester, hanishin, ageaamide A, agesamide B and cyclooroidin. 
 
Figure 3.10.  Pd-catalyzed enantioselective N-alkylation of indoles and pyrroles Data 






Reaction of o-QM with Heteroaromtics 
 o-QMs are highly reactive intermediates and their reaction with various 
nucleophiles has been published.  However, reports of reactions of heteroaromatics with 
o-QMs are limited.  The most recent report came in 2006 from Kaïm and coworkers, 
wherein they described a novel method to synthesize o-QM in situ (Figure 3.11).  
Aldehydes were reacted with amines and phenols to give Mannich adducts like 65, which 
were treated with dibromoethane in the presence of a Lewis acid to give the o-QMs.  
Subsequently, the o-QM was reacted with N-Me-indole to give the desired product 66.  It 
should be noted that only two examples are reported in this paper.   
 






UResults and Discussion 
 As described in Chapter 2, we have developed a sequential intramolecular/ 
intermolecular dialkoxylation reaction.  Desiring to further expand the scope of this 
process, other nucleophiles were explored.  Indole being a prevalent heterocycle in 
pharmaceuticals and natural products, it was chosen as a preferred nucleophile to study.  
The proposed reaction mechanism for the formation of the desired product, using 
heteroaromatics as nucleophiles, is shown in Figure 3.12.  We proposed the substrate 
would undergo an intramolecular nucleopalladation, with subsequent formation of a 
reactive o-QM intermediate A.  To this intermediate, addition of electron-rich 
heteroaromatic derivatives could be accomplished, via electrophilic aromatic substitution, 
to give intermediate B.  Rearomatization of B would give the desired product. 
 
Figure 3.12. Proposed mechanism of Pd-catalyzed sequential intra- intermolecular 




When N-Me-indole was treated with substrate 31 under similar conditions to the 
previous report, it gave the desired product in 61% yield with excellent enantio- and 
diastereoselectivity (Table 3.1, entry 1).  Encouraged by this result, further optimization 
of the reaction conditions was conducted.  Increasing the amount of base and using a 
mixture of 4:1 toluene:THF gave a slightly increased yield and enantioselectivity of the 
desired product (Table 3.1, entries 2-3).  Finally, addition of 15 equivalents of 
nucleophile provided the optimal conditions, giving an 81% yield of the desired product 
and excellent enantioselectivity and diastereoselectivity (Table 3.1, entry 4).  It should be 
noted that 5 equivalents of indole also gave the desired product, albeit in lower yield, 
without any deterioration of enantioselectivity or diastereoselectivity (Table 3.1, entry 5).   






Having identified the optimized conditions, the scope of the alkene 
difunctionalization reaction was explored.  Beginning with the exogenous nucleophile, it 
was found that N-alkyl-protected indoles were well tolerated, including an indole 
containing a removable protecting group (Table 3.2, compounds 67 and 68).  Various 2-
substituted indoles with varied steric and electronic parameters were also found to be 
compatible, leading to good yields and excellent enantioselectivity (Table 3.2, 
compounds 69-71).  As evidenced by compounds 72-75, the electronic nature of indole 
ring substituent had little effect on the reaction outcome.  Additionally, 5-bromoindole 
was tolerated, giving a 62% yield and an excellent enantiomeric ratio (er) of 98:2 (Table 
3.2, compounds 73).  This result showcases the potential for further functionalization of 
these compounds with Pd0 catalysis.  Furthermore, the chemistry presented is not limited 
to only indole as a nucleophilic heterocycle, as demonstrated by the successful use of N-
methylpyrrole (Table 3.2, compound 76).  A caveat to this chemistry is the requirement 
of N-protection of the indole, with the electron-poor protecting groups (such as Ts or 
Boc) substantially decreasing the yield. 
 Next, in exploring vinyl phenols, it was found that electron-withdrawing 
substituents generally gave higher yields.  High diastereoselectivity and enantioselectivity 
were observed in all cases (Table 3.3, compounds 78-82).  Both tetrahydrofuran and 
tetrahydropyran ring systems were formed in good yields with excellent er and 
diastereomeric ratio (dr) (Table 3.3, compounds 83 and 84).  A 1,4-dioxane product was 
also generated, albeit in modest yield, from a substrate containing an ether linkage (Table 















98.5: 1.5 er, 8 h 
62% Yield 
98:2 er, 6 h 
4 mol% Pd(MeCN)2CI2 
8 mol% CuCI ~OH Nu 
14 mol% (S)-/Pr-Quinox, "'" 
----------l.. 1.0 0 
1 equiv. KHC03, rt 
Balloon O2, 15 equiv. NuH 
toluene:THF (4:1), 0.05M 
61% Yield 











98.5:1.5 er, 10 h 
57% Yield 
99:1 er, 3 h 
61% Yield 
98.5:1.5 er, 8 h 
50% Yield 




92.5:7.5 er, 4 h 
er for major diastereomer determined by SFC using a column equipped with a 
chiral stationary phase. dr rn 20:t for all compounds. dr determined by 'H NMR. 
Major diastereomer determined by X-ray crystal analysis of entry 73. Absolute 
configuration was assigned by comparison with a previous report. 
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Table 3.3. Scope of phenols and intramolecular nucleophiles. 
 
 
4 mol% Pd(MeCN)2CI2 
OH R R 8 mol% CuCI ~ 14 mol% (S)-iPr-Quinox, I '<:: "OH ----------l ... j. .& 1 equiv. KHC03, r.t 
R' Balloon O2, 15 equiv. NuH 









82% Yield, 5 h 
97:3 er 
I 
toluene:THF (4:1), 0.1 M 
CF3 
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62% Yield, 12 h 
92.5:7.5 er 
CI 










30% Yield, 36 h 
92:8 er 
er for major diastereomer determined by SFC using a column equipped with a 
chiral stationary phase. dr rn 20:1 for all compounds. dr determined by 'H NMR. 
Major diastereomer determined by X-ray crystal analysis of entry 73. Absolute 




With the goal of showcasing the utility of the product’s phenol moiety for 
synthesizing tetracyclic core structures, which resembles the core of the communesin 
natural product class, further derivatization of 83 was performed (Figure 3.13).  
Treatment of 83 with NBS resulted in rapid oxidative cyclization, affording 86 as the 
fused tetracyclic product in 92% yield.H30H  Additionally, treatment of 83 with DMDO 
resulted in the formation of the tertiary alcohol 87 in good yield, albeit with low dr.H31H  
Compound 87, which has homology with the core structure of the communesin class of 
natural productsH32H and contains four contiguous stereocenters can be synthesized from 
salicylaldehyde in just four steps.  This clearly demonstrates the utility of this method to 
rapidly access a relatively complex molecular scaffold. 
 
 






In view of the ease with which we were able to access diverse analogues and the 
unique architecture of the products formed, we chose to evaluate the biological activity of 
several racemic variants using a luminal-type breast cancer cell line (MCF-7).  These 
studies were performed by Prof. Matthew S. Sigman and Dr. Keith M. Gligorich in the 
laboratory of Prof. Brian Welm at the Huntsman Cancer Institute.  Excitingly, various 
compounds were found to be cytotoxic with moderate to good selectivity for cancerous 
cells over normal cells.  Interestingly, tetracyclic compound 87, which resembles the core 
of communesin B, did not show any toxicity towards cancer cells (Figure 3.14).  On the 
other hand, compound 72 is more effective than natural product communesin B.  This is 
encouraging, since compound 72 is structurally simpler than communesin B and is also 
more modular.  Of most interest, compounds 69 and 72 showcased different phenotypes, 
when cell cycle analysis was performed.  It was observed that compound 69 caused a G1 
arrest while 72 caused a G2 arrest similar to that induced by taxol (Figure 3.15).  This 
ﬁnding suggests that modest structural changes in the indole framework have a signiﬁcant 
bearing on the molecular target of these compounds.  Currently, we are performing 
further biological studies to understand the mode of action of these two promising 
compounds.   
UDetermination of Product Stereochemistry 
The relative stereochemistry was determined by X-ray crystal analysis of 
compound 73, and the absolute configuration was assigned based on analogy with our 
































 We have developed a highly enantioselective alkene difunctionalization with 
indoles as an exogenous nucleophiles, furnishing 3-substituted indoles in excellent yield 
and stereoselectivity.H33H  The products obtained can be readily processed to biologically 
relevant tetracyclic core structures.  Moreover, the newly synthesized 3-substituted 
indoles demonstrated encouraging µM activity against breast cancer cell lines.  Currently, 
further studies on the mode of action of these compounds and improvement of their 
selectivity and cytotoxicity are underway.   
Experimentals 
General Information 
Unless otherwise noted, all reactions were run under a nitrogen atmosphere with 
stirring.  Toluene, dichloromethane, and THF were dried before use by passing through a 
column of activated alumina.  Triethylamine was distilled from CaH2. All other reagents 
(including indoles) were purchased from commercial sources and used without further 
purification.  Yields were calculated for material judged homogeneous by thin-layer 
chromatography and NMR.  Thin-layer chromatography was performed with EMD silica 
gel 60 F254 plates eluting with the solvents indicated, visualized by a 254 nm UV lamp, 
and stained either with potassium permanganate, p-anisaldehyde, phosphomolybdic acid, 
or ninhydrin.  Flash column chromatography was performed with EcoChrom MP Silitech 
32-63D 60Å silica gel, slurry packed with solvents indicated in glass columns.  Nuclear 
magnetic resonance spectra were acquired at 400 MHz for 1H, and 100 MHz for 13C.  
Chemical shifts for proton nuclear magnetic resonance (1H NMR) spectra are reported in 
parts per million downfield relative to the line of CHCl3 singlet at 7.26 ppm.  Chemical 
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shifts for carbon nuclear magnetic resonance (13C NMR) spectra are reported in parts per 
million downfield relative to the center-line of the CDCl3 triplet at 77.2 ppm.  The 
abbreviations s, d, t, q, td, dd and m stand for the resonance multiplicities singlet, doublet, 
triplet, quartet, triplet of doublet, doublet of doublet and multiplet, respectively.  Optical 
rotations were obtained (Na D line) using a Perkin Elmer Model 343 Polarimeter fitted 
with a micro cell with a 1 dm path length.  Concentrations are reported in g/100 mL. IR 
spectra were recorded using a Nicolate FTIR instrument. SFC (super critical fluid 
chromatography) analysis was performed at 40 °C and 200 bar backpressure, using a 
Thar instrument fitted with chiral stationary phase (as indicated).  Glassware for all 






Preparation of 29 
To an oven-dried 500 mL round bottom flask equipped with a stir bar were added 
23.4 g of 27 (51.0 mmol, 2.30 equiv.) and 200 mL toluene.  To this was added a solution 
of 5.80 g KOtBu (51.2 mmol, 2.33 equiv.) in 40 mL of THF dropwise via cannulation.  
The reaction mixture slowly turned a deep red color over 4 h.  The mixture was cooled to 
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–78 °C and 2.70 g of salicylaldehyde 28 (22.2 mmol, 1.00 equiv.), dissolved in 20 mL of 
toluene, was added dropwise via cannulation.  The mixture was allowed to slowly warm 
to ambient temperature and stirred 48 h then quenched with 50 mL of saturated NH4Cl 
solution.  The mixture was diluted with 100 mL of diethyl ether and washed with 100 mL 
(2 x 50 mL) of water and 60 mL of brine.  The organic layer was dried over MgSO4, 
filtered, and the solvent removed in vacuo.  The crude mixture was purified by flash 
silica-gel column chromatography with 10%-20% EtOAc/Hexanes as eluent to give 4.15 
g of 29 (85% yield, average of two reactions).  Isomeric ratio (E/Z): 10:1, Major isomer: 
Rf = 0.52 w/ 33% EtOAc/Hexane, colorless oil, 1H-NMR (300 MHz, CDCl3) δ = 7.02-
7.28 (m, 2 H), 6.85-6.95 (m, 2 H), 6.38-6.48 (d, J = 11.2 Hz, 2 H), 5.89 (s, 1 H), 5.74-
5.86 (m, 1 H), 4.08-4.16 (m, 2 H), 2.37-2.48 (m, 4 H), 1.18-1.29 (m, 3 H). 13C-NMR 
{1H} (75 MHz, CDCl3) δ = 173.3, 153.1, 134.4, 129.9, 128.8, 125.1, 123.8, 120.5, 116.1, 
60.9, 33.9, 24.3, 14.3.  IR 3392, 2981, 1705, 1450, 1269, 1195, 1154, 754 cm-1.  HRMS 
C13H16O3 (M+Na)+ calcd. 243.0997, obsvd. 243.0996. 
Preparation of 89 
The same procedure as that of 29 was followed,  Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.32 w/ 20% EtOAc/Hexane, colorless oil, 1H-NMR (400 MHz, CDCl3) δ = 
7.09 (dd, J = 8.6 Hz, J = 2.6 Hz, 1 H), 7.04 (d, J = 2.6 Hz, 1 H), 6.82 (d, J = 8.6 Hz, 1 H), 
6.34 (d, J = 11.3 Hz, 1 H), 6.29 (s, 1 H), 5.79 (dt, J = 11.3 Hz, J = 6.9 Hz, 1 H), 4.13 (q, J 
= 7.2 Hz, 2 H), 2.47-2.37 (m, 4 H), 1.23 (t, J = 7.2 Hz, 3 H). 13C-NMR {1H} (75 MHz, 
CDCl3) δ = 173.8, 151.7, 134.9, 129.4, 128.6, 125.3, 124.9, 124.2, 117.3, 61.1, 33.6, 
24.2, 14.3.  IR 3392, 2980, 1702, 1478, 1269, 1195, 1148, 814 cm-1.  HRMS C13H15O3Cl 
(M+Na)+ calcd. 277.0607, obsvd. 277.0618. 
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Preparation of 88 
The same procedure as that of 29 was followed, Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.32 w/ 20% EtOAc/Hexane, colorless oil, 1H-NMR (400 MHz, CDCl3) δ = 
6.85-6.77 (m, 2 H), 6.37 (dd, J = 11.1 Hz, J = 6.4 Hz, 1 H), 6.01 (d, J = 39.4 Hz, 1 H), 
5.84-5.77 (m, 1 H), 4.13 (q, J = 7.2 Hz, 2 H), 2.47-2.36 (m, 4 H), 1.23 (t, J = 7.1 Hz, 3 
H). 13C-NMR {1H} (75 MHz, CDCl3) δ = 173.1, 157.9, 149.1, 134.9 (d), 124.4 (d), 116.8 
(q), 115.8 (q), 115.2 (q), 61.0, 34.7, 24.2, 14.3.  IR 3392, 2980, 1702, 1478, 1269, 1195, 
1148, 814 cm-1.  HRMS C13H15O3F (M+Ag)+ calcd. 345.0056, obsvd. 345.0081. 
Preparation of 90 
The same procedure as that of 29 was followed,  Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.42 w/ 33% EtOAc/Hexane, colorless oil, 1H-NMR (400 MHz, CDCl3) δ = 
6.98 (d, J = 8.2 Hz, 1 H), 6.93 (s, 1 H), 6.83 (dd, J = 8.2 Hz, J = 0.8 Hz, 1 H), 6.47 (d, J = 
11.2 Hz, 1 H), 5.84-5.77 (m, 1 H), 4.17 (q, J = 8.3 Hz, 2 H), 2.49-2.47 (m, 4 H), 2.30 (s, 3 
H) 1.27 (t, J = 8.3 Hz, 3 H). 13C-NMR {1H} (75 MHz, CDCl3) δ = 173.7, 150.8, 133.4, 
130.2, 129.3, 125.4, 123.5, 115.7, 60.8, 33.9, 28.2, 24.2, 20.7.  IR 3411, 2981, 1711, 
1494, 1178, 906, 787, 726 cm-1.  HRMS C14H18O3 (M+Na)+ calcd. 257.1154, obsvd. 
257.1165. 
Preparation of 91 
The same procedure as that of 29 was followed,  Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.30 w/ 20% EtOAc/Hexane, colorless oil, 1H-NMR (400 MHz, CDCl3) δ = 
7.02 (d, J = 8.2 Hz, 1 H), 6.60 (s, 1 H), 6.46-6.39 (m, 3 H), 5.66 (dt, J = 11.8 Hz, J = 6.2 
Hz, 1 H), 4.11 (q, J = 7.2 Hz, 2 H), 3.73 (s, 3 H), 2.40-2.48 (m, 4 H), 1.22 (t, J = 7.2 Hz, 
3 H). 13C-NMR {1H} (75 MHz, CDCl3) δ = 174.6, 154.3, 147.0, 134.3, 130.6, 124.9, 
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116.8, 114.3, 60.9, 55.4, 34.1, 24.3, 14.3.  IR 3408, 2980, 1729, 1492, 1197, 1145, 808 
cm-1.  HRMS C14H18O4 (M+Na)+ calcd. 273.1103, obsvd. 273.1111. 
Preparation of 30 
To an oven dried 500 mL round bottom flask equipped with a stir bar were added 
4.10 g of 29 (18.6 mmol, 1.00 equiv.) in 180 mL THF.  To this was slowly added a 
solution of 3.0 M MeMgBr (130 mmol, 7.00 equiv.) at 0 °C.  The reaction mixture was 
then allowed to warm to room temperature and was stirred for 12 h.  The reaction was 
quenched by the slow addition of 20 mL of 1 M HCl solution.  The mixture was diluted 
with 50 mL of diethyl ether and washed with 100 mL (2 x 50 mL) of water and 60 mL of 
brine.  The organic extract was dried over MgSO4, filtered, and the solvent was removed 
in vacuo.  The crude mixture was purified by flash silica-gel column chromatography 
with 1 L of 50% Hexane/EtOAC as eluent to give 3.34 g of 30 in 87% yield.  Isomeric 
ratio (E/Z): 10:1, Major isomer: Rf = 0.32 w/ 33% EtOAc/Hexane, colorless solid.  MP = 
74-75 °C.  1H-NMR (400 MHz, CDCl3): δ 7.28-7.07 (m, 2 H), 6.95-6.87 (m, 2 H), 6.40-
6.37 (d, J = 10.9 Hz), 5.95-5.88 (m, 1 H), 5.34 (s, 1 H), 2.28-2.19 (m, 2 H), 1.67-1.57 (m, 
2 H), 1.19 (s, 6 H). 13C-NMR {1H} (100 MHz, CDCl3): δ 152.9, 137.0, 129.8, 128.8, 
123.9, 123.4, 120.4, 115.5, 71.3, 43.3, 29.4, 24.1.  IR 3410, 3013, 2971, 1604, 1448, 
1377, 1261, 1210, 1147, 1131, 904, 755 cm-1.  HRMS C13H18O2 (M+Na)+ calcd. 
229.1204, obsvd. 229.1201. 
Preparation of 92 
The same procedure as that of 30 was followed, Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.32 w/ 33% EtOAc/Hexane, colorless solid.  MP = 121-122 °C.  1H-NMR 
(400 MHz, CDCl3): δ 7.46-7.38 (m, 2 H), 6.98 (d, J = 8.4 Hz, 1 H), 6.37 (d, J = 11.2 Hz), 
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6.0 (dt, J = 11.2 Hz, J = 7.4 Hz, 1 H), 2.25-2.19 (m, 2 H), 1.67-1.57 (m, 2 H), 1.19 (s, 6 
H). 13C-NMR {1H} (100 MHz, CDCl3): δ 155.8, 138.3, 127.2, 127.1, 126.0, 125.9, 124.3, 
122.3, 115.8, 71.7, 42.9, 29.4, 24.2.  IR 3247, 2970, 1612, 1442, 1324, 1283, 1107, 1073, 
906, 783 cm-1.  HRMS C14H17O2F3 (M+Na)+ calcd. 297.2606, obsvd. 297.2617. 
Preparation of 93 
The same procedure as that of 30 was followed, Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.20 w/ 20% EtOAc/Hexane, colorless solid.  MP = 102-103 °C.  1H-NMR 
(400 MHz, CDCl3): δ 7.01 (dd, J = 8.6 Hz, J = 2.6 Hz, 1 H), 7.06 (d, J = 2.6 Hz, 1 H), 
6.81 (d, J = 8.6 Hz), 6.28 (d, J = 11.2 Hz, 1 H), 5.94-5.89 (m, 1 H), 2.21-2.16 (m, 2 H), 
1.61-1.58 (m, 2 H), 1.19 (s, 6 H). 13C-NMR {1H} (100 MHz, CDCl3): δ 151.7, 137.7, 
129.4, 128.5, 125.6, 124.9, 122.5, 116.3, 71.6, 42.9, 29.4, 24.1.  IR 3455, 2964, 1604, 
1468, 1375, 1254, 1210, 1136, 926, 775 cm-1.  HRMS C13H15O2Cl (M+Na)+ calcd. 
263.0815, obsvd. 263.0801. 
Preparation of 94 
The same procedure as that of 30 was followed, Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.30 w/ 20% EtOAc/Hexane, colorless solid.  1H-NMR (400 MHz, CDCl3): 
δ 6.85-6.79 (m, 3 H), 6.31 (d, J = 11.2 Hz), 5.91 (dt, J = 11.2 Hz, J = 7.4 Hz, 1 H), 2.24-
2.18 (m, 2 H), 1.61-1.58 (m, 2 H), 1.19 (s, 6 H). 13C-NMR {1H} (100 MHz, CDCl3): δ 
157.9, 155.5, 149.0, 137.5, 122.8, 116.5, 116.4, 116.0, 115.8, 115.2, 114.9, 71.5, 43.0, 
29.4, 24.1.  IR 3261, 2970, 1652, 1485, 1434, 1183, 876, 769 cm-1.  HRMS C13H17O2F 




Preparation of 95 
The same procedure as that of 30 was followed, Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.20 w/ 20% EtOAc/Hexane, colorless solid.  MP = 130-132 °C.  1H-NMR 
(400 MHz, CDCl3): δ 6.98-6.95 (m, 1 H), 6.90 (s, 1 H), 6.79 (d, J = 8.2 Hz, 1 H), 6.35 (d, 
J = 11.2 Hz, 1 H), 5.89 (dt, J = 11.2 Hz, J = 7.4 Hz, 1 H), 5.2 (bs, 1 H), 2.27 (s, 3 H), 
2.24-2.18 (m, 2 H), 1.67-1.57 (m, 2 H), 1.19 (s, 6 H). 13C-NMR {1H} (100 MHz, CDCl3): 
δ 150.7, 136.6, 130.1, 129.5, 129.3, 123.6, 115.3, 71.3, 43.3, 29.4, 24.1, 20.7.  IR 3405, 
3085, 2966, 1503, 1421, 1371, 1274, 1202, 1151, 1122, 807, 713 cm-1. HRMS C14H20O2 
(M+Na)+ calcd. 243.1361, obsvd. 243.1369. 
Preparation of 96 
The same procedure as that of 30 was followed, Isomeric ratio (E/Z): 10:1, Major 
isomer: Rf = 0.30 w/ 33% EtOAc/Hexane, colorless solid.  1H-NMR (400 MHz, CDCl3): 
δ 6.83 (d, J = 8.7 Hz, 2 H), 6.74 (dd, J = 8.7 Hz, J = 3.0 Hz, 1 H), 6.66 (d, J = 2.9 Hz, 1 
H), 6.35 (d, J = 11.2 Hz, 1 H), 5.91 (dt, J =11.2 Hz, J = 7.4 Hz, 1 H), 5.01 (bs, 1 H), 3.77 
(s, 3 H), 2.27-2.18 (m, 2 H), 1.64-1.58 (m, 2 H), 1.19 (s, 6 H). 13C-NMR {1H} (100 MHz, 
CDCl3): δ 159.8, 154.3, 135.9, 131.1, 123.6, 116.2, 106.5, 101.3, 71.3, 55.9, 43.2, 29.5, 
24.2.  IR 3410, 3013, 2971, 1604, 1448, 1377, 1261, 1210, 1147, 1131, 904, 784 cm-1.  
HRMS C14H20O3 (M+Na)+ calcd. 259.1310, obsvd. 259.1320. 
Optimization of Reaction Conditions (Table 3.1) 





`Entry 1, Table 3.1  
To a 25 mL Schlenk flask equipped with a stir bar were added 3.1 mg 
Pd(MeCN)2Cl2 (0.012 mmol, 0.040 equiv.), 2.4 mg of CuCl (0.024 mmol, 0.080 equiv.), 
10.0 mg of iPrQuinox ligand (0.042 mmol, 0.140 equiv.), 12.0 mg of KHCO3 (0.120 
mmol, 0.400 equiv.), 2.6 mL of toluene.  A three-way joint fitted with a balloon of O2 
was attached and the flask was evacuated and refilled with O2 three times.  The mixture 
was stirred for 20 min at room temperature under an atmosphere of O2.  To the reaction 
mixture, 61.9 mg of 30 (0.300 mmol, 1 equiv.) and 375 µL of N-methyl indole (3.00 
mmol, 10.0 equiv.) were added and the flask was evacuated and refilled with O2 three 
more times.  The reaction mixture was stirred for 3 h and diluted with 10 mL of EtOAc.  
The reaction mixture was pass through a plug of silica gel and concentrated in vacuo.  
The crude mixture was purified with flash silica-gel column chromatography.  
Entry 2, Table 3.1 
 To a 25 mL Schlenk flask equipped with a stir bar were added 3.1 mg 
Pd(MeCN)2Cl2 (0.012 mmol, 0.040 equiv.), 2.4 mg of CuCl (0.024 mmol, 0.080 equiv.), 
10.0 mg of iPrQuinox ligand (0.042 mmol, 0.140 equiv.), 30.0 mg of KHCO3 (0.300 
mmol, 1.00 equiv.), 2.6 mL of toluene.  A three-way joint fitted with a balloon of O2 was 
attached and the flask was evacuated and refilled with O2 three times.  The mixture was 
stirred for 20 min at room temperature under an atmosphere of O2.  To the reaction 
mixture, 61.9 mg of 30 (0.300 mmol, 1 equiv.) and 375 µL of N-methyl indole (3.00 
mmol, 10.0 equiv.) were added and the flask was evacuated and refilled with O2 three 
more times.  The reaction mixture was stirred for 3 h and diluted with 10 mL of EtOAc.  
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The reaction mixture was pass through plug of silica gel and concentrated in vacuo.  The 
crude mixture was purified with flash silica-gel column chromatography. 
Entry 3, Table 3.1 
 To a 25 mL Schlenk flask equipped with a stir bar were added 3.1 mg 
Pd(MeCN)2Cl2 (0.012 mmol, 0.040 equiv.), 2.4 mg of CuCl (0.024 mmol, 0.080 equiv.), 
10.0 mg of iPrQuinox ligand (0.042 mmol, 0.140 equiv.), 30.0 mg of KHCO3 (0.300 
mmol, 1.00 equiv.), 1.95 mL of toluene and 0.5 mL of THF.  A three-way joint fitted 
with a balloon of O2 was attached and the flask was evacuated and refilled with O2 three 
times.  The mixture was stirred for 20 min at room temperature under an atmosphere of 
O2.  To the reaction mixture, 61.9 mg of 30 (0.300 mmol, 1 equiv.) and 375 µL of N-
methyl indole (3.00 mmol, 10.0 equiv.) were added and the flask was evacuated and 
refilled with O2 three more times.  The reaction mixture was stirred for 3 h and diluted 
with 10 mL of EtOAc.  The reaction mixture was pass through a plug of silica gel and 
concentrated in vacuo.  The crude mixture was purified with flash silica-gel column 
chromatography.  
Entry 4, Table 3.1 
The same procedure as that of entry 3 was followed,except 5 equiv. of N-methyl 
indole was used. 
Entry 5, Table 3.1 
The same procedure as that of entry 3 was followed, except 15 equiv. of N-methyl 




Scope of Indole Derivatives 
General Procedure 
To a 25 mL Schlenk flask equipped with a stir bar was added 3.1 mg 
Pd(MeCN)2Cl2 (0.012 mmol, 0.040 equiv.), 2.4 mg of CuCl (0.024 mmol, 0.080 equiv.), 
10.0 mg of iPrQuinox ligand (0.042 mmol, 0.140 equiv.), 30.0 mg of KHCO3 (0.300 
mmol, 1.000 equiv.), 4.8 mL of toluene and 1.2 mL of THF. A three-way joint fitted with 
a balloon of O2 was attached and the flask was evacuated and refilled with O2 three times.  
The mixture was stirred for 20 min at room temperature under an atmosphere of O2.  To 
the reaction mixture, 61.9 mg of 30 (0.300 mmol, 1 equiv.) and 15.0 equiv. of 
corresponding indole were added and the flask was evacuated and refilled with O2 three 
more times.  The reaction mixture was stirred for given time and diluted with 10 mL of 
EtOAc.  The reaction mixture was then pass through silica gel to remove metal 
complexes and concentrated in vacuo.  The crude mixture was purified with flash silica-
gel column chromatography. 
Preparation of 67 
The same procedure as that of general procedure was followed except 932.8 mg 
of N-Bn-indole (4.500 mmol, 15.0 equiv.) was added.  Yield = 58% (average of two run), 
diastereomeric ratio: >20:1, [α]20D = +8.0° (c = 0.18, CHCl3), Rf = 0.52 w/ 20% 
EtOAC/Hex, colorless solid, M.P. = 64-66 °C (decomposed). 1H-NMR (400 MHz, 
CDCl3) δ = 8.89 (s, 1 H), 7.35-7.25 (m, 5 H), 7.17-7.10 (m, 5 H), 7.01 (ddd, J = 7.9 Hz, J 
= 5.1 Hz, J = 1.1 Hz, 2 H), 6.87 (dd, J = 7.7 Hz, J = 1.7 Hz, 1 H), 6.71 (td, J = 7.4 Hz, J = 
1.3 Hz, 1 H), 5.39-5.30 (m, 2 H), 4.98 (d, J = 2.5 Hz, 1 H), 4.84 (td, J = 7.2 Hz, J = 2.6 
Hz, 1 H), 2.19-2.11 (m, 1 H), 1.96-1.87 (m, 1 H), 1.69 (ddd, J  = 12.2 Hz, J = 7.9 Hz, J = 
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6.6 Hz, 1 H), 1.33-1.24 (m, 4 H), 1.17 (s, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 
155.8, 137.9, 136.6, 131.1, 129.0, 128.3, 128.2, 128.1, 127.8, 126.8, 126.6, 122.2, 120.1, 
119.1, 119.4, 118.2, 114.2, 109.7, 82.5, 82.4, 50.2, 41.6, 38.7, 28.4, 27.9, 27.4. IR 3211, 
2969, 1611, 1482, 1466, 1369, 1811, 1038, 1014, 883, 739 cm-1.  HRMS C28H30NO2 
(M+Na)+ calcd. 412.2277, obsvd. 412.2281. 
Preparation of 68 
The same procedure as that of general procedure was followed except 770.0 mg 
of indole (4.500 mmol, 15.0 equiv.) was added.  Yield = 61% (average of two run), 
diastereomeric ratio: >20:1, [α]20D = +1.0° (c = 0.56, CHCl3), Rf = 0.58 w/ 20% 
EtOAC/Hex, colorless solid, M.P. = 128-130 °C.  1H-NMR (400 MHz, CDCl3) δ = 8.96 
(s, 1 H), 7.38 (dd, J = 8.2 Hz, J = 0.5 Hz, 1 H), 7.32 (dd, J = 8.0 Hz, J = 0.5 Hz, 1 H), 
7.26 (s, 1 H), 7.22 (t, J = 7.6 Hz, 1 H), 7.18-7.14 (m, 1 H), 7.05-7.02 (m, 2 H), 6.92 (dd, J 
= 7.7 Hz, J = 1.6 Hz, 1 H), 6.74 (t, J = 7.4 Hz, 1 H), 4.99 (d, J = 2.5 Hz, 1 H), 4.89 (td, J 
= 7.2 Hz, J = 2.6 Hz, 1 H), 4.04 (qd, J = 15.9 Hz, J = 6.7 Hz, 2 H), 2.27-2.19 (m, 1 H), 
2.03-1.94 (m, 1 H), 1.76 (dt, J  = 12.2 Hz, J = 7.3 Hz, 1 H), 1.41-1.34 (m, 4 H), 1.26 (s, 3 
H), 0.71-0.67 (m, 2 H), 0.46-0.42 (m, 2 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 
155.8, 136.4, 131.1, 128.3, 128.2, 128.1, 126.0, 121.8, 120.1, 119.9, 119.1, 118.1, 113.4, 
109.4, 82.6, 82.5, 50.8, 41.8, 38.7, 28.5, 27.9, 27.5, 11.6, 4.4, 4.3.  IR 3211, 2969, 1611, 
1482, 1466, 1369, 1811, 1038, 1014, 883, 781 cm-1.  HRMS C25H29NO2 (M+Na)+ calcd. 
398.2096, obsvd. 398.2107. 
Preparation of 69 
The same procedure as that of general procedure was followed except 932.8 mg 
of N-methyl-2-phenyl-indole (4.500 mmol, 15.0 equiv.) was added.  Yield = 61% 
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(average of two run), diastereomeric ratio: >20:1, [α]20D = -14.0° (c = 0.17, CHCl3), Rf = 
0.35 w/ 20% EtOAC/Hex, colorless solid, M.P. = 89-90 °C (decomposed). . 1H-NMR 
(400 MHz, CDCl3) δ = 8.77 (s, 1 H), 7.69 (d, J = 8.1 Hz, 1 H), 7.45 (bs, 3 H), 7.37 (d, J = 
8.3 Hz, 2 H), 7.29-7.22 (m, 2 H), 7.14-7.07 (m, 2 H), 6.91 (dd, J = 8.0 Hz, J = 1.3 Hz, 1 
H), 6.72 (td, J = 7.5 Hz, J = 1.3 Hz, 1 H), 4.80 (d, J = 2.2 Hz, 1 H), 4.61 (td, J = 7.4 Hz, J 
= 2.2 Hz, 1 H), 3.56 (s, 3 H), 1.96-1.84 (m, 2 H), 1.64 (ddd, J  = 12.2 Hz, J = 7.9 Hz, J = 
7.1 Hz, 1 H), 1.49 (ddd, J  = 12.1 Hz, J = 8.7 Hz, J = 6.1 Hz, 1 H), 1.20 (s, 3 H), 1.17 (s, 
3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 155.3, 139.4, 137.5, 131.9, 131.2, 128.7, 
128.6, 127.9, 127.8, 127.4, 121.8, 121.4, 119.8, 119.6, 117.4, 112.6, 109.6, 82.3, 81.6, 
42.4, 39.1, 31.1, 29.7, 27.9, 27.1. IR 3202, 3056, 2965, 2924, 1729, 1610, 1455, 1367, 
1238, 1018, 883, 741 cm-1.  HRMS C28H29NO2 (M+Na)+ calcd. 434.2096, obsvd. 
434.2087. 
Preparation of 70 
The same procedure as that of general procedure was followed except 653.4 mg 
of 1,2-dimethyl-indole (4.500 mmol, 15.0 equiv.) was added. Yield = 70% (average of 
two run), diastereomeric ratio: >20:1, [α]20D = -25.5° (c = 0.14, CHCl3), Rf = 0.36 w/ 20% 
EtOAC/Hex, colorless solid, M.P. = . 1H-NMR (400 MHz, CDCl3) δ = 8.72 (s, 1 H), 7.61 
(d, J = 7.9 Hz, 1 H), 7.29 (d, J = 8.1 Hz, 1 H), 7.12 (td, J = 6.9 Hz, J = 1.1 Hz, 2 H), 7.08 
(qd, J = 7.5 Hz, J = 1.1 Hz, 1 H), 6.92 (dd, J = 8.0 Hz, J = 1.3 Hz, 1 H), 6.72 (td, J = 7.5 
Hz, J = 1.2 Hz, 1 H), 4.81 (d, J = 2.3 Hz, 1 H), 4.74 (ddd, J = 8.5 Hz, J = 6.4 Hz, J = 2.3 
Hz, 1 H), 3.67 (s, 3 H), 2.32 (s, 3 H), 2.27-2.19 (m, 1 H), 2.01-1.91 (m, 1 H), 1.74 (dt, J  
= 12.2 Hz, J = 7.8 Hz, 1 H), 1.57-1.50 (m, 1 H), 1.27 (s, 3 H), 1.18 (s, 3H).  13C-NMR 
{1H} (100 MHz, CDCl3) δ = 155.2, 136.9, 135.1, 131.1, 128.0, 127.8, 120.7, 119.9, 
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119.8, 117.5, 110.3, 108.9, 94.7, 82.7, 82.0, 42.3, 39.0, 33.1, 29.9, 28.2, 27.6, 11.3. IR  
3303, 2966, 2925, 1659, 1613, 1485, 1366, 1274, 1036, 751 cm-1.  HRMS C23H27NO2 
(M+Na)+ calcd. 372.1939, obsvd. 372.1953. 
Preparation of 71 
The same procedure as that of general procedure was followed except 914.8 mg 
of ethyl-1-methyl-1H-indole-2-carboxylate (4.500 mmol, 15.0 equiv.) was added.  Yield 
= 51% (average of two run), diastereomeric ratio: >20:1, [α]20D = -141.0° (c = 0.19, 
CHCl3), Rf = 0.36 w/ 20% EtOAC/Hex, colorless solid, M.P. = 160-161 °C.  1H-NMR 
(400 MHz, CDCl3) δ = 8.58 (S, 1 H), 7.85 (dt, J = 8.2 Hz, J = 0.9 Hz, 1 H), 7.43 (dd, J = 
7.7 Hz, J = 1.6 Hz, 1 H), 7.31-7.25 (m, 2 H), 7.09 (td, J = 8.2 Hz, J = 2.0 Hz, 1 H), 7.03 
(ddd, J = 8.2 Hz, J = 6.0 Hz, J = 2.0 Hz, 1 H), 6.88 (dd, J = 8.1 Hz, J = 1.3 Hz, 1 H), 6.83 
(td, J = 7.5 Hz, J = 1.3 Hz, 1 H), 5.25 (d, J = 5.9 Hz, 1 H), 5.03 (apprt. q, J = 6.3 Hz, 1 
H), 4.56-4.43 (m, 2 H), 3.93 (s, 3 H), 2.23 (ddt, J = 12.6 Hz, J = 7.8 Hz, J = 6.4 Hz, 1 H), 
1.86 (ddt, J = 12.6 Hz, J = 8.6 Hz, J = 6.8 Hz, 1 H), 1.73 (ddd, J = 12.2 Hz, J = 7.8 Hz, J 
= 6.8 Hz, 1 H) 1.61 (ddd, J = 12.2 Hz, J = 8.6 Hz, J = 6.4 Hz, 1 H), 1.46 (t, J = 7.1 Hz, 3 
H), 1.21 (s, 3 H), 1.04 (s, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 164.3, 155.4, 
139.2, 129.8, 127.8, 127.3, 126.6,126.0, 125.1, 123.7, 123.3, 120, 119.8, 117.2, 110.4, 
81.9, 80.4, 61.7, 42.8, 38.4, 32.5, 30.9, 28.6, 27.9, 14.4. IR 3333, 2968, 2929, 1672, 1526, 
1407, 1382, 1236, 1128, 1015, 739 cm-1.  HRMS C25H29NO4 (M+Na)+ calcd. 430.1994, 
obsvd. 430.1997. 
Preparation of 72 
The same procedure as that of general procedure was followed except 851.4 mg 
of methyl 1-methyl-1H-indole-6-carboxylate (4.500 mmol, 15.0 equiv.) was added.  
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Yield = 50% (average of two run), diastereomeric ratio: >20:1, [α]20D = -20.2° (c = 0.17, 
CHCl3), Rf = 0.46 w/ 20% EtOAC/Hex, colorless solid, M.P. = >180 °C.  1H-NMR (400 
MHz, CDCl3) δ = 8.87 (s, 1 H), 8.07 (t, J = 0.7 Hz, 1 H), 7.69 (dd, J = 8.4 Hz, J  = 1.4 
Hz, 1 H), 7.29-7.27 (m, 1 H), 7.24 (s, 1 H), 7.12 (td, J = 7.6 Hz, J = 1.6 Hz, 1 H), 6.99 
(dd, J = 8.0 Hz, J = 1.2 Hz, 1 H), 6.83 (dd, J = 7.7 Hz, J = 1.6 Hz, 1 H), 6.70 (td, J = 7.4 
Hz, J = 1.1 Hz, 1 H), 4.91 (d, J = 2.5 Hz, 1 H), 4.81 (td, J = 7.2 Hz, J = 2.7 Hz, 1 H), 
3.93 (s, 3 H), 3.86 (s, 3 H), 2.22-2.13 (m, 1 H), 1.90 (ddt, J = 12.4 Hz, J = 8.8 Hz, J = 7.3 
Hz, 1 H) 1.72 (dt, J  = 11.9 Hz, J = 7.4 Hz, 1 H), 1.37-1.26 (m, 4 H), 1.19 (s, 3 H).  13C-
NMR {1H} (100 MHz, CDCl3) δ = 168.4, 155.6, 136.3, 131.6, 131.0, 130.6, 128.3, 128.2, 
127.9, 123.6, 120.2, 120.1, 119.4, 118.3, 113.9, 111.8, 94.6, 82.6, 82.2, 52.1, 41.8, 38.6, 
33.2, 28.5, 27.9, 27.5. IR 3249, 2968, 1709, 1617, 1480, 1370, 1231, 1091, 1039, 889, 
770 cm-1.  HRMS C24H27NO4 (M+Na)+ calcd. 416.1838, obsvd. 416.1834. 
Preparation of 73 
The same procedure as that of general procedure was followed except 945.5 mg 
of 5-bromo-1-methyl-1H-indole (4.500 mmol, 15.0 equiv.) was added.  Yield = 62% 
(average of two run), diastereomeric ratio: >20:1, [α]20D = -56.4° (c = 0.56, CHCl3), Rf = 
0.4 w/ 20% EtOAC/Hex, colorless solid, M.P. = 140-142 °C.  1H-NMR (400 MHz, 
CDCl3) δ = 8.87 (S, 1 H), 7.41 (d, J = 1.8 Hz, 1 H), 7.26 (dd, J = 8.5 Hz, J = 2.0 Hz, 1 
H), 7.16-7.09 (m, 3 H), 6.98 (dd, J = 8.0 Hz, J = 1.2 Hz, 1 H), 6.85 (dd, J = 7.7 Hz, J = 
1.6 Hz, 1 H), 6.72 (td, J = 7.4 Hz, J = 1.2 Hz, 1 H), 4.82 (d, J = 2.5 Hz, 1 H), 4.78 (td, J = 
7.2 Hz, J = 2.5 Hz, 1 H), 3.82 (s, 3 H), 2.20-2.12 (m, 1 H), 1.88 (ddt, J = 12.4 Hz, J = 8.8 
Hz, J = 7.2 Hz, 1 H), 1.71 (ddd, J = 12.1 Hz, J = 7.8 Hz, J = 7.0 Hz, 1 H), 1.31 (m, 4 H), 
1.23 (s, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 155.6, 135.5, 130.9, 129.8, 128.5, 
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128.3, 127.8, 124.8, 122.1, 120.2, 118.3, 113.0, 112.7, 110.7, 82.6, 82.3, 41.7, 38.6, 33.1, 
28.6, 27.9, 27.5, IR 3206, 2968, 2926, 1609, 1581, 1475, 1288, 1263, 1039, 790, 754 cm-
1.  HRMS C22H34NBrO2 (M+Na)+ calcd. 436.0888, obsvd. 436.0907. 
Preparation of 74 
The same procedure as that of general procedure was followed except 716.4 mg 
of 7-ethyl-1-methyl-1H-indole (4.500 mmol, 15.0 equiv.) was added.  Yield = 65% 
(average of two run), diastereomeric ratio: >20:1, [α]20D = +25.5° (c = 0.48, CHCl3), Rf = 
0.5 w/ 20% EtOAC/Hex, colorless solid, M.P. = 60-62 °C (decomposed). . 1H-NMR (400 
MHz, CDCl3) δ = 8.87 (S, 1 H), 7.15-7.10 (m, 2 H), 7.02-6.87 (m, 5 H), 6.72 (td, J = 7.4 
Hz, J = 1.3 Hz, 1 H), 4.94 (d, J = 2.6 Hz, 1 H), 4.85 (td, J = 7.2 Hz, J = 2.7 Hz, 1 H), 4.06 
(s, 3 H), 3.14 (qd, J = 7.5 Hz, J = 2.9 Hz, 2 H), 2.24-2.16 (m, 1 H), 1.99-1.90 (m, 1 H), 
1.74 (ddd, J = 12.1 Hz, J = 8.0 Hz, J = 6.6 Hz, 1 H), 1.39 (t, J = 7.5 Hz, 4 H), 1.31 (s, 3 
H), 1.24 (s, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 155.7, 134.9, 131.0, 129.5, 
129.1, 128.1,128, 127.7, 122.9, 120.2, 119.5, 118.1, 117.9, 113.2, 82.5, 82.4, 41.4, 38.7, 
36.9, 28.4, 27.9, 27.4, 25.6, 16.8, IR 3210, 2967, 1608, 1580, 1451, 1367, 1323, 1037, 
870, 753 cm-1.  HRMS C24H29NO2 (M+H)+ calcd. 364.2277, obsvd. 364.2294. 
Preparation of 75 
The same procedure as that of general procedure was followed except 725.4 mg 
of 5-methoxy-1-methyl-1H-indole (4.500 mmol, 15.0 equiv.) was added.  Yield = 57% 
(average of two run), diastereomeric ratio: >20:1, [α]20D = -26.5° (c = 0.60, CHCl3), Rf = 
0.58 w/ 20% EtOAC/Hex, colorless solid, M.P. = 138-140 °C.  1H-NMR (400 MHz, 
CDCl3) δ = 8.83 (s, 1 H), 7.18 (d, J = 8.8 Hz, 1 H), 7.13-7.09 (m, 1 H), 7.02 (s, 1 H), 6.98 
(dd, J = 8.0 Hz, J = 1.2 Hz, 1 H), 6.87 (td, J = 8.1 Hz, J = 2.1 Hz, 1 H), 6.71 (td, J = 7.4 
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Hz, J = 1.2 Hz, 1 H), 6.65 (d, J = 2.4 Hz, 1 H), 4.89 (d, J = 2.6 Hz, 1 H), 4.83 (td, J = 7.2 
Hz, J = 2.8 Hz, 1 H), 3.78 (s, 3 H), 3.70 (s, 3 H), 2.18 (ddt, J = 12.7 Hz, J = 7.9 Hz, J = 
6.5 Hz, 1 H), 1.93 (ddt, J = 12.5 Hz, J = 8.9 Hz, J = 7.1 Hz, 1 H) 1.72 (ddd, J  = 12.2 Hz, 
J = 8.0 Hz, J = 6.7 Hz, 1 H), 1.37-1.29 (m, 4 H), 1.21 (s, 3 H).  13C-NMR {1H} (100 
MHz, CDCl3) δ = 155.8, 153.9, 133.3, 131.1, 128.3, 128.1, 127.9, 127.8, 120.1, 118.1, 
112.8, 112.2, 109.9, 101.7, 94.6, 82.5, 82.4, 56.1, 41.5, 41.5, 38.7, 33.2, 28.4, 27.9, 27.4. 
IR 3207, 2965, 2831, 1622, 1579, 1489, 1369, 1270, 1174, 1035, 1015, 798, 755 cm-1.  
HRMS C23H27NO3 (M+Na)+ calcd. 388.1889, obsvd. 388.1894. 
Preparation of 76 
To a 25 mL Schlenk flask equipped with a stir bar were added 3.1 mg 
Pd(MeCN)2Cl2 (0.012 mmol, 0.040 equiv.), 2.4 mg of CuCl (0.024 mmol, 0.080 equiv.), 
10.0 mg of iPrQuinox ligand (0.300 mmol, 0.140 equiv.), 30.0 mg of KHCO3 (0.300 
mmol, 1.000 equiv.), 2.0 mL of toluene and 0.5 mL of THF. A three-way joint fitted with 
a balloon of O2 was attached and the flask was evacuated and refilled with O2 three times.  
The mixture was stirred for 20 min at room temperature under an atmosphere of O2.  To 
the reaction mixture, 61.9 mg of 30 (0.300 mmol, 1 equiv.) and 400 µL of N-
methylpyrrole (4.50 mmol, 15.0 equiv.) were added and the flask was evacuated and 
refilled with O2 three more times.  The reaction mixture was stirred for 3 h in the dark 
and diluted with 10 mL of EtOAc.  The reaction mixture was pass through silica gel to 
remove metal complexes and concentrated in vacuo.  The crude mixture was purified 
with flash silica-gel column chromatography.  Yield = 53% (average of two run), 
diastereomeric ratio = 20:1,  [α]20D = +47.4° (c = 0.34, CHCl3), Rf = 0.6 w/ 20% 
EtOAC/Hex, colorless solid, M.P. = 94-96 °C.  1H-NMR (400 MHz, CDCl3) δ = 8.54 (s, 
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1 H), 7.13 (td, J = 7.6 Hz, J = 1.5 Hz, 1 H), 6.97 (dd, J = 8.0 Hz, J = 1.2 Hz, 1 H), 6.77 
(td, J = 7.5 Hz, J = 1.2 Hz, 1 H), 6.59 (dd, J = 2.5 Hz, J = 1.8 Hz, 1 H), 6.13 (dd, J = 3.5 
Hz, J = 2.8 Hz, 1 H), 6.04 (ddd, J = 3.7 Hz, J = 1.9 Hz, J = 1.2 Hz, 1 H), 4.83 (td, J = 7.1 
Hz, J = 2.8 Hz, 1 H), 4.74 (d, J = 2.7 Hz, 1 H), 3.14 (s, 3 H), 2.23 (dq, J = 12.7 Hz, J = 
7.6 Hz, 1 H), 1.86 (dddd, J = 12.7 Hz, J = 9.1 Hz, J = 6.9 Hz, J = 5.7 Hz, 1 H), 1.69 (ddd, 
J = 12.2 Hz, J = 8.1 Hz, J = 5.7 Hz, 1 H) 1.28-1.24 (m, 4 H), 1.20 (s, 3 H).  13C-NMR 
{1H} (100 MHz, CDCl3) δ = 155.7, 131.1, 130.3, 128.3, 126.4, 122.2, 120.6, 118.1, 
107.6, 106.5, 82.0, 81.9, 41.1, 38.7, 33.9, 27.7, 27.6, 26.9. IR 3248, 2969, 2928, 1582, 
1483, 1302, 1232, 1037, 1013, 877, 757 cm-1.  HRMS C18H23NO2 (M+Na)+ calcd. 
308.1626, obsvd. 308.1628. 
Substrate Scope (Table 3.3) 
General Procedure  
To a 25 mL Schlenk flask equipped with a stir bar were added 3.1 mg 
Pd(MeCN)2Cl2 (0.012 mmol, 0.040 equiv.), 2.4 mg of CuCl (0.024 mmol, 0.080 equiv.), 
10.0 mg of iPrQuinox ligand (0.042 mmol, 0.140 equiv.), 30.0 mg of KHCO3 (0.300 
mmol, 1.000 equiv.), 1.95 mL of toluene and 0.5 mL of THF. A three-way joint fitted 
with a balloon of O2 was attached and the flask was evacuated and refilled with O2 three 
times.  The mixture was stirred for 20 min at room temperature under an atmosphere of 
O2.  To the reaction mixture, 61.9 mg of 30 (0.300 mmol, 1 equiv.) and 560 µL of N-
methyl indole (4.50 mmol, 15.0 equiv.) were added and the flask was evacuated and 
refilled with O2 three more times.  The reaction mixture was stirred for 3 h and diluted 
with 10 mL of EtOAc.  The reaction mixture was then pass through silica gel to remove 
123 
 
metal complexes and concentrated in vacuo.  The crude mixture was purified with flash 
silica-gel column chromatography.  
Preparation of 77 
The same procedure as that of general procedure was followed.  Yield = 81% 
(average of two run), diastereomeric ratio: >20:1, [α]20D = +7.2° (c = 0.31, CHCl3) Rf = 
0.66 w/ 33% EtOAC/Hex, colorless solid, M.P. = 108-110 °C. 1H-NMR (400 MHz, 
CDCl3) δ = 8.88 (s, 1 H), 7.30 (dd, J = 8.2 Hz, J = 0.7 Hz, 1 H), 7.25 (d, J = 7.9 Hz, 1 H), 
7.20 (td, J = 7.6 Hz, J = 1.0 Hz, 1 H), 7.11 (td, J = 7.6 Hz, J = 1.5 Hz, 1 H), 7.05 (s, 1 H), 
7.00 (td, J = 8.2 Hz, J = 0.9 Hz, 2 H), 6.85 (dd, J = 7.7 Hz, J = 1.5 Hz, 1 H), 4.95 (d, J = 
2.6 Hz, 1 H), 4.84 (td, J = 7.2 Hz, J = 2.7 Hz, 1 H), 3.82 (s, 3 H), 2.23-2.16 (m, 1 H), 
1.93 (ddt, J  = 12.5 Hz, J = 8.9 Hz, J = 7.1 Hz, 1 H), 1.72 (ddd, J  = 12.2 Hz, J = 7.9 Hz, 
J = 6.7 Hz, 1 H), 1.34-1.28 (s, 4 H), 1.21 (s, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ 
= 155.7, 136.9, 131.1, 128.1, 127.9, 127.2, 121.9, 120.1, 119.6, 119.1, 118.1, 113.3, 
109.2, 82.4, 41.4, 38.6, 33.0, 28.3, 27.9, 27.4. IR 3209, 2967, 2925, 1612, 1581, 1482, 
1369, 1269, 1229, 1038, 1012, 883 cm-1. HRMS C22H25NO2 (M+Na)+ calcd. 358.1783, 
obsvd. 358.1787. 
Preparation of 78 
The same procedure as that of general procedure was followed except 82.3 mg of 
92 (0.300 mmol, 1 equiv.) was added.  Yield = 87% (average of two run), diastereomeric 
ratio: >20:1, [α]20D = -10.0° (c = 0.24, CHCl3), Rf = 0.35 w/ 20% EtOAC/Hex, colorless 
solid, M.P. = 102-104 °C (decomposed). 1H-NMR (400 MHz, CDCl3) δ = 9.53 (s, 1 H), 
7.4 (dd, J = 8.4 Hz, J = 2.2 Hz, 1 H), 7.33 (ddd, J = 8.4 Hz, J = 7.4 Hz, J = 0.8 Hz, 1 H), 
7.25 (ddd, J = 8.2 Hz, J = 7.0 Hz, J = 1.1 Hz, 1 H), 7.20 (d, J = 2.2 Hz, 1 H), 7.12 (s, 1 
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H), 7.08-7.04 (m, 2 H), 4.94 (d, J = 2.5 Hz, 1 H), 4.82 (ddd, J = 7.8 Hz, J = 6.9 Hz, J = 
2.5 Hz, 1 H), 3.82 (s, 3 H), 2.22 (dddd, J = 12.5 Hz, J = 7.9 Hz, J = 6.7 Hz, J = 5.8 Hz, 1 
H), 1.89 (dddd, J = 12.4 Hz, J = 8.8 Hz, J = 7.8 Hz, J = 7.2 Hz, 1 H), 1.77 (dt, J = 12.2 
Hz, J = 7.5 Hz, 1 H), 1.44-1.37 (m, 1 H), 1.32 (s, 3 H), 1.22 (s, 3 H). 13C-NMR {1H} (100 
MHz, CDCl3) δ = 158.8, 136.9, 128.8, (128.3, 128.2, 128.2, CF3), 127.8, 127.4, 125.5, 
122.1, 119.4, 119.3, 118.5, 112.1, 109.4, 82.9, 82.3, 41.9, 38.6, 33.1, 29.9, 28.6, 27.9, 
27.5.   IR 2966, 2924, 1614, 1466, 1324, 1279, 1108, 1074, 739 cm-1.  HRMS 
C23H24O2F3 (M+Na)+ calcd. 404.1838, obsvd. 404.1843. 
Preparation of 94 
The same procedure as that of general procedure was followed except 72.4 mg of 
4.S13 (0.300 mmol, 1 equiv.) was added.  Yield = 87% (average of two run), 
diastereomeric ratio: >20:1, [α]20D = -10.0° (c = 0.24, CHCl3), Rf = 0.52 w/ 20% 
EtOAC/Hex, colorless solid, M.P. = 98-100 °C (decomposed). 1H-NMR (400 MHz, 
CDCl3) δ = 8.90 (s, 1 H), 7.33-7.20 (m, 3 H), 7.08-7.01 (m, 2 H), 6.92 (d, J = 8.5 Hz, 1 
H), 6.82 (d, J = 2.6 Hz, 1 H), 4.94 (d, J = 2.6 Hz, 1 H), 4.79 (td, J = 7.3 Hz, J = 2.6 Hz, 1 
H), 3.82 (s, 3 H), 2.20 (ddt, J = 12.6 Hz, J = 7.9 Hz, J = 6.5 Hz, 1 H), 1.96-1.88 (m, 1 H), 
1.74 (ddd, J = 12.2 Hz, J = 7.9 Hz, J = 6.7 Hz, 1 H), 1.40-1.28 (m, 4 H), 1.20 (s, 3 H). 
13C-NMR {1H} (100 MHz, CDCl3) δ = 154.5, 136.9, 130.5, 130.0, 128.0, 127.7, 127.2, 
124.8, 122.1, 119.5, 119.4, 119.3, 112.5, 109.3, 82.5, 82.4, 41.2, 38.7, 33.1, 28.3, 27.9, 
27.4. IR 3204, 2969, 2927, 1719, 1475, 1370 1264, 1014, 877, 738 cm-1.  HRMS 




Preparation of 80 
To a 25 mL Schlenk flask equipped with a stir bar were added 2.6 mg 
Pd(MeCN)2Cl2 (0.010 mmol, 0.040 equiv.), 2.0 mg of CuCl (0.020 mmol, 0.080 equiv.), 
8.4 mg of iPrQuinox ligand (0.035 mmol, 0.140 equiv.), 25.0 mg of KHCO3 (0.250 
mmol, 1.000 equiv.), 1.6 mL of toluene and 0.4 mL of THF. A three-way joint fitted with 
a balloon of O2 was attached and the flask was evacuated and refilled with O2 three times.  
The mixture was stirred for 20 min at room temperature under an atmosphere of O2.  To 
the reaction mixture, 56.0 mg of 93 (0.250 mmol, 1 equiv.) and 470 µL of N-methyl 
indole (3.75 mmol, 15.0 equiv.) were added and the flask was evacuated and refilled with 
O2 three more times.  The reaction mixture was stirred for 3 h and diluted with 10 mL of 
EtOAc.  The reaction mixture was then pass through silica gel to remove metal 
complexes and concentrated in vacuo.  The crude mixture was purified with flash silica-
gel column chromatography.  
Yield = 78% (average of two run), diastereomeric ratio: >20:1, [α]20D = +39.3° (c 
= 0.45, CHCl3), Rf = 0.55 w/ 20% EtOAC/Hex, colorless liquid, 1H-NMR (400 MHz, 
CDCl3) δ = 8.59 (s, 1 H), 7.30 (d, J = 8.0 Hz, 1 H), 7.21 (t, J = 8.4 Hz, 2 H), 7.03-6.98 
(m, 2 H), 6.92 (dd, J = 8.8 Hz, J = 5.0 Hz 1 H), 6.78 (td, J = 8.3 Hz, J = 3.1 Hz, 1 H), 
6.53 (dd, J = 9.9 Hz, J = 3.1 Hz, 1 H), 4.98 (d, J = 2.7 Hz, 1 H), 4.82 (td, J = 7.2 Hz, J = 
2.7 Hz, 1 H), 3.82 (s, 3 H), 2.25-2.16 (m, 1 H), 1.91 (dddd, J = 12.5 Hz, J = 8.9 Hz, J = 
7.3 Hz, J = 6.6 Hz, 1 H), 1.73 (ddd, J = 12.2 Hz, J = 8.0 Hz, J = 6.5 Hz, 1 H) 1.35-1.28 
(m, 4 H), 1.19 (s, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 158.1, 151.8, 137.0, 
129.7, 129.6, 127.1, 122.2, 119.7, 119.3, 118.9, 118.8, 117.2, 116.9, 114.5, 114.3, 112.8, 
109.3, 82.5, 82.4, 40.9, 38.7, 33.0, 28.1, 27.8, 27.3. IR 3242, 2970, 1716, 1486, 1372, 
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1233, 1184, 877, 761 cm-1.  HRMS C22H24NO2F (M+Na)+ calcd. 376.1689, obsvd. 
376.1683. 
Preparation of 81 
The same procedure as that of general procedure was followed except 66.1 mg of 
95 (0.300 mmol, 1 equiv.) was added.  Yield = 58% (average of two run), diastereomeric 
ratio: >20:1, [α]20D = -8.2° (c = 0.36, CHCl3), Rf = 0.44 w/ 20% EtOAC/Hex, colorless 
solid, M.P. = 109-111 °C. 1H-NMR (400 MHz, CDCl3) δ = 8.75 (s, 1 H), 7.35 (d, J = 8.0 
Hz, 1 H), 7.31 (d, J = 8.2 Hz, 1 H), 7.22 (ddd, J = 8.1 Hz, J = 7.0 Hz, J = 1.1 Hz, 1 H), 
7.11 (s, 1 H), 7.04 (ddd, J = 8.0 Hz, J = 7.0 Hz, J = 1.0 Hz, 1 H), 6.93 (dd, J = 8.1 Hz, J = 
2.0 Hz, 1 H), 6.89 (d, J = 8.0 Hz, 1 H), 6.72 (d, J = 1.5 Hz, 1 H), 4.88 (d, J = 2.6 Hz, 1 
H), 4.80 (td, J = 7.2 Hz, J = 2.6 Hz, 1 H), 3.81 (s, 3 H), 2.22-2.12 (m, 4 H), 1.94 (ddt, J = 
12.4 Hz, J = 8.9 Hz, J = 7.3 Hz, 1 H), 1.72 (ddd, J = 12.1 Hz, J = 7.8 Hz, J = 7.1 Hz, 1 H) 
1.40-1.34 (m, 1 H), 1.30 (s, 3 H), 1.21 (s, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 
155.3, 136.9, 131.4, 129.0, 128.7, 128.0, 127.4, 121.9, 119.7, 119.1, 117.9, 113.4, 109.2, 
82.6, 82.5, 41.9, 38.7, 33.1, 28.7, 28.1, 27.6, 20.8. IR 3237, 2967, 2926, 1613, 1492, 
1423, 1326, 1263, 1038, 880, 747 cm-1.  HRMS C23H27O2N (M+Na)+ calcd. 372.1939, 
obsvd. 372.1944. 
Preparation of 82 
The same procedure as that of general procedure was followed except 70.1 mg of  
96 (0.300 mmol, 1 equiv.) was added.  Yield = 44% (average of two run), diastereomeric 
ratio: >20:1, [α]20D = +18.2° (c = 0.52, CHCl3), Rf = 0.41 w/ 20% EtOAC/Hex, colorless 
solid, M.P. = 85-88 °C (decomposed). 1H-NMR (400 MHz, CDCl3) δ = 8.40 (s, 1 H), 
7.30-7.27 (m, 2 H), 7.19 (td, J = 7.6 Hz, J = 1.2 Hz, 1 H), 7.03-7.00 (m, 2 H), 6.92 (d, J = 
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8.7 Hz, 1 H), 6.67 (dd, J = 8.7 Hz, J = 3.1 Hz, 1 H), 6.45 (d, J = 3.1 Hz, 1 H), 4.95 (d, J = 
2.7 Hz, 1 H), 4.81 (td, J = 7.2 Hz, J = 2.7 Hz, 1 H), 3.81 (s, 3 H), 3.59 (s, 3 H), 2.22-2.14 
(m, 1 H), 1.95 (ddt, J = 12.5 Hz, J = 8.9 Hz, J = 7.0 Hz, 1 H) 1.71 (ddd, J  = 12.2 Hz, J = 
8.0 Hz, J = 6.7 Hz, 1 H), 1.36-1.28 (m, 4 H), 1.20 (s, 3 H).  13C-NMR {1H} (100 MHz, 
CDCl3) δ = 153.2, 149.7, 136.9, 129.3, 127.9, 127.1, 121.9, 119.8, 119.2, 118.4, 117.4, 
113.2, 112.2, 109.1, 82.5, 82.3, 55.7, 41.3, 38.7, 33.0, 28.3, 27.9, 27.4. IR 3247, 2966, 
2926, 1613, 1488, 1465, 1369, 1262, 1040, 878, 775 cm-1.  HRMS C23H27NO3 (M+Na)+ 
calcd. 388.1889, obsvd. 388.1893. 
Preparation of 83 
To a 250 mL Schlenk flask equipped with a stir bar were added 15.6 mg 
Pd(MeCN)2Cl2 (0.06 mmol, 0.040 equiv.), 11.9 mg of CuCl (0.12 mmol, 0.080 equiv.), 
50.5 mg of iPrQuinox ligand (0.210 mmol, 0.140 equiv.), 150.0 mg of KHCO3 (1.50 
mmol, 1.00 equiv.), 9.7 mL of toluene and 2.4 mL of THF. A three-way joint fitted with a 
balloon of O2 was attached and the flask was evacuated and refilled with O2 three times.  
The mixture was stirred for 20 min at room temperature under an atmosphere of O2.  To 
the reaction mixture, 267.0 mg of 31 (1.500 mmol, 1.00 equiv.) and 2.81 mL of N-methyl 
indole (22.5 mmol, 15.0 equiv.) were added and the flask was evacuated and refilled with 
O2 three more times.  The reaction mixture was stirred for 5 h and diluted with 50 mL of 
EtOAc.  The reaction mixture was then pass through silica gel to remove metal 
complexes and concentrated in vacuo.  The crude mixture was purified with flash silica-
gel column chromatography.  
  Yield = 82% (average of two run, Note: 2.56 g of N-methyl indole was 
recovered), diastereomeric ratio: >20:1, [α]20D = +4.0° (c = 0.56, CHCl3), Rf = 0.5 w/ 33% 
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EtOAC/Hex, colorless solid, M.P. = 148-150 °C. 1H-NMR (400 MHz, CDCl3) δ = 8.79 
(s, 1 H), 7.32-7.27 (m, 2 H), 7.21 (ddd, J = 8.2 Hz, J = 7.0 Hz, J = 1.1 Hz, 1 H), 7.12 (td, 
J = 7.6 Hz, J = 1.4 Hz, 1 H), 7.07 (s, 1 H), 7.04-7.01 (m, 1 H), 7.00-6.97 (m, 1 H), 6.89 
(dd, J = 7.7 Hz, J = 1.7 Hz, 1 H), 6.71 (td, J = 7.4 Hz, J = 1.3 Hz, 1 H), 4.98 (d, J = 2.85 
Hz, 1 H), 4.77 (td, J = 7.3 Hz, J = 2.9 Hz, 1 H), 3.92-3.78 (m, 5 H), 2.19-2.1 (m, 1 H), 
1.93-1.83 (m, 2 H), 1.62-1.54 (m, 1 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 155.7, 
137.1, 131.1, 128.2, 128.0, 127.9, 127.8, 127.1, 122, 120.2, 119.8, 119.2, 113.3, 109.2, 
83.5, 68.6, 41.9, 33.0, 28.3, 26.4. IR 3303, 2932, 2867, 1650, 1603, 1455, 1357, 1251, 
1093, 1054, 976, 781 cm-1.  HRMS C20H21NO2 (M+K)+ calcd. 346.1209, obsvd. 
346.1219 
Preparation of 84 
The same procedure as that of general procedure was followed except 57.7 mg of 
36 (0.300 mmol, 1 equiv.) was added.  Yield = 62% (average of two run), diastereomeric 
ratio: >20:1, [α]20D = -43.0° (c = 0.13, CHCl3), Rf = 0.33 w/ 20% EtOAC/Hex, colorless 
solid, M.P. = 140-141 °C. 1H-NMR (400 MHz, CDCl3) δ = 9.16 (S, 1 H), 7.41 (dt, J = 
8.0 Hz, J = 0.92 Hz, 1 H), 7.3 (dt, J = 8.2 Hz, J = 0.9 Hz, 1 H), 7.21 (ddd, J = 8.2 Hz, J = 
7.0 Hz, J = 1.1 Hz, 1 H), 7.16-7.11 (m, 1 H), 7.09-7.04 (m, 2 H), 6.95 (dd, J = 8.0 Hz, J = 
1.3 Hz, 1 H), 6.76 (td, J = 7.4 Hz, J = 1.3 Hz, 1 H), 4.52 (d, J = 2.0 Hz, 1 H), 4.24-4.23 
(m, 2 H), 3.79 (s, 3 H), 3.69-3.62 (m, 2 H), 1.88-1.77 (m, 2 H), 1.61-1.53 (m, 4 H). 13C-
NMR {1H} (100 MHz, CDCl3) δ = 155.4, 136.7, 131.3, 129.4, 128.4, 128.3,127.5, 121.6, 
119.9, 119.4, 119.1, 118.1, 112.5, 109.3, 82.7, 69.4, 46.3, 33, 29.7, 25.6, 23.5. IR 3049, 
2933, 2854, 1612, 1454, 1374, 1264, 1173, 1081, 937, 907, 736 cm-1.  HRMS C21H23NO2 
(M+Na)+ calcd. 344.1626, obsvd. 344.1629. 
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Preparation of 85 
The same procedure as that of general procedure was followed except 58.0 mg of 
39 (0.300 mmol, 1 equiv.) was added.  Yield = 30% (average of two run), diastereomeric 
ratio: >20:1, [α]20D = -26.0° (c = 0.78, CHCl3), Rf = 0.45 w/ 50% EtOAC/Hex, colorless 
oil, 1H-NMR (400 MHz, CDCl3) δ = 7.86 (s, 1 H), 7.26-7.24 (m, 2 H), 7.22 (s, 1 H), 
7.22-7.17 (m, 1 H), 7.14-7.09 (m, 1 H), 7.03-6.99 (m, 2 H), 6.91 (dd, J = 8.0 Hz, J = 1.1 
Hz, 1 H), 6.75 (td, J = 7.5 Hz, J = 1.2 Hz, 1 H), 4.58 (d, J = 3.4 Hz, 1 H), 4.39 (dt, J = 
10.1 Hz, J = 2.9 Hz, 1 H), 4.00-3.88 (m, 3 H), 3.79 (s, 3 H), 3.72 (dd, J = 11.8 Hz, J = 2.3 
Hz, 1 H), 3.59 (dt, J = 11.3 Hz, J = 5.7 Hz, 1 H), 3.47 (dd, J = 11.8 Hz, J = 10.1 Hz, 1 H).  
13C-NMR {1H} (100 MHz, CDCl3) δ = 155.8, 136.9, 130.7, 128.4, 127.9, 127.3, 121.9, 
120.5, 119.4, 119.3, 117.8, 112.2, 109.3, 79.4, 69.8, 67.6, 66.3, 41.6, 33.0. IR 3049, 2933, 
2854, 1612, 1454, 1374, 1264, 1173, 1081, 937, 907, 736 cm-1.  HRMS C20H21NO3 
(M+Na)+ calcd. 346.1419, obsvd. 346.1429. 
Product Derivatization 
Synthesis of 86   
 In a dry round bottom flask 89 mg (0.29 mmol, 1.0 equiv.) of 83 was dissolved in 
2.9 mL of DCM.  To this 80 mg (0.32 mmol, 1.1 equiv.) of PPTS was added and the 
reaction mixture was cooled to -78 °C.  At this temperature solution of 57 mg (0.32 
mmol, 1.1 equiv.) of NBS in 2.9 mL of THF was added dropwise.  The reaction mixture 
was allowed to stir for 15 min at -78 °C and quenched with 2 mL of NaHCO3.  The 
organic phase was diluted with 5 mL of DCM and washed with water (10 mL X 2) 
followed by brine (10 mL) wash.  The organic layer was dried on Na2SO4 and 
concentrated in vacuo.  The crude mixture was purified by silica gel column 
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chromatography with 2% to 10% EtOAc:Hex as eluent to give the desired product in 
92% yield.  Yield = 92% (average of two run), [α]20D = +140.3° (c = 0.39, CHCl3), Rf = 
0.66 w/ 20% EtOAC/Hex, colorless solid, M.P. = 114-120 °C.  1H-NMR (400 MHz, 
CDCl3) δ = 7.66-7.63 (m, 1 H), 7.59-7.56 (m, 1 H), 7.33-7.25 (m, 2 H), 7.21-7.11 (m, 4 
H), 4.77 (d, J = 3.5 Hz, 1 H), 4.57 (td, J = 6.8 Hz, J = 3.6 Hz, 1 H), 3.74 (m, 5 H), 1.65-
1.57 (m, 2 H), 1.40-1.30 (m, 2 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 152.7, 146.1, 
133.9, 132.1, 127.9, 125.2, 123.8, 121.8, 120.1, 120.0, 119.9, 117.8, 116.7, 108.7, 86.9, 
82.6, 68.9, 39.0, 38.9, 30.0, 28.0, 27.4, 26.1. IR 2929, 2866, 1638, 1602, 1419, 1380, 
1233, 1064, 735 cm-1.  HRMS C20H19O2N (M+Na)+ calcd. 306.1494, obsvd. 309.1503. 
Synthesis of 87   
 In a dry round bottom flask 80 mg (0.26 mmol, 1.0 equiv.) of 1g was dissolved in 
2.6 mL of DCM.  The reaction mixture was cooled to -78 °C, at this temperature 4.8 mL 
of DMDO in acetone (0.78 mmol, 3.0 equiv.) was added dropwise.  The reaction mixture 
was allow to stir for 2h (till completion) at -78 °C and quench with 2 mL of water.  The 
organic phase was diluted with 5 mL of DCM and washed with water (10 mL X 2) 
followed by brine (10 mL) wash.  The organic layer was dried on Na2SO4 and 
concentrated in vacuo.  The crude mixture was purified by silica gel column 
chromatography with 5% to 50% EtOAc:Hex as eluent to give the desired product in 
73% yield.  Yield = 73% (average of two run), Diastereomeric ratio: 1:1, Note: two 
diastereomers were readily separated by column chromatography (5% EtOAc:Hex to 
50% EtOAc:Hex). 








N "> ~ I b OH 
CI 
Conditions 
SFC, 5% Methanol, 3 mL/min, 
Whelko chiral column 
Retention time er 
9.80 and 10.54 min 97:3 
SFC, 5% Methanol, 3 mL/min, 9.80 and 10.54 min 95.5:4.5 
OD-H chiral column 
SFC, 3% Methanol, 3 mLimin, 13.26 and 14.26 min 97:3 
Whelko chiral column 
SFC, 5% Methanol, 3 mL/min, 
AD-H chiral column 
SFC, 1% Methanol, 4 mL/min, 
Whelko column 
5.09 and 5.80 min 95.5:4.5 
20.86 and 23.37 min94.5:5.5 
SFC, 7% Methanol, 3 mL/min, 10.66 and 11.60 min 95.5:4.5 
Whelko chiral column 
SFC, 5% Methanol, 3 mL/min, 11.31 and 12.13 min 97:3 
AD-H chiral column 
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Table 3.5. Separation conditions for determination of enantiopurity (for nucleophiles) 
 
Compound Conditions Retention time er 
SFC, 5% Methanol, 3 mUmin, 8.26 and 10.58 min 97:3 
AD-H chiral column 
SFC, 3% Methanol, 3 mUmin, 9.99 and 17.77 min 98.5:1.5 
OJ-H chiral column 
SFC, 3% Methanol, 3 mUmin, 7.41 and 8.42 min 98.5:1.5 
OJ-H chiral column 
SFC, 3% Methanol, 3 mUmin, 7.53 and 8.67 min 98.5:1.5 
OJ-H chiral column 
SFC, 5% Methanol, 3 mUmin, 6.61 and 8.81 min 98.5:1.5 
AD-H chiral column 
o 
o 
I SFC, 5% Methanol, 3 mUmin, 11.25 and 12.48 min 98:2 
OJ-H chiral column 
Br SFC, 10% Methanol, 3 mUmin, 6.98 and 8.82 min 98:2 




[α]20D = +114.5° (c = 1.05, CHCl3), Rf = 0.5 w/ 20% EtOAC/Hex, colorless liquid, 
1H-NMR (400 MHz, CDCl3) δ = 7.42 (dd, J = 7.4 Hz, J = 1.2 Hz, 1 H), 7.13-7.09 (m, 1 
H), 7.02-6.96 (m, 2 H), 6.87 (td, J = 7.5 Hz, J = 1.2 Hz, 1 H), 6.80 (dd, J = 7.6 Hz, J = 
1.2 Hz, 1 H), 6.58 (td, J = 7.4 Hz, J = 0.9 Hz, 1 H), 6.16 (d, J = 7.8 Hz, 1 H), 5.70 (s, 1 
H), 5.49 (s, 1 H), 4.82 (dt, J = 10.6 Hz, J = 6.6 Hz, 1 H), 4.19 (dt, J = 8.3 Hz, J = 6.3 Hz, 
1 H), 4.01-3.97 (m, 1 H) 3.20 (d, J = 10.59, 1 H), 2.88 (s, 3 H), 2.52 (dq, J = 12.5 Hz, J = 
7.2 Hz, 1 H), 2.09 (dt, J = 13.8 Hz, J = 7.0 Hz, 2 H), 1.90-1.81 (m, 1 H).  13C-NMR {1H} 
(100 MHz, CDCl3) δ = 154.7, 151.5, 129.6, 128.9, 127.7, 127.4, 125.5, 125.1, 123.0, 
118.1, 103.9, 86.0, 78.4, 68.7, 48.0, 32.8, 30.6, 26.1. IR 3354, 2928, 2875, 1611, 1456, 
1374, 741 cm-1.  HRMS C20H21O3N (M+Na)+ calcd. 346.1419, obsvd. 346.1425. 
Diastereomer 2  
[α]20D = +14.7° (c = 0.90, CHCl3), Rf = 0.3 w/ 20% EtOAC/Hex, colorless liquid, 
1H-NMR (400 MHz, CDCl3) δ = 7.09 (dd, J = 7.4 Hz, J = 0.9 Hz, 1 H), 7.03-6.96 (m, 2 
H), 6.87 (dd, J = 7.4 Hz, J = 1.6 Hz, 1 H), 6.83-6.81 (m, 1 H), 6.76 (td, J = 7.4 Hz, J = 
1.2 Hz, 1 H), 6.57 (td, J = 7.4 Hz, J = 0.9 Hz, 1 H), 6.35 (s, 1 H), 6.23 (d, J = 7.83 Hz, 1 
H), 5.58 (s, 1 H), 4.54 (ddd, J = 9.8 Hz, J = 7.8 Hz, J = 6.3 Hz, 1 H), 4.15-4.09 (m, 1 H), 
3.98 (td, J = 8.1 Hz, J = 5.3 Hz, 1 H), 3.29 (d, J = 9.8 Hz, 1 H), 2.98 (s, 3 H), 2.04 (m, 2 
H), 1.90-1.71 (m, 2 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 154.1, 151.1, 131.3, 
129.7, 129.3, 128.4, 126.9, 122.8, 123.6, 118.2, 117.9, 105.4, 101.4, 83.4, 80.9, 69.2, 
50.3, 32.4, 30.2, 24.8. IR 3354, 2928, 2875, 1611, 1456, 1374, 741 cm-1.  HRMS 






The following reagents were obtained from commercial sources as indicated: 
DMEM/F12 containing 2.5 mM L-glutamine and 15 mM HEPES buffer (HyClone); fetal 
bovine serum (FBS) was heat inactivated (HyClone); 100x insulin-transferrin-selenium-X 
(Gibco); 100x penicillin-streptomycin-glutamine (PS) (Gibco); Human Epidermal 
Growth Factor (EGF), Recombinant (BD Biosciences); Molecular biology grade DMSO 
(Sigma); 5-Bromo-2’-deoxyuridine (BrdU) (Sigma); 0.05% Trypsin-EDTA  (Gibco); 
Bovine serum albumin (BSA) fraction V (EMD); Absolute Reagent Alcohol (EtOH) 
(Mallinckrodt); Concentrated HCl (Sigma); Sodium tetraborate decahydrate  (Sigma); 
Triton X-100 (Sigma); Tween-20 (Bio-Rad); Hanks’ balanced salt solution (HBSS) with 
calcium chloride and magnesium chloride (Gibco); G3G4 mouse anti-BrdU concentrate 
(Developmental Studies Hybridoma Bank at the University of Iowa);  Alexa Fluor-488 
goat anti-mouse IgG (Invitrogen); and Propidium Iodide (Calbiochem).  
Initial Evaluation of Compounds 67-87  
 MCF-7 (Luminal ER+) cells were seeded at 3,500 cells per well in a 96 well flat 
bottom plate with DMEM/F12 media supplemented with 10% FBS, 1x ITS-X, 1x PS, 2.5 
nM EGF and incubated with 5% CO2 at 37 °C overnight.  The compounds 67-87, were 
dissolved in molecular biology grade DMSO to achieve a 10 mM stock.  The 10 mM 
DMSO stock solutions were subsequently diluted to a final concentration of 10 µM using 
DMEM/F12 media supplemented with 2% FBS, 1x ITS-X, 1x PS, 2.5 nM EGF.  The 
media was aspirated from the 96 well plate containing the MCF-7 cells and the media 
containing the compounds or DMSO vehicle controls were added.  After culturing for 3 
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days, cell proliferation was measured by metabolic reduction of MTS [(3 - (4,5 – 
dimethylthiazol - 2-yl) – 5 - (3 - carboxymethoxyphenyl) - 2 - (4 - sulfophenyl) - 2H - 
tetrazolium, inner salt)].  This assay was performed using the CellTiter 96 AQueous Non-
Radioactive Cell Proliferation Assay (Promega).  The absorbance values were normalized 
to the DMSO vehicle controls.   
Dose Response of Compounds (±)-69, (+)-69, 
(–)-69, (±)-72, (+)-72, and (–)-72 
MCF-7 (Luminal ER+) cells were seeded at 1,500 cells per well and MCF-10A 
(normal breast) cells were seeded at 9,000 cells per well in a 96 well flat bottom plate 
with DMEM/F12 media supplemented with 10% FBS, 1x ITS-X, 1x PS, 2.5 nM EGF 
and incubated with 5% CO2 at 37 °C overnight.  The compounds (±)-69, (+)-69, (–)-69, 
(±)-72, (+)-72, and (–)-72, were dissolved in molecular biology grade DMSO to achieve a 
30 mM stock.  The 30 mM DMSO stock solutions were subsequently diluted using 
DMEM/F12 media supplemented with 2% FBS, 1x ITS-X, 1x PS, 2.5 nM EGF to 
achieve 12 different concentrations using an automated liquid handler (EP Motion 5075, 
Eppendorf).  Additionally, the corresponding DMSO vehicle controls for each 
concentration were diluted using the same media.  The media was aspirated from the 96 
well plate containing the cells and the media containing the different dilutions of 
compounds and DMSO vehicle controls were added (day 0).  The cells were also treated 
on days 2 and 4 by aspirating the media and adding fresh media containing the 
compounds and DMSO vehicle controls.  On day 5 of treatment, the MTS assay was 
performed using the CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay 
(Promega).  The absorbance values were normalized to the DMSO vehicle controls 
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corresponding to each concentration.  The normalized values were plotted as an average 
± standard deviation of 4 wells per condition and these data were analyzed using the dose 
response nonlinear curve fitting function with Origin 8.0. 
BrdU/PI Cell Cycle Analysis of (±)-69 and (±)-72 
MCF-7 (Luminal ER+) cells were seeded at 150,000 cells per well in a 6 well flat 
bottom plate with DMEM/F12 media supplemented with 10% FBS, 1x ITS-X, 1x PS, 2.5 
nM EGF and incubated with 5% CO2 at 37 °C overnight.  The 30 mM DMSO stock 
solutions of compounds (±)-69 and (±)-72 were diluted to a final concentration of 10 µM 
using DMEM/F12 media supplemented with 2% FBS, 1x ITS-X, 1x PS, 2.5 nM EGF.  
The media was aspirated from the 6 well plate containing the cells and the media 
containing 10 µM of compounds (±)-69 and (±)-72 and DMSO vehicle control were 
added (day 0).  After 24 h of culture (day 1), three additional wells were treated with 
media containing 800 nM Taxol as a positive control.  After 48 h of culture (day 2), a 
concentrated stock of BrdU dissolved in phosphate buffered saline (PBS) was added to 
each well to achieve a 10 µM final concentration and was incubated for 30 min.  For each 
well, the media was subsequently collected in a 15 mL conical vial and each well was 
washed with 1 mL of PBS.  The PBS was added to the corresponding conical vial 
containing media and each well was treated with 1 mL of Trypsin-EDTA for 5 min.  The 
single cell suspension was added to the corresponding conical vial containing media.  The 
suspension was spun for 4 min/ 1500 RPM/ 4 °C and the supernatant was removed.  The 
pellet was washed by suspending in 5 mL of chilled HBSS supplemented with 2% BSA 
and was subsequently spun for 4 min/ 1500 RPM/ 4 °C.  The supernatant was removed 
and the cell pellet was suspended in 300 uL of PBS.  With a gentle vortex, 700 uL of 
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absolute ethanol was added drop wise and was kept at -20 °C overnight.  After warming 
to room temperature, the mixture was spun for 4 min/ 1500 RPM/ 4 °C and the 
supernatant was removed.  The cell pellet was suspended in 1 mL of PBS, spun for 4 
min/ 1500 RPM/ 4 °C, and the supernatant was removed.  The cell pellet was suspended 
with 1 mL of 2 N HCl containing 0.5% TritonX-100, incubated at room temperature for 
30 min, spun for 4 min/ 1500 RPM/ 4 °C, and the supernatant was removed. The pellet 
was suspended in 1 mL of 0.1 M of sodium tetraborate decahydrate buffer at pH = 8.0, 
spun for 4 min/ 1500 RPM/ 4 °C, and the supernatant was removed.  The cells were 
blocked with 1 mL of PBS containing 2% BSA and 0.5% tween-20 for 15 min, spun for 4 
min/ 1500 RPM/ 4 °C, and the supernatant was removed.  The cells were stained with 
300 µL of 10 µg/mL of mouse anti-BrdU primary antibody diluted with PBS containing 
2% BSA and 0.5% tween-20 at 4 °C for 1 h.  The cells were washed with 1 mL of PBS 
containing 2 % BSA and 0.5% tween-20, spun for 4 min/ 1500 RPM/ 4 °C, and the 
supernatant was removed.  The cells were stained with 500 µL of Alexa Fluor-488 goat 
anti-mouse IgG secondary antibody diluted 1:1000 with PBS containing 2% BSA and 
0.5% tween-20 at 4 °C for 1 h.  The cells were washed with 1 mL of PBS containing 2 % 
BSA and 0.5% tween-20 for 15 min, spun for 4 min/ 1500 RPM/ 4 °C, and the 
supernatant was removed.  The cells were stained with 250 µL of 5 µg/mL propidium 
iodide in PBS at room temperature and passed through a 35 µm filter.  The suspension 
was analyzed using a BD FACScan flowcytometer.  The percent of cells in G1, S, and G2 
were measured and reported as an average ± standard deviation for three independent 
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PALLADIUM-CATALYZED HYDROHETEROARYLATION  
REACTIONS OF VINYL PHENOLS 
Introduction 
 In recent years, substantial attention has been given to metal-catalyzed 
hydrofunctionalization reactions with significant focus on hydroheteroarylation 
reactions.1-6  When using vinyl arenes as substrates, these reactions rapidly generate 
molecular complexity around biologically relevant 1,1-diaryl substructures.7-13  Thus, our 
group has developed various hydrofunctionalization reactions of styrenes14-16 and 
dienes17 using alkyl and aryl organometallics as reaction partners.  We have also reported 
the hydroalkoxylation of vinyl phenols.14-19  These reactions have generally been limited 
to the introduction of simple arenes and alkyl groups as the organometallic reaction 
partner.  Thus, hydrofunctionalization reactions that allow for facile incorporation of 
broad classes of heteroaromatic compounds are highly desired.  Moreover, as discussed 
in Chapter 3, compounds 69 and 72 demonstrate interesting biological activity against 
breast cancer cell lines, which provides an additional impetus for the development of a 
hydrofunctionalization of vinyl phenols with heterocycles to furnish structures analogous 





Figure 4.1.  Biological activity of compound 69 and 72 against breast cancer cell lines 





Hydrofunctionalization of alkenes with various arenes has been extensively 
reported in the chemical literature.20-21  However, reports of hydroheteroarylation of 
alkenes are scarce.22-24  In this chapter, relevant recent advances are discussed in detail.   
In 2006, Widenhoefer and coworkers reported an interesting hydroheteroarylation 
reaction of simple alkenes with indoles, using [PtCl2(CH2=CH2)2] as a catalyst.25  The 
most striking feature of this method is the use of ethylene in the reaction with indole to 
give the corresponding Markovnikov addition product in excellent yield (Figure 4.2a).  
However, when styrenes are used as the substrate, mixtures of Markovnikov and anti-
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Markovnikov products were observed (Figure 4.2b).  Here, the selectivity is based on the 
stability of the corresponding benzylic carbocation.  Cabocationic intermediate C is 
proposed as the key intermediate, which on reaction with indole leads to product 
formation (Figure 4.2c).   
In 2007, Liu and coworkers reported a Au-catalyzed hydroarylation of styrenes 
with indoles (Figure 4.3).26  Interestingly, they observed that catalytic TfOH (which 
 
 






Figure 4.3. Acid catalyzed hydroheteroarylation of alkenes with N-phenylsulfonyl-(Bs)-




could form under reported Au-catalyzed conditions after every catalytic cycle) also 
promoted the reaction.  Thus, the scope of this transformation was explored with catalytic 
amounts of TfOH.  The scope of this reaction is limited in both reaction partners.  
Moreover, only N-phenylsulfonyl-(Bs)-protected indoles were used in this report.  Later, 
Che and coworkers reported an improved Au-catalyzed hydroheteroarylation of alkenes 
with broad substrate scope (Figure 4.4). 27-28  Under optimized conditions, dienes as well 
as trisubstituted alkenes led to product formation with excellent selectivity.  The 
proposed mechanism for these processes proceeds via the coordination of the alkene 
carbon-carbon double bond to cationic [AuPPh3]+, which is attacked by the nucleophilic 
indole to give a gold complex B.  This undergoes subsequent protonolysis at the Au-C 



















 In 2006, Hiyama and coworkers reported an elegant example of a Ni-catalyzed 
hydroheteroarylation of alkynes (Figure 4.5).29  The scope of this reaction is broad with 
respect to heterocycles, however, only symmetrical alkynes gave satisfactory yields of 
the desired product.  More recently, Hiyama and coworkers reported a similar 
transformation for styrenes with broad scope in both coupling partners (Figure 4.6).22-24   
The proposed mechanism is shown in Figure 4.6.  Reversible oxidative addition of an Ar-
H bond to the nickel0/IiMes catalyst results in nickel hydride A.  The coordination of 
vinylarene to give intermediate B and subsequent hydronickelation leads to 1-
arylethylnickel C, that reductively eliminates 1,1-diarylethanes irreversibly to regenerate 
active catalyst. 
 


















As described above, a number of methods for the hydroheteroarylation of styrenes 
are available.  However, Pd-hydride species have never been utilized for such reactions.  
Thus, we became interested in developing a Pd-catalyzed hydroheteroarylation of 
styrenes to yield products analogous to compounds 69 and 72.    
When vinyl phenol 18 was subjected to our previously reported alkene 
hydroalkoxylation reaction conditions, it gave a poor yield of the desired product using 
N-methyl indole as the nucleophile (Figure 4.7).18  Furthermore, indole derivatives 
lacking a protecting group on nitrogen were not tolerated, severely limiting the scope of 
the process.30  To overcome these issues, alternative methods to generate Pd-hydrides 
were explored.  We envisioned that oxidative addition of the alkyl halide with Pd0 would 
result in the formation of a Pd-alkyl intermediate A (Figure 4.8).  Because, Pd-alkyl 
complexes are known to undergo facile β-hydride elimination, intermediate A should 
readily generate Pd-hydride B and the corresponding alkene.  Insertion of substrate 18 
into Pd-hydride B would give intermediate C, which would decompose to the quinone 
methide intermediate D.  The nucleophilic aromatic substitution reaction of indole with 
intermediate D would result in product formation with concomitant release of Pd0.  To 
our knowledge, this approach to generate Pd-hydrides has never been used to perform 
hydrofunctionalization reactions of alkenes.  Additionally, the proposed Pd0-catalyzed 
process should allow for the use of phosphine ligands, which were previously 
























Reaction Optimization and Scope 
Initial investigation of this proposed process began with the selection of Pd2(dba)3 
and P(Cy)3, with an alkyl bromide as the potential hydride source based on Fu’s reported 
Pd-catalyzed alkyl-alkyl cross-couplings.31-32  It should be noted that Fu’s conditions are 
generally designed to slow β-hydride elimination of the Pd-alkyl generated from 
oxidative addition of an alkyl electrophile.  However, when the reaction is performed 
above 50 °C, β-hydride elimination is observed.31-32  The reaction of substrate 18 with 
1,2-dimethylindole, in the presence of 2 equivalents of C12H25Br as a source of hydride, 
gave the desired product 99 in 33% yield, with 26% yield of undesired alkylation of 
phenol 100 (Table 4.1, entry 1).  Use of bidentate ligands did not improve the reaction 
outcome (Table 4.1, entry 2-4).  Upon systematic screening, 17 mol% ligand loading was 
found to give the best result (Table 4.1, compare entries 1 and 5).  The formation of 100 
is thought to proceed via a nucleophilic substitution of bromide with a phenoxide, and 
could be potentially overcome by the use of a sec-alkyl bromide or an alkyl chloride; in 
both cases SN2 processes should be slower.  Indeed, cyclohexyl bromide and butyl 
chloride exclusively gave the desired product but reactions were slower and did not 
proceed to completion (Table 4.1, entries 6, 7).  Due to low cost (~$ 0.03/g) and ease, 
butyl chloride was chosen as a hydride source.  Changing the solvent from toluene to 
THF or DMA resulted in significantly lower yield of the desired product (Table 4.1, 
entries 8, 9).  Finally, addition of 6 equivalents of butyl chloride and longer reaction time 






Table 4.1. Optimization of reaction conditions. 
 
 
OH 5 mol% Pd2dba3 
R,O X mol% ligand ~ ~ ~ 1 equiv. KHC03, 80 'C RX. solvent, t h 18 / 
co-1.0 8 99 100 
15 equiv. 
Entry X Ligand RX t (h) Solvent % Conv.a% 99b% 100b 
1 20 P(Cyh 2 equiv. C12H2SBr 48 Toluene 87 
2 10 dcpe 2 equiv. C12H2SBr 48 Toluene 71 
3 10 dppf 2 equiv. C12H2SBr 48 Toluene 68 
4 10 BINAP 2 equiv. C12H2SBr 48 Toluene 44 
5 17 P(Cyh 2 equiv. C12H2SBr 48 Toluene 76 
6 17 P(Cyh 4 equiv.CyBr 60 Toluene 65 
7 17 P(Cyh 4 equiv. C4HgCI 60 Toluene 81 
8 17 P(Cyh 4 equiv. C4HgCI 60 THF 
9 17 P(Cyh 4 equiv. C4HgCI 60 DMA 














[a] The conversion was measured by GC with an internal standard. 
[b] The yield was determined by GC. Concentration of the reaction 














Having optimized the reaction conditions, we moved our attention to evaluate the 
scope, starting with indole nucleophiles.  To our delight, under the optimized conditions 
unprotected 1H-indole gave the product in 80% isolated yield with recovery of the 
remaining nucleophile in >90% yield (Table 4.2, compound 101).  Unprotected 
indoles/heteroaromatics as nucleophiles are beneficial because they not only avoid an 
undesired protection-deprotection sequence, but they also provide flexibility for further 
synthetic modifications.  N-alkyl substituted indoles performed well to give products in 
good yields (Table 4.2, compounds 98, 102).  Indoles with different steric and electronic 
parameters, including sterically demanding 2-subtituted indoles are well tolerated under 
the reaction conditions (Table 4.2, compounds 103-108).  Using a 3-substituted indole as 
the nucleophile, the less nucleophilic 2-position of indole can be functionalized under the 
optimized reaction conditions (Table 4.2, compound 109).  The nucleophile scope was 
further expanded to include other nucleophilic heterocycles such as pyrroles, a furan and 
an indolizine (Table 4.2, compounds 110-114).  Indolizines are isoelectronic to indoles 
and often used in medicinal chemistry to replace indoles during structure-activity 
relationship (SAR) studies.   
Next, the effect of the electronic and steric parameters on the phenol was 
evaluated.  Both electron withdrawing and electron rich vinyl phenols gave good yields 
of the desired products (Table 4.3, entries 115-118).  The p-vinylphenol also reacted 
under the optimized conditions, albeit in low yield (Table 4.3, entry 119).  
To further demonstrate the utility of the developed methodology, an inverse 
electron demand Diels-Alder reaction with an electron rich cyclic enamine was 
conducted (See Chapter 1, Figure 4.9).  The reaction proceeded smoothly to give  
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Table 4.2.  Scope of exogenous nucleophiles. 
 
OH 5 mol% Pd2dba3 













































60% Yieldb 63% Yield 
a) Yields are averages of at least two runs at 0.3 mmol scale. b) Reactions 
performed at 1 OO~. c) 1 mL of nucleophile was used. d) Performed on a 
























chromane derivative 120 in 63% yield as a single diastereomer.  This transformation 
showcases the effectiveness of the method to generate relatively complex frameworks 
from a simple substrate, in a single step, with excellent diastereoselectivity.  Nucleophiles 
that failed to provide the desired hydrofunctionalized products are shown in Figure 4.10. 
Accessing Interesting Indole Core Structures 
The phenol, which is a mechanistic requirement for quinone methide formation, 
provides a handle for further derivatization of products to biologically relevant scaffolds 
as demonstrated in Figure 4.11.  Conversion of phenol 101 to the corresponding triflate, 
followed by an intramolecular Heck reaction gives the potent antioxidant 121 in 87% 
yield (Figure 4.11a).33-34  The tetracyclic indanoindole scaffolds are also found in various 
biologically active compounds and exhibits a range of biological activity.33,35-47  
Furthermore, the indole core (in 121) is still intact and allows for further derivatization.  
Compound 101 can also be converted to compound 122 in excellent yield (Figure 4.11b), 
which is structurally equivalent to a hydroheteroarylated styrene and is a common 
scaffold found in many pharmacophores.7-13  Furthermore, the treatment of compound 
101 with NBS gives tetracyclic compound 123 in excellent yield (Figure 4.11c). 
 










To support our mechanistic hypothesis, a control experiment in the absence of the 
alkyl chloride was performed (Figure 4.12a).  To our surprise, product formation was still 
observed presumably via a 1,5-sigmatropic rearrangement, albeit in lower yields.48  
Additionally, a reaction of the vinyl phenol with indoles in the absence of any catalyst 








sigmatropic rearrangements are not commonly used for o-QM formation and 
functionalization and often require more forcing conditions.  Additionally, the observed 
1,5-sigmatropic rearrangement is promising and could provide an alternative method to 
utilize reaction partners, that are currently not compatible with known methods for o-QM 
formation and functionalization. 
To probe the origin of the hydrogen incorporated into the desired product 125, 
deuterium labeling experiments were performed.  The use of deuterated phenol 124 under 
standard reaction conditions resulted in <5% deuterium incorporation in the desired 
product (Figure 4.13a).  However, reaction of deuterated phenol in the presence of a 









These experiments suggest that in the presence of the alkyl halide a mechanism involving 
a Pd-hydride dictates the product formation over a 1,5-sigmatropic rearrangement.  The 
deuterium labelling experiments in conjunction with the above control experiments 
(Figure 4.12) suggest that both of the proposed reaction pathways could be contributing 
to product formation.49 
Conclusion 
 We have successfully utilized a Pd-hydride, generated from an alkyl halide, in the 
hydrofunctionalization reaction of vinyl phenols.  This method allows for the use of 
various heterocycles as exogenous nucleophiles.  Moreover, the products obtained can be 
rapidly processed to biologically relevant scaffolds.  In addition, they are analogous to 
compounds 69 and 72 and are currently being screened against various cancer cell lines. 
The method serves as a proof-of-concept, and currently, we are applying this approach to 





Unless otherwise noted, all reactions were run under a nitrogen atmosphere with 
stirring.  Toluene, dichloromethane, and THF were dried before use by passing through a 
column of activated alumina. All other reagents (including indoles) were purchased from 
commercial sources and used without further purification.  Yields were calculated for 
material judged homogeneous by thin-layer chromatography and NMR.  Thin-layer 
chromatography was performed with EMD silica gel 60 F254 plates eluting with the 
solvents indicated, visualized by a 254 nm UV lamp, and stained either with potassium 
permanganate, p-anisaldehyde, phosphomolybdic acid or vanillin.  Flash column 
chromatography was performed with EcoChrom MP Silitech 32-63D 60Å silica gel, 
slurry packed with solvents indicated in glass columns. Nuclear magnetic resonance 
spectra were acquired at 400 MHz for 1H, and 100 MHz for 13C. Chemical shifts for 
proton nuclear magnetic resonance (1H NMR) spectra are reported in parts per million 
downfield relative to the line of CHCl3 singlet at 7.26 ppm. Chemical shifts for carbon 
nuclear magnetic resonance (13C NMR) spectra are reported in parts per million 
downfield relative to the center-line of the CDCl3 triplet at 77.2 ppm. The abbreviations s, 
d, t, q, td, dd and m stand for the resonance multiplicities singlet, doublet, triplet, quartet, 
triplet of doublet, doublet of doublet and multiplet, respectively.  IR spectra were 
recorded using a Nicolate FT-IR instrument.  Glassware for all reactions was oven-dried 







To an oven-dried 500 mL round bottom flask equipped with a stir bar were added 
34.2 g of phosphine salt (96.0 mmol, 2.30 equiv.) and 300 mL toluene. To this was added 
a solution of 10.80 g KOtBu (96.9 mmol, 2.33 equiv.) in 80 mL of THF dropwise via 
cannulation.  The reaction mixture slowly turned a deep red color over 4 h.  The mixture 
was cooled to –0 °C and 5.00 g of salicylaldehyde (41.1 mmol, 1.00 equiv.), dissolved in 
20 mL of toluene, was added dropwise.  The mixture was allowed to slowly warm to 
ambient temperature and stirred 8 hours then quenched with 50 mL of saturated NH4Cl 
solution.  The mixture was diluted with 100 mL of diethyl ether and washed with 100 mL 
(2 x 50 mL) of water and 60 mL of brine.  The organic layer was dried over MgSO4, 
filtered, and the solvent removed in vacuo.  The crude mixture was purified by flash 
silica-gel column chromatography with 10%-20% EtOAc/Hexanes as eluent. 
1H-NMR was matched with literature 1H-NMR for all substrates.18 
Reaction Optimization (see Table 4.1 in text) 
Entry 1, Table 4.1 
In the glovebox, to a 2.5 dram vial equipped with a stir bar were added 4.7 mg 
Pd2dba3 (0.0050 mmol, 0.050 equiv.), 5.6 mg P(Cy)3 (0.020 mmol, 0.20 equiv.) and 200 
µL of toluene. The reaction mixture was allowed to stir for ca.15 min.  In a separate 2.5 
dram vial equipped with a stir bar was added 50.0 mg of alkyl bromide (0.02 mmol, 2.0 
equiv.), 10.0 mg of KHCO3 (0.10 mmol, 1.0 equiv.), 217.5 mg of 1,2-dimethylindole 
(1.500 mmol, 15.00 equiv.) and 200 µL of standard solution of 3 (0.10 mmol, 1.00 
equiv.) in toluene (standard solution: 18.0 mg of 3, and 10 µL of undecane as internal 
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standard in 300 µL of toluene).  To this an additional 600 µL of toluene and the catalyst 
solution were added.   The vial was capped and was heated to 80 °C for 48 h in an oil 
bath. At this point the vial was open to air, and the reaction was analyzed by GC using an 
internal standard to calculate conversion as well as yield of various products.   
Entry 2, Table 4.1 
 The same procedure as described for entry 1 was used, except 4.22 mg dcpe 
(0.0100 mmol, 0.100 equiv.) was added as ligand.   
Entry 3, Table 4.1 
 The same procedure as described for entry 1 was used, except 5.84 mg dppf 
(0.0100 mmol, 0.100 equiv.) was added as ligand. 
Entry 4, Table 4.1 
 The same procedure as described for entry 1 was used, except 6.20 mg BINAP 
(0.0100 mmol, 0.100 equiv.) was added as ligand. 
Entry 5, Table 4.1 
 In the glovebox, to a 2.5 dram vial equipped with a stir bar were added 4.7 mg 
Pd2dba3 (0.0050 mmol, 0.050 equiv.), 5.0 mg P(Cy)3 (0.017 mmol, 0.17 equiv.) and 200 
µL of toluene. The reaction mixture was allowed to stir for ca.15 min.  In a separate 2.5 
dram vial equipped with a stir bar was added 50.0 mg of alkyl bromide (0.02 mmol, 2.0 
equiv.), 10.0 mg of KHCO3 (0.10 mmol, 1.0 equiv.) and 217.5 mg of 1, 2-dimethylindole 
(1.500 mmol, 15.00 equiv.) and 200 µL of standard solution of 3 (0.10 mmol, 1.00 
equiv.) in toluene (standard solution: 18.0 mg of 3, and 10 µL of undecane as internal 
standard in 300 µL of toluene).  To this, an additional 600 µL of toluene and the catalyst 
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solution were added.   The vial was capped and was heated to 80 °C for 48 h in an oil 
bath. At this point the vial was open to air and the reaction was analyzed by GC using an 
internal standard to calculate conversion as well as yield of various products.   
Entry 6, Table 4.1 
The same procedure as described for entry 5 was used, except 49.0 µL CyBr (0.40 
mmol, 4.00 equiv.) was added and the reaction was run for  60 h.  
Entry 7, Table 4.1 
 The same procedure as described for entry 5 was used, except 19.0 µL C4H9Cl 
(0.40 mmol, 4.00 equiv.) was added and the reaction was run for 60 h.  
Entry 8, Table 4.1 
The same procedure as described for entry 5 was used, except THF was used as 
solvent. 
Entry 9, Table 4.1  
The same procedure as described for entry 5 was used, except DMA was used as 
solvent. 
Entry 10, Table 4.1  
The same procedure as described for entry 5 was used, except 28.0 µL C4H9Cl 







In the glovebox, to a 2.5 dram vial equipped with a stir bar was added 14.1 mg 
Pd2dba3 (0.015 mmol, 0.050 equiv.), 15.0 mg P(Cy)3 (0.051 mmol, 0.17 equiv.) and 1.0 
mL of toluene.  The reaction mixture was allowed to stir for ca.15 min.  In a separate 25 
mL sealed flask equipped with a stir bar was added 165.0 µL of C4H9Cl (1.80 mmol, 6.0 
equiv.), 30.0 mg of KHCO3 (0.30 mmol, 1.0 equiv.) and 526.5 mg of 1H-indole (4.500 
mmol, 15.00 equiv.) and 36.0 mg of 18 (0.30 mmol, 1.00 equiv.) in 2.0 mL of toluene.  
To this, catalyst solution was added.   The flask was capped and was heated to 80 °C for 
72 h, in oil bath, and diluted with 10 mL of EtOAc. The reaction mixture was then passed 
through silica gel to remove metal complexes and concentrated in vacuo. The crude 
mixture was purified with flash silica-gel column chromatography. 
Note: Most of the compounds were found to be light sensitive and turned brown, yellow 
or green over a period of time.   
Preparation of 101 
The same procedure as that of general procedure was followed.  This reaction was 
scaled up to 1.5 mmol.  Yield = 80% (average of two run), Rf = 0.30 w/ 20% EtOAC/Hex, 
pale green solid, M.P. = 95-97 °C.  1H-NMR (400 MHz, CDCl3) δ = 7.96 (s,1 H), 7.40 (d, 
J = 8.0 Hz, 1 H), 7.32 (dt, J = 7.6 Hz, J = 1.8 Hz, 2 H), 7.21-7.13 (m, 2 H), 7.06-7.02 (m, 
1 H), 6.96 (ddd, J = 14.4 Hz, J = 6.9 Hz, J = 1.5 Hz, 2 H), 6.78 (dd, J = 8.0 Hz, J = 1.1 
Hz, 1 H), 5.28 (s, 1 H), 4.54 (q, J = 7.1 Hz, 1 H), 1.75 (d, J = 7.1 Hz, 3 H).  13C-NMR 
{1H} (100 MHz, CDCl3) δ = 154.3, 137.1, 131.7, 128.6, 127.8, 126.8, 122.7, 121.5, 
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121.1, 119.9, 119.8, 119.6, 116.6, 111.5, 32.4, 20.5. IR 3406, 2963, 1584, 1451, 1335, 
1095, 738 cm-1. HRMS C16H16NO (M)+ calcd. 238.1232, obsvd. 238.1239. 
Preparation of 98 
The same procedure as that of general procedure was followed except 589 mg of 
N-methylindole (4.50mmol, 15.0 equiv.) was added.  Yield = 68% (average of two run), 
Rf = 0.35 w/ 20% EtOAC/Hex, sticky oil.  1H-NMR (400 MHz, CDCl3) δ = 7.40 (dt, J = 
8.0 Hz, J = 1.0 Hz, 1 H), 7.34-7.29 (m, 1 H), 7.23 (ddd, J = 8.1 Hz, J = 7.0 Hz, J = 1.1 
Hz, 1 H), 7.15 (td, J = 7.7 Hz, J = 1.6 Hz, 1 H), 7.03 (ddd, J = 8.0 Hz, J = 6.9 Hz, 1.0 Hz, 
1 H), 6.95 (dt, J = 7.4 Hz, J = 1.3 Hz, 1 H), 6.91 (d, J = 1.0 Hz, 1 H), 6.78 (dd, J = 8.0 
Hz, J = 1.2 Hz, 1 H), 5. 26 (s, 1 H), 4.53 (q, J = 7.1 Hz, 1 H), 3.74 (s, 3 H), 1.75 (d, J = 
7.1 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 154.3, 137.9, 131.7, 128.5, 127.8, 
127.2, 126.2, 122.3, 121.0, 119.9, 119.3, 117.9, 116.6, 109.6, 33.0, 32.4, 20.6. IR 3356, 
2963, 1737, 1612, 752 cm-1. HRMS C17H17NO (M+Na)+ calcd. 274.1208, obsvd. 
274.1205. 
Preparation of 102 
The same procedure as that of general procedure was followed except 770.0 mg 
of indole (4.500 mmol, 15.0 equiv.) was added.  Yield = 74% (average of two run), Rf = 
0.35 w/ 20% EtOAC/Hex, colorless liquid, 1H-NMR (400 MHz, CDCl3) δ = 7.36 (m, 3 
H), 7.23-7.19 (m, 1 H), 7.17-7.12 (m, 1 H), 7.10 (s, 1 H), 7.02 (ddt, J = 7.9 Hz, J = 7.0 
Hz, 0.9 Hz, 1 H), 6.95 (dt, J = 7.5 Hz, J = 0.9 Hz, 1 H), 6.78 (d, J = 8.0 Hz, 1 H), 5. 34 (s, 
1 H), 4.53 (q, J = 7.1 Hz, 1 H), 3.95 (d, J = 6.8 Hz, 2 H), 1.77 (d, J = 7.1 Hz, 3 H), 1.32-
1.22 (m, 1 H), 0.65-0.60 (m, 2 H), 0.38-0.34 (m, 2 H).  13C-NMR {1H} (100 MHz, 
CDCl3) δ = 154.5, 137.5, 131.8, 128.6, 127.8, 127.3, 124.9, 122.3, 121.0, 120.1, 119.3, 
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117.9, 116.6, 109.8, 50.9, 32.7, 20.6, 11.5, 4.4, 4.3. IR 3419, 2963, 2928, 1611, 1451, 
1219, 733 cm-1. HRMS C20H22NO (M)+ calcd. 292.1701, obsvd. 292.1704. 
Preparation of 103 
The same procedure as that of general procedure was followed except 932.8 mg 
of N-methyl-2-phenyl-indole (4.500 mmol, 15.0 equiv.) was added. Yield = 68% 
(average of two run), Rf = 0.47 w/ 20% EtOAC/Hex, colorless solid.  M.P. = 169-171 °C.  
1H-NMR (400 MHz, CDCl3) δ = 7.45 (m, 4 H), 7.34-7.29 (m, 2 H), 7.23 -7.19 (m, 1 H), 
7.12-7.09 (m, 1 H), 7.02-6.91 (m, 3 H), 6.69 (dd, J = 7.9 Hz, J = 1.2 Hz, 1 H), 5. 17 (s, 1 
H), 4.31 (q, J = 7.1 Hz, 1 H), 3.56 (s, 3 H), 1.75 (d, J = 7.1 Hz, 3 H).  13C-NMR {1H} 
(100 MHz, CDCl3) δ = 154.8, 137.9, 137.8, 131.4, 130.8, 129.0, 128.9, 127.7, 127.0, 
126.0, 122.3, 120.6, 119.7, 116.2, 114.7, 109.8, 31.0, 30.9, 20.7. IR 3311, 2929, 2851, 
1590, 1448, 1328, 1232, 1071, 1023, 749 cm-1. HRMS C23H22NO (M)+ calcd. 328.1701, 
obsvd. 328.1704. 
Preparation of 104 
V except 653.4 mg of 1,2-dimethyl-indole (4.500 mmol, 15.0 equiv.) was added. 
Yield = 82% (average of two run), Rf = 0.45 w/ 20% EtOAC/Hex, colorless solid, M.P. = 
94-96 °C. 1H-NMR (400 MHz, CDCl3) δ = 7.53 (dt, J = 7.6 Hz, J = 1.1 Hz, 1 H), 7.31 (d, 
J = 7.9 Hz, 1 H), 7.25 (d, J = 8.2 Hz, 1 H), 7.19-7.12 (m, 2 H), 7.04-6.95 (m, 2 H), 6.76 
(dd, J = 7.9 Hz, J = 1.3 Hz, 1 H), 5. 25 (s, 1 H), 4.48 (q, J = 7.2 Hz, 1 H), 3.63 (s, 3 H), 
2.32 (s, 3 H), 1.73 (d, J = 7.2 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 155.0, 
133.7, 131.2, 127.8, 126.9, 126.2, 121.3, 120.7, 119.4, 118.8, 116.4, 112.0, 109.1, 30.9, 
29.7, 20.1, 10.5.  IR 3406, 2970, 1609, 1470, 1452, 739 cm-1. HRMS C18H20NO (M)+ 
calcd. 266.1545, obsvd. 266.1546. 
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Preparation of 105 
V except 851.4 mg of ethyl 1H-indole-2-carboxylate (4.500 mmol, 15.0 equiv.) 
was added. Yield = 53% (average of two run), Rf = 0.21 w/ 33% EtOAC/Hex, colorless 
solid, M.P. = 135-137 °C 1H-NMR (400 MHz, CDCl3) δ = 8.68 (s, 1 H), 7.77 (d, J = 8.3 
Hz, 1 H), 7.69 (d, J = 6.9 Hz, 1 H), 7.32 (dd, J = 8.3 Hz, J = 0.8 Hz, 1 H), 7.25 (d, J = 8.6 
Hz, 1 H), 7.11-7.07 (m, 1 H), 7.03-6.94 (m, 2 H), 6.82 (dd, J = 8.0 Hz, J = 1.0 Hz, 1 H), 
5.32 (q, J = 7.1 Hz, 1 H), 4.40-4.32 (m, 1 H), 4.26-4.18 (m, 1 H), 1.85 (d, J = 7.1 Hz, 3 
H), 1.31 (td, J = 7.1 Hz, J = 0.8 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 164.3, 
155.4, 137.0, 129.8, 128.3, 127.4, 126.6, 126.4, 123.2, 122.0, 120.8, 120.6, 117.0, 112.7, 
62.3, 30.2, 20.4, 14.8.  IR 3327, 2924, 1716, 1245, 748 cm-1. HRMS C19H19NO3 
(M+Na)+ calcd. 332.1263, obsvd. 332.1263. 
Preparation of 106 
The same procedure as that of general procedure was followed except 788.4 mg 
of methyl 1H-indole-6-carboxylate (4.500 mmol, 15.0 equiv.) was added.  Yield = 63% 
(average of two run), Rf = 0.31 w/ 50% EtOAC/Hex, colorless solid, M.P. = 88-90 °C. 
1H-NMR (400 MHz, Acetone-D6) δ = 8.33 (s, 1 H), 8.12 (s, 1 H), 7.60 (dd, J = 8.4 Hz, J 
= 1.5 Hz, 1 H), 7.49 (dd, J = 2.7 Hz, J = 0.9 Hz, 1 H), 7.43 (d, J = 8.4 Hz, 1 H), 7.00-6.96 
(m, 2 H), 6.89 (dd, J = 7.4 Hz, J = 0.9 Hz, 1 H), 6.68 (td, J = 7.4 Hz, J = 1.1 Hz, 1 H), 
4.88 (q, J = 7.1 Hz, 1 H), 3.84 (s, 3 H), 1.66 (d, J = 7.1 Hz, 3 H).  13C-NMR {1H} (100 
MHz, Acetone-D6) δ = 167.6, 154.4, 136.5, 133.3, 130.8, 128.1, 126.8, 125.7, 123.2, 
121.1, 119.8, 119.4, 119.0, 115.3, 113.6, 51.2, 20.6.  IR 3405, 2962, 1715, 1472, 1304, 




Preparation of 107 
The same procedure as that of general procedure was followed except 653.4 mg 
of 7-ethyl-1H-indole (4.500 mmol, 15.0 equiv.) was added. Yield = 86% (average of two 
run), Rf = 0.42 w/ 20% EtOAC/Hex, colorless solid, M.P. = 98-100 °C. 1H-NMR (400 
MHz, CDCl3) δ = 7.98 (s, 1 H), 7.31 (dd, J = 8.3 Hz, J = 1.7 Hz, 1 H), 7.27 (dd, J = 7.6 
Hz, J = 0.7 Hz, 1 H), 7.13 (td, J = 7.7 Hz, J = 1.7 Hz, 1 H), 7.04-6.97 (m, 3 H), 6.94 (td, J 
= 7.5 Hz, J = 1.3 Hz, 1 H),  6.77 (dd, J = 8.0 Hz, J = 1.2 Hz, 1 H), 5.26 (bs, 1 H), 4.52 (q, 
J = 7.1 Hz, 1 H), 2.82 (q, J = 7.6 Hz, 2 H), 1.74 (d, J = 7.1 Hz, 3 H), 1.34 (t, J = 7.6 Hz, 3 
H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 154.3, 136.0, 131.7, 128.5, 127.8, 126.8, 
126.6, 121.3, 121.1, 121.0, 120.2, 120.1, 117.6, 116.6, 32.6, 24.1, 20.5, 14.0. IR 3415, 
2963, 2930, 1587, 1450, 1217, 784 cm-1. HRMS C18H20NO (M)+calcd. 266.1545, obsvd. 
266.1545. 
Preparation of 108 
The same procedure as that of general procedure was followed except 780.0 mg 
of 5-methoxy-1H-indole (4.500 mmol, 15.0 equiv.) was added. Yield = 83% (average of 
two run), Rf = 0.22 w/ 20% EtOAC/Hex, colorless solid, M.P. = 148-150 C  1H-NMR 
(400 MHz, CDCl3) δ = 7.97 (s, 1 H), 7.33 (dd, J = 7.6 Hz, J = 1.6 Hz, 1 H), 7.21 (d, J = 
8.7 Hz, 1 H), 7.14 (td, J = 7.6 Hz, J = 1.6 Hz, 1 H), 7.02 (d, J = 1.6 Hz, 1 H), 6.95 (td, J = 
7.5 Hz, J = 1.2 Hz, 1 H), 6.86 (dd, J = 8.7 Hz, J = 2.4 Hz, 1 H), 6.82-6.77 (m, 2 H), 5.32 
(bs, 1 H), 4.50 (q, J = 7.1 Hz, 1 H), 3.72 (s, 3 H), 1.75 (d, J = 7.1 Hz, 3 H).  13C-NMR 
{1H} (100 MHz, CDCl3) δ = 154.3, 154.0, 132.3, 131.6, 128.6, 127.8, 127.2, 122.3, 
121.1, 119.2, 116.6, 112.8, 112.2, 101.8, 55.9, 32.5, 20.4. IR 3410, 2963, 1583, 1451, 
1272, 1208, 743 cm-1. HRMS C17H18NO2 (M)+ calcd. 268.1338, obsvd. 268.1342. 
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Preparation of 109 
The same procedure as that of general procedure was followed except 590.4 mg 
of 3-methyl-1H-indole (4.500 mmol, 15.0 equiv.) was added and reaction was heated to 
100 °C. Yield = 68% (average of two run), Rf = 0.45 w/ 20% EtOAC/Hex, colorless thick 
liquid, 1H-NMR (400 MHz, CDCl3) δ = 7.52-7.50 (m, 1 H), 7.23-7.21 (m, 1 H), 7.08-
7.03 (m, 2 H), 6.98-6.94 (m, 2 H), 6.79 (t, J = 7.5 Hz, 1 H), 6.65 (d, J = 8.0 Hz, 1 H), 
5.84 (q, J = 7.0 Hz, 1 H), 4.95 (bs, 1 H), 2.28 (s, 3 H), 1.78 (d, J = 7.0 Hz, 3 H).  13C-
NMR {1H} (100 MHz, CDCl3) δ = 153.2, 136.6, 129.4, 129.0, 128.8, 128.7, 126.9, 122.7, 
121.8, 121.4, 119.2, 116.1, 111.2, 110.1, 49.7, 20.2, 10.0. IR 3507, 2975, 2931, 1609, 
1456, 737 cm-1. HRMS C17H18NO (M)+ calcd. 252.1388, obsvd. 252.1391. 
Preparation of 110 
The same procedure as that of general procedure was followed except 1 mL of 
1H-pyrrole was added. Yield = 72% (average of two run), Rf = 0.35 w/ 20% EtOAC/Hex, 
yellow oil, 1H-NMR (400 MHz, CDCl3) δ = 8.06 (s, 1 H), 7.18-7.13 (m, 2 H), 6.93 (td, J 
= 7.5 Hz, J = 1.2 Hz, 1 H), 6.78 (dd, J = 8.0 Hz, J = 1.2 Hz, 1 H), 6.71 (q, J = 2.3 Hz, 1 
H), 6.20 (t, J = 2.4 Hz, 2 H), 5.35 (bs, 1 H), 4.32 (q, J = 7.2 Hz, 1 H), 1.68 (d, J = 7.2 Hz, 
3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 154.1, 134.9, 131.1, 128.8, 128.2, 121.2, 
118.3, 116.8, 108.4, 105.1, 32.2, 19.3.  IR 3410, 2970, 1592, 1452, 905, 721 cm-1. HRMS 
C12H14NO (M)+ calcd. 188.1075, obsvd. 188.1088. 
Preparation of 111 
The same procedure as that of general procedure was followed except 1 mL of 1-
methyl-1H-pyrrole was added.  C2:C3 alkylation ratio = 4:1,  Yield = 52% (average of 
two run), Rf = 0.50 w/ 20% EtOAC/Hex, yellow oil, 1H-NMR (400 MHz, CDCl3) δ = 
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7.11-7.03 (m, 2 H), 6.85 (td, J = 7.5 Hz, J = 1.2 Hz, 1 H), 6.74 (dd, J = 8.0 Hz, J = 1.2 
Hz, 1 H), 6.61 (q, J = 2.3 Hz, 1 H), 6.20 (ddd, J = 3.3 Hz, J = 1.9 Hz, J = 1.2 Hz, 1 H), 
6.15 (t, J = 3.2 Hz, 3 H), 5.51 (s, 1 H), 4.20 (q, J = 7.2 Hz, 1 H), 3.29 (s, 3 H), 1.65 (d, J 
= 7.2 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 154.2, 135.1, 130.1, 129.2, 128.0, 
123.5, 121.0, 117.0, 107.1, 105.8, 34.5, 34.1, 20.1.  IR 3369, 2969, 2928, 1594, 1484, 
1381, 789 cm-1.  HRMS C13H15NO (M+Na)+ calcd. 224.1051, obsvd. 224.1051. 
Preparation of 112 
The same procedure as that of general procedure was followed except 427.9 mg 
of 2,5-dimethyl-1H-pyrrole was added. Yield = 73% (average of two run), Rf = 0.45 w/ 
20% EtOAC/Hex, yellow oil, 1H-NMR (400 MHz, Acetone-D6) δ = 9.1 (s, 1 H), 7.73 (s, 
1 H), 7.13 (dd, J = 7.6 Hz, J = 1.7 Hz, 1 H), 6.94 (dd, J = 7.6 Hz, J = 1.7 Hz, 1 H), 6.78-
6.70 (m, 2 H), 5.73 (s, 1 H), 4.35 (q, J = 7.2 Hz, 1 H), 2.15 (s, 3 H), 1.99 (s, 3 H), 1.44 (d, 
J = 7.2 Hz, 3 H).  13C-NMR {1H} (100 MHz, Acetone-D6) δ = 154.3, 134.8, 128.1, 126.2, 
124.2, 122.4, 121.2, 119.6, 115.1, 104.9, 21.5, 12.4, 10.4. IR 3369, 2969, 2928, 1594, 
1484, 1381, 789 cm-1. HRMS C14H17NO (M+Na)+ calcd. 238.1208, obsvd. 238.1209. 
Preparation of 113 
The same procedure as that of general procedure was followed except 787 mg of 
methyl indolizine-1-carboxylate (4.500 mmol, 15.0 equiv.) was added and reaction was 
heated to 100 °C. Yield = 60% (average of two run), Rf = 0.25 w/ 20% EtOAC/Hex, pale 
yellow solid, M.P. = 212-214 °C.  1H-NMR (400 MHz, Acetone-D6) δ = 8.72 (s, 1 H), 
8.16 (dd, J = 9.1 Hz, J = 1.1 Hz, 1 H), 7.87 (d, J = 7.1 Hz, 1 H), 7.11-6.95 (m, 2 H), 6.93 
(dd, J = 8.0 Hz, J = 1.0 Hz, 1 H), 6.74-6.65 (m, 3 H), 4.82 (q, J = 7.0 Hz, 1 H), 3.84 (s, 3 
H), 1.70 (d, J = 7.1 Hz, 3 H).  13C-NMR {1H} (100 MHz, Acetone-D6) δ = 164.7, 154.3, 
169 
 
130.6, 129.5, 128.8, 128.0, 127.7, 127.2, 123.9, 121.8, 120.3, 119.4, 115.4, 113.4, 112.4, 
112.2, 50.0, 29.1, 19.6. IR 3243, 2931, 1651, 1526, 1231, 1229, 778 cm-1. HRMS 
C18H18NO (M)+calcd. 296.1287, obsvd. 296.1291. 
Preparation of 114 
The same procedure as that of general procedure was followed except 441.0 mg 
of 2-methoxyfuran was added. Yield = 63% (average of two run), the product 
decomposed overtime and gave mixture of unidentified materials.  Rf = 0.55 w/ 20% 
EtOAC/Hex, yellow oil, 1H-NMR (400 MHz, CDCl3) δ = 7.11-7.05 (m, 2 H), 6.86 (td, J 
= 7.5 Hz, J = 1.2 Hz, 1 H), 6.74 (dd, J = 7.9 Hz, J = 1.2 Hz, 1 H), 5.92 (d, J = 3.2 Hz, 1 
H), 5.25 (s, 1 H), 5.02 (d, J = 3.2 Hz, 1 H), 4.28 (q, J = 7.2 Hz, 1 H), 3.76 (s, 3 H), 1.53 
(d, J = 7.2 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 161.2, 153.5, 147.9, 129.9, 
128.5, 127.8, 121.1, 116.4, 106.5, 79.6, 57.8, 33.5, 18.6. IR 3399, 2950, 1712, 1595, 
1451, 1226, 727 cm-1. HRMS C13H14O3 (M+Na)+calcd. 241.0841, obsvd. 241.0849. 
Preparation of 115 
The same procedure as that of general procedure was followed. Yield = 83% 
(average of two run), Rf = 0.25 w/ 20% EtOAC/Hex, Sticky oil.  1H-NMR (400 MHz, 
CDCl3) δ = 8.03 (s,1 H), 7.35 (dd, J = 10.7 Hz, J = 8.1 Hz, 2 H), 7.18 (ddd, J = 8.1 Hz, J 
= 7.1 Hz, J = 1.1 Hz, 1 H), 7.04-6.96 (m, 2 H), 6.79 (td, J = 8.4 Hz, J = 3.1 Hz, 1 H), 6.68 
(dd, J = 8.8 Hz, J = 4.8 Hz, 1 H), 4.94 (s, 1 H), 4.48 (q, J = 7.1 Hz, 1 H), 1.69 (d, J = 7.1 
Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 158.7, 150.1, 137.1, 133.3, 126.6, 
122.9, 121.5, 119.9, 119.7, 119.0, 117.3, 114.9, 113.9, 111.5, 32.3, 20.3. IR 3406, 2966, 
1617, 1487, 1336, 727 cm-1. HRMS C16H15NOF (M)+ calcd. 256.1138, obsvd. 256.1151. 
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Preparation of 116 
The same procedure as that of general procedure was followed.  Yield = 91% 
(average of two run), Rf = 0.30 w/ 20% EtOAC/Hex, Sticky oil.  1H-NMR (400 MHz, 
CDCl3) δ = 7.99 (s,1 H), 7.39 (d, J = 8.0 Hz, 1 H), 7.32 (d, J = 8.1 Hz, 1 H), 7.18-7.14 
(m, 1 H), 7.08 (s, 1 H), 7.01 (t, J = 7.5 Hz, 2 H), 6.91 (dd, J = 8.0 Hz, J = 1.7 Hz, 1 H), 
6.65 (d, J = 8.0 Hz, 1 H), 4.95 (s, 1 H), 4.46 (q, J = 7.1 Hz, 1 H), 2.27 (s, 3 H), 1.71 (d, J 
= 7.1 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 151.9, 137.1, 131.3, 130.1, 129.1, 
128.2, 126.9, 122.7, 121.4, 119.9, 119.8, 116.4, 111.4, 32.5, 20.9, 20.5. IR 3406, 2966, 
2929, 1617, 1455, 1097, 742 cm-1.  HRMS C17H18NO (M)+ calcd. 252.1388, obsvd. 
252.1396. 
Preparation of 117 
The same procedure as that of general procedure was followed. Yield = 90% 
(average of two run), Rf = 0.30 w/ 20% EtOAC/Hex, M.P. = 105-107 °C.  1H-NMR (400 
MHz, CDCl3) δ = 8.05 (s,1 H), 7.44 (d, J = 8.0 Hz, 1 H), 7.32 (d, J = 8.2 Hz, 1 H), 7.20 
(t, J = 7.6 Hz, 1 H), 7.06 (d, J = 8.0 Hz, 1 H), 7.00 (d, J = 2.4 Hz, 1 H), 6.92 (d, J = 2.7 
Hz, 1 H), 6.74-6.71 (m, 2 H), 4.97 (s, 1 H), 4.52 (q, J = 7.1 Hz, 1 H), 3.79 (s, 3 H), 1.74 
(d, J = 7.1 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 153.8, 148.1, 137.0, 133.0, 
126.7, 122.7, 121.4, 119.8, 119.7, 119.4, 117.0, 114.7, 111.9, 111.4, 55.8, 32.5, 20.4.  IR 
3413, 3311, 2973, 1506, 1456, 1097, 810, 738 cm-1. HRMS C17H18NO2 (M)+ calcd. 
268.1338, obsvd. 268.1342. 
Preparation of 118 
The same procedure as that of general procedure was followed. Yield = 61% 
(average of two run), Rf = 0.30 w/ 20% EtOAC/Hex, pale green solid, M.P. = 94-96 °C.  
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1H-NMR (400 MHz, CDCl3) δ = 7.98 (s,1 H), 7.40 (dd, J = 8.0 Hz, J = 0.6 Hz, 1 H), 7.32 
(dt, J = 8.0 Hz, J = 0.8 Hz, 1 H), 7.20-7.17 (m, 2 H), 7.04-7.00 (m, 3 H), 6.86 (t, J = 7.5 
Hz, 1 H), 5.23 (s, 1 H), 4.49 (q, J = 7.1 Hz, 1 H), 2.17 (s, 3 H), 1.74 (d, J = 7.1 Hz, 3 H).  
13C-NMR {1H} (100 MHz, CDCl3) δ = 152.7, 137.2, 131.0, 129.3, 126.8, 126.2, 125.0, 
122.8, 121.5, 120.5, 120.0, 119.9, 119.7, 111.5, 33.0, 20.5, 16.1. IR 3406, 2966, 2929, 
1617, 1455, 1097, 742 cm-1. HRMS C17H17NO (M+Na)+ calcd. 274.1208, obsvd. 
274.1212. 
Preparation of 119 
The same procedure as that of general procedure was followed. Yield = 38% 
(average of two run), Rf = 0.28 w/ 20% EtOAC/Hex, pale green solid, M.P. = 145-147 
°C.  1H-NMR (400 MHz, CDCl3) δ = 7.91 (s,1 H), 7.35-7.30 (m, 2 H), 7.15-7.11 (m, 3 
H), 7.01-6.96 (m, 2 H), 6.71-6.69 (m, 2 H), 4.66 (s, 1 H), 4.29 (q, J = 7.1 Hz, 1 H), 1.65 
(d, J = 7.1 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 153.7, 139.4, 136.9, 128.8, 
128.7, 127.1, 122.1, 121.9, 121.2, 120.0, 119.3, 115.3, 111.2, 36.3, 22.7.  IR 3415, 2963, 
1611, 1510, 1455, 1222, 745 cm-1. HRMS C16H15NO (M+Na)+ calcd. 260.1051, obsvd. 
260.1065. 
Accessing Interesting Indole Core Structure 
Synthesis of Triflate (S2) 
In a dry round bottom flask 200 mg (0.85 mmol, 1.0 equiv.) of 101 was dissolved 
in 8.0 mL of DCM.  To this 135 µL (1.27 mmol, 1.5 equiv.) of 2,6-lutidine  was added 
and the reaction mixture was cooled to -78 °C.  At this temperature 213 µL (1.27 mmol, 
1.5 equiv.) of Tf2O was added drop wise.  The reaction mixture was allowed to stir for 1 
h at -78 °C and slowly warmed to room temperature.  On completion, reaction mixture 
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was quenched with water.  The organic phase was diluted with 5 mL of DCM and 
washed with water (10 mL x 2) followed by brine (10 mL) wash.  The organic layer was 
dried on Na2SO4 and concentrated in vacuo.  The crude mixture was passed through 
small silica plug with DCM as eluent and was taken forward without further purification.    
Synthesis of 121 
In the glovebox, to a 2.5 dram vial equipped with a stir bar was added 32.1 mg 
Pd2dba3 (0.035 mmol, 0.1 equiv.), 30.0 mg dppb (0.070 mmol, 0.2 equiv.) and 1.0 mL of 
DMA.  The reaction mixture was allowed to stir for ca.15 min.  In a separate 2.5 mL 
dram vial equipped with a stir bar was added 130.0 mg of S2 (0.35 mmol, 1.0 equiv.) and 
343.0 mg of KOAc (3.50 mmol, 10.0 equiv.) in 2.5 mL of DMA.  To this, catalyst 
solution was added.   The vial was capped and was heated to 100 °C for 8 h, in oil bath, 
and diluted with 3 mL of EtOAc. The reaction mixture was then passed through silica gel 
to remove metal complexes and concentrated in vacuo. The crude mixture was purified 
with flash silica-gel column chromatography to give product in 87% isolated yield.   
The 1H-NMR spectrum of product was matched with literature.34  
Synthesis of 122 
 In a dry round bottom flask 28 mg (0.020 mmol, 0.10 equiv.) of Pd(OH)2/C was 
taken and 1 mL of EtOAc was added. To this a solution of 74 mg (0.20 mmol, 1.0 equiv.) 
of triflate in 3 mL of MeOH was added followed by addition of 110 µL of TEA (1.0 
mmol, 5.0 equiv.).  The flask was evacuated and refilled three times with hydrogen 
balloon.  The reaction was allowed to stir for 3 h. On completion, reaction mixture was 
passed though silica plug to give desired product in 87% isolated yield.    
The 1H-NMR spectrum of product was matched with literature.50 
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Synthesis of 123 
 In a dry round bottom flask 60 mg (0.25 mmol, 1.0 equiv.) of 101 was dissolved 
in 2.0 mL of DCM.  To this 70 mg (0.28 mmol, 1.1 equiv.) of PPTS was added and the 
reaction mixture was cooled to -78 °C.  At this temperature, a solution of 50 mg (0.28 
mmol, 1.1 equiv.) of NBS in 2.0 mL of THF was added dropwise.  The reaction mixture 
was allowed to stir for 45 min at -78 °C and quenched with 2 mL of NaHCO3.  The 
organic phase was diluted with 5 mL of DCM and washed with water (10 mL X 2) 
followed by brine (10 mL) wash.  The organic layer was dried on Na2SO4 and 
concentrated in vacuo.  The crude mixture was purified by silica gel column 
chromatography with 2% to 10% EtOAc:Hex as eluent to give desired product in 80% 
yield.  Rf = 0.56 w/ 20% EtOAC/Hex, yellow solid, M.P. = 114-120 °C.  1H-NMR (400 
MHz, CDCl3) δ = 7.76 (s, 1 H), 7.50-7.48 (m, 1 H), 7.35-7.31 (m, 1 H), 7.28-7.19 (m, 2 
H), 7.14-7.10 (m, 3 H), 7.01-7.04 (m, 1 H), 4.41 (q, J = 6.8 Hz, 1 H), 1.68 (d, J = 6.8 Hz, 
3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 150.8, 140.2, 131.1, 129.9, 127.6, 127.0, 
126.4, 124.1, 123.2, 120.5, 120.3, 117.8, 117.0, 110.8, 29.3, 24.8.  IR 2963, 1718, 1616, 
1599, 1455, 1369, 746 cm-1.  HRMS C16H13NO (M)+ calcd. 235.0997, obsvd. 235.0996. 
Inverse Electron Demand Diels-Alder Reaction 
In the glovebox, to a 2.5 dram vial equipped with a stir bar was added 14.1 mg 
Pd2dba3 (0.015 mmol, 0.050 equiv.), 15.0 mg P(Cy)3 (0.051 mmol, 0.17 equiv.) and 1.0 
mL of toluene.  The reaction mixture was allowed to stir for ca.15 min.  In a separate 25 
mL sealed flask equipped with a stir bar was added 165.0 µL of C4H9Cl (1.80 mmol, 6.0 
equiv.), 30.0 mg of KHCO3 (0.30 mmol, 1.0 equiv.) and 761.5 mg of tert-butyl 2,3-
dihydro-1H-pyrrole-1-carboxylate (4.500 mmol, 15.0 equiv.) and 36.0 mg of 18 (0.30 
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mmol, 1.00 equiv.) in 2.0 mL of toluene.  To this catalyst solution was added.   The flask 
was capped and was heated to 100 °C for 72 h, in oil bath, and diluted with 10 mL of 
EtOAc. The reaction mixture was then passed through silica gel to remove metal 
complexes and concentrated in vacuo. The crude mixture was purified with flash silica-
gel column chromatography. 
Yield = 63% (average of two run), Rf = 0.42 w/ 20% EtOAC/Hex, Sticky Oil, 1H-
NMR (400 MHz, Benzene-D6, 70 °C) δ = 6.93-6.90 (m, 2 H), 6.82 (dd, J = 8.4 Hz, J = 
1.1 Hz, 1 H), 6.74 (t, J = 7.4 Hz, 1 H), 5.69 (s, 1 H), 3.35-2.95 (m, 4 H), 2.71 (quintet, J = 
6.8 Hz, 1 H), 1.83-1.75 (m, 1 H), 1.44 (s, 9 H), 0.89 (d, J = 6.8 Hz, 3 H).  13C-NMR {1H} 
(100 MHz, CDCl3) δ = 152.7, 126.0, 125.6, 120.8, 116.9, 86.0, 79.3, 45.0, 43.7, 28.4, 
22.3, 15.7. IR 2973, 1701, 1455, 1391, 1168, 754 cm-1.  HRMS C17H23O3N (M+Na)+ 
calcd. 312.1576, obsvd. 312.1574. 
Control Experiments (Figure 4.11) 
Reaction A 
In the glovebox, to a 2.5 dram vial equipped with a stir bar were added 4.7 mg 
Pd2dba3 (0.005 mmol, 0.050 equiv.), 5.0 mg P(Cy)3 (0.017 mmol, 0.17 equiv.) and 500 
µL of toluene.  The reaction mixture was allowed to stir for ca.15 min.  In a separate 2.5 
dram vial equipped with a stir bar was added 10.0 mg of KHCO3 (0.10 mmol, 1.0 equiv.) 
and 217.5 mg of 1,2-dimethylindole (1.500 mmol, 15.0 equiv.) and 12.0 mg of 18 (0.10 
mmol, 1.00 equiv.) in 500 µL of toluene.  To this catalyst solution was added.   The flask 
was capped and was heated to 80 °C for 72 h, in oil bath, and diluted with 3 mL of 
EtOAc. The reaction mixture was then passed through silica gel and concentrated in 




To a 2.5 dram vial equipped with a stir bar were added 217.5 mg of 1,2-
dimethylindole (1.500 mmol, 15.0 equiv.) and 12.0 mg of 18 (0.10 mmol, 1.00 equiv.) in 
1.0 mL of toluene. After purging with N2, the flask was capped and was heated to 80 °C 
for 72 h, in oil bath, and diluted with 3 mL of EtOAc. The reaction mixture was then 
passed through silica gel and concentrated in vacuo. The crude mixture was purified with 
flash silica-gel column chromatography. 
Deuterium Labeling Experiments 
For these reactions (Figure 4.12) the same procedure as the general procedure was 
followed.  Except for reaction A, OD-phenol (124) was used, whereas for reaction B, 
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ACID-CATALYZED HYDROFUNCTIONALIZATION  
OF VINYL INDOLES: AN EFFICIENT METHOD 
TO SYNTHESIZE BISINDOLYLMETHANES  
Introduction 
 Bisindolylmethane (BIM) scaffolds are present in many natural products isolated 
from terrestrial and marine natural sources.1  These natural products exhibit various 
biological activities, including anti-cancer activity against multiple cancer cell-lines.2  
Naturally occurring bisindolylmethane, such as Vibrindole A (127), is useful in the 
treatment of fibromyalgia, chronic fatigue, and irritable bowel syndrome.3-5  
Diindolylmethane 128 inhibits the proliferation of both estrogen-dependent and 
independent cultured breast tumor cells (Figure 5.1).6-8  Additionally, synthetic 
bisindolylmethanes are important pharmacophores with various biological activities,9-12 
and they recently have found use in material chemistry.13-15  Because of their extensive 
utility, numerous methods are available to synthesize symmetrical BIMs.1  Nevertheless, 
the efficient synthesis of unsymmetrical BIMs is still a challenge.  Because of this 
limitation and our recent discovery of Pd-hydride chemistry (discussed in Chapter 4), we 
became interested in developing Pd-catalyzed hydrofunctionalization of vinyl indoles to 




Figure 5.1. Examples of biologically relevant bisindolylmethanes. 
Background 
Bisindolylmethanes are a highly important molecular scaffold in the 
pharmaceutical industry.1  Thus, various groups have reported the synthesis of 
unsymmetrical bisindolylmethanes in recent years.  Most of these examples follow a 
leaving group strategy as shown in Figure 5.2.15  Herein, some of the recent 
developments are presented.16-19 
In 2005, Ji and coworkers reported the synthesis of unsymmetrical 
bisindolylmethanes catalyzed by ceric ammonium nitrate (CAN) (Figure 5.3).20  The 
reaction of indoles with derivatives of (1H-indol-3-yl) methanol , in the presence of 10 
mol% CAN, gave the desired products in excellent yield.  The reaction is proposed to 
proceed via alkylideneindoleninium intermediate A.   
In 2006, Tse and coworkers reported a similar method for the preparation of 
unsymmetrical bisindolylmethanes (Figure 5.4).16-17  In this chemistry, the authors used 
silica as a mild acid to promote the formation of the key cationic alkylideneindoleninium 
intermediate, which reacts with an equivalent of indole to give the desired product.  In 
this report, alcohol 131 and aziridine precursor 129 were used as key substrates for the 
preparation of potentially pharmacologically active bisindoles 132 and 130 in good to 
excellent yields.  This method’s key feature is the absence of organic solvent.  The 




Figure 5.2. Common strategy to synthesize unsymmetrical bisindolylmethanes. 
 
 
Figure 5.3. Synthesis of unsymmetrical bisindolylmethanes catalyzed by ceric 




in situ.  However, when alkene 133 was reacted with a catalytic amount of 
methylsulfonic acid (MsOH), with DCM as a solvent, no product formation was 
observed.  Based on this observation, the authors ruled out in situ alkene generation from 
alcohol substrate 131.  Later, they expanded the scope of this process to include other 
nucleophiles. 





Figure 5.4.  Silica gel catalyzed, solvent free synthesis of unsymmetrical 




bisindolylmethanes (Figure 5.5).21  Treating readily available gramine derivatives with 
indoles in the presence of RhI-catalyzed gave the desired bisindoles in good yields.  
Because this reaction can be performed in aqueous media, this method is attractive for 
manufacturing processes.  The proposed mechanism of product formation is shown in 
Figure 5.5b, where coordination of RhI with nitrogen followed by base promoted 









reacts with exogenous indole to give the desired product.   
In 2008, Palmisano and coworkers reported a three-component, one-pot domino 
reaction that combines the allylindation of 1H-indole-3-carbaldehyde with the 
dehydrative alkylation of heterocycles (Figure 5.6).22  The scope of this process is broad 
in both reaction partners.  However, only allylindium is used as the initiator of the 
domino process.  The proposed reaction mechanism is shown in Figure 5.6b, the initial 
reaction of allyindium with 1H-indole-3-carbaldehyde gives sec-alcohol 134 as the 
product.  The subsequent indium-catalyzed dehydration of 134 followed by Friedel–






Figure 5.6.  A three-component, one-pot domino reaction to synthesize bisindoles. Data 




 In 2010, You and coworkers reported the first enantioselective preparation of 
bisindolylmethanes (Figure 5.7).18  Chiral phosphoric acids were used as the Brønsted 
acid catalyst for reacting amine 135 and indoles.  The presence of an arene at the benzylic 
position of indole 135 is necessary for stabilization of proposed cationic indoleninium 
intermediate, which limits the scope significantly.  Moreover, bisindolylmethanes can 




Figure 5.7. Chiral Brønsted acid catalyzed enantioselective preparation of 




 As discussed above, various methods are available for synthesizing 
unsymmetrical bisindolylmethanes.  However, an efficient and simple method of 
constructing bisindolylmethanes, with broad substrate scope, has not been reported.  
Besides, our approach to access bisindolylmethanes via alkene hydrofuncationalization 
would provide a mechanistically distinct route to these biologically relevant scaffolds.   
Approach 
 With our recent success in the development of a Pd0-catalyzed 
hydrofunctionalization of vinyl phenols, we choose to utilize a similar concept to 
synthesize unsymmetrical bisindolylmethanes from vinyl indoles.  The mechanistic 
proposal is shown in Figure 5.8, initiates with the oxidative addition of an alkyl halide 


























provide the requisite Pd-hydride B.  Insertion of an alkene in the Pd-hydride B followed 
by reduction of PdII to Pd0 would lead to the key intermediate D.  Nucleophilic attack of 
the indole on intermediate D followed by re-aromatization of indole would lead to 
formation of the desired product.  This approach would provide a mechanistically distinct 
method for accessing biologically relevant bisindolylmethanes.   
Reaction Optimization and Scope 
Reaction optimization and evaluation of substrate scope was conducted in 
collaboration with German exchange student Mr. Jaroslaw Osiak. 
 The reaction of 137 under previously optimized reaction conditions (Chapter 4) 
resulted in no desired product formation (Figure 5.9).  We believe this could be due to 
poor binding of an alkene with an electron rich Pd-catalyst.  To increase the binding 
efficacy of alkenes with the Pd-catalyst, a cationic Pd complex was desired.  Based on 
findings reported by former group member Dr. Kaveri Balan, where use of cationic Pd-
complex had a significant impact on reaction outcome, alkyl tosylate as a sacrificial 
hydride source, DMA as a solvent, and IiPr-carbene as a ligand were used.  Excitingly, 
under this new set of conditions, 82% yield of the desired product was observed.  
Because, 1 equivalent of p-TsOH (related to Pd) was generated at the end of every 
catalytic cycle (see Figure 5.8) and the lack of base to neutralize generated acid in 
reaction conditions; a control reaction with 20 mol% p-TsOH was conducted to probe for 
Brønsted acid-catalyzed pathways.  Interestingly, 82% yield of the desired product was 
observed suggesting that p-TsOH could be an active catalyst under the Pd-catalyst 
conditions.  Since, a simple Brønsted acid provided the desired product in excellent yield, 









When 137 was treated with 20 mol% of p-TsOH in either dichloromethane 
(DCM), dichloroethane (DCE) or toluene, complete conversion of 137 was observed 
within a few hours with <10% yield of the desired product and poor mass balance (Table 
5.1, entries 1-3).  This observation alludes to the tendency of substrate 137 to polymerize 
under acidic conditions.  In Lewis basic DMA, we have observed good yield of the 
desired product, even at elevated temperature .  Thus, a reaction at room temperature 
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in DMA was performed to give the desired product in 89% GC yield (Table 5.1, entry 4).  
Further optimization of acid and nucleophile loadings gave the optimal conditions, in 
which 81% isolated yield of the desired product was obtained (Table 5.1, compare entries 
4, 5 and 6). 
 With this optimized system in hand, the scope of exogenous nucleophiles was 
explored.  The unprotected 1H-indole as a nucleophile gave the natural product 
Vibrindole A in 80% isolated yield without the exclusion of air or moisture from the 
system with >90% recovery of the remaining nucleophile (Table 5.2, compound 127).  N-
methyl indole also gave the corresponding 3,3’-bisindolylmethane in good yield (Table 












8 h, 80% Yield 
16 h, 55% Yield 
16 h, 62% Yield 
TsOH (10 mol%) 
.. 
DMA, 0.2 M, rt 
r(Y~, R'-~ 10 equiv. 
8 h, 81% Yield 
Br 
12 h, 42% Yield 
Et 
146 COOMe 
8 h, 85% Yield 
MeO 





16 h, 55% Yield 
16 h, 68% Yield 16 h, 84% Yieldb 
a) Yields are averages of at least two runs at 0.3 mmol scale. 
b) Reactions were performed at 70 ·C. 
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tolerated under the reaction conditions including sterically demanding 2-substituted 
indoles (Table 5.2, compounds 139-143).  The 2,3’-bisindolylmethanes can also be 
obtained using this method, as demonstrated by the successful use of 3-methyl indole to 
give the desired product in good yield albeit higher reaction temperature was required 
(Table 5.2, compound 144).  A pyrrole and an indolizine can also be used as nucleophile 
to provide the corresponding bis-heteroarylmethanes in good yields (Table 5.2, 
compounds 145 and 146).  Additionally, a disubstituted vinylindole gave the desired 
product in 84% yield (Table 5.2, compound 147).    
Encouraged by these results, trisubstituted vinyl indole 148 was prepared in high 
yield by condensation of indole with the corresponding cyclic ketone.23  As expected, the 
substrate 148 underwent a smooth hydrofunctionalization reaction with the exogenous 
nucleophile, N-Me-indole, to give the desired product in excellent yield (Table 5.3, 
compound 149).  The BIM obtained (149) is chemically intriguing with its one all- 
substituted carbon center.  Moreover, it is also biologically intriguing due to its similarity 
to BIM 151, which shows interesting in vivo activity against lung cancer cells.24  
Additionally, both electron-rich and electron-deficient indoles are well tolerated under 
the reaction conditions (Table 5.3, compounds 150 and 152).  Both a pyrrole and an 
indolizine as exogenous nucleophiles gave the desired products in good yields (Table 5.3, 
compounds 153-154). 
Biological Study 
In light of the previously established biological activity of diindolylmethane (128) 
against a breast cancer cell line25-27 and our recent discovery of cytotoxic indole 



















synthesized bisindolylmethanes was probed in the MCF-7 breast cancer cell line.  These 
studies were conducted by Ms. Rachel Vaden.  Interestingly, several compounds, 
including compounds 139 and 149, were found to reduce cell count in comparison to the 
DMSO control in MCF-7 cell lines (Figure 5.10).  Excitingly, compound 149 displays 
excellent differential activity between MCF-7 and MCF-10A (normal breast) cells.  Even 
at the highest concentration evaluated (100 µM) 149 does not generally affect the growth 
of MCF-10A cells whereas it leads to an EC50 of 4.3 µM in MCF-7 cells (Figure 5.10).  
Additionally, compound 154 demonstrated an EC50 of ~50 nM although no selectivity for 
either cell line is observed (Figure 5.11). 
 













A simple and efficient reaction to access biologically relevant bisindolylmethanes 
from vinyl indoles has been reported.  This method offers a distinct alternative to access 
alkylideneindoleninium intermediates in situ,29 which could be subjected to the reaction 
of various nucleophiles providing functionalized indoles.  Broad scope and ease of the 
reaction highlight this method.  Future work is focused on the further evaluation of 
analogs of compound 149, as well as identification of its biological target. 
Experimental 
General Information 
Toluene, dichloromethane, and THF were dried before use by passing through a 
column of activated alumina. All other reagents (including indoles) were purchased from 
commercial sources and used without further purification.  Yields were calculated for 
material judged homogeneous by thin-layer chromatography and NMR.  Thin-layer 
chromatography was performed with EMD silica gel 60 F254 plates eluting with the 
solvents indicated, visualized by a 254 nm UV lamp, and stained either with potassium 
permanganate, p-anisaldehyde, phosphomolybdic acid or vanillin.  Flash column 
chromatography was performed with EcoChrom MP Silitech 32-63D 60Å silica gel, 
slurry packed with solvents indicated in glass columns. Nuclear magnetic resonance 
spectra were acquired at 400 MHz for 1H, and 100 MHz for 13C. Chemical shifts for 
proton nuclear magnetic resonance (1H NMR) spectra are reported in parts per million 
downfield relative to the line of CHCl3 singlet at 7.26 ppm. Chemical shifts for carbon 
nuclear magnetic resonance (13C NMR) spectra are reported in parts per million 
downfield relative to the center-line of the CDCl3 triplet at 77.2 ppm. The abbreviations s, 
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d, t, q, td, dd and m stand for the resonance multiplicities singlet, doublet, triplet, quartet, 
triplet of doublet, doublet of doublet and multiplet, respectively.  IR spectra were 
recorded using a Nicolate FT-IR instrument.  Glassware for all reactions was oven-dried 
at 110 oC and cooled while purging with nitrogen prior to use. 
Substrate Synthesis 
Substrate 137 was synthesized using literature procedure.28 1H-NMR was matched 
with literature 1H-NMR for all substrates.  Note: Substrates were stored at -28 °C in 
dark.   
Procedure for Optimization 
Figure 5.9, Reaction A 
 In the glovebox, to a 2.5 dram vial equipped with a stir bar were added 4.7 mg 
Pd2dba3 (0.0050 mmol, 0.050 equiv.), 5.6 mg P(Cy)3 (0.020 mmol, 0.20 equiv.) and 200 
µL of toluene. The reaction mixture was allowed to stir for ca.15 min.  In a separate 2.5 
dram vial equipped with a stir bar were added 165 µL of butyl chloride (0.06 mmol, 6.0 
equiv.), 10.0 mg of KHCO3 (0.10 mmol, 1.0 equiv.), 175.5 mg of N-H-dimethylindole 
(1.500 mmol, 15.00 equiv.) and 200 µL of standard solution of 137 (0.10 mmol, 1.00 
equiv.) in toluene (standard solution: 21.5 mg of 137, and 10 µL of undecane as internal 
standard in 300 µL of toluene).  To this an additional 600 µL of toluene and the catalyst 
solution were added.   The vial was capped and was heated to 80 °C for 72 h in an oil 
bath. At this point the vial was open to air and the reaction was analyzed by GC using an 




Figure 5.9, Reaction B 
 In the glovebox, to a 2.5 dram vial equipped with a stir bar were added 4.7 mg 
Pd2dba3 (0.0050 mmol, 0.050 equiv.), 5.0 mg IiPrcarbene (0.010 mmol, 0.10 equiv.) and 
200 µL of DMA. The reaction mixture was allowed to stir for ca.15 min.  In a separate 
2.5 dram vial equipped with a stir bar were added 70 mg of butyl chloride (0.03 mmol, 
3.0 equiv.), 175.5 mg of N-H-dimethylindole (1.500 mmol, 15.00 equiv.) and 200 µL of 
standard solution of 137 (0.10 mmol, 1.00 equiv.) in DMA (standard solution: 21.5 mg 
of 137, and 10 µL of undecane as internal standard in 300 µL of DMA).  To this an 
additional 600 µL of DMA and the catalyst solution were added.   The vial was capped 
and was heated to 80 °C for 16 h in an oil bath. At this point the vial was open to air and 
the reaction was analyzed by GC using an internal standard to calculate conversion as 
well as yield of various products. 
Figure 5.9, Reaction C 
 To a 2.5 dram vial equipped with a stir bar were added 3.44 mg p-TsOH (0.0200 
mmol, 0.200 equiv.), 175.5 mg of N-H-indole (1.500 mmol, 15.00 equiv.) and 200 µL of 
standard solution of 137 (0.100 mmol, 1.00 equiv.) (standard solution: 21.5 mg of 137, 
and 10 µL of undecane as internal standard in 300 µL of toluene).  To this an additional 
800 µL of toluene was added.  The vial was capped and was stirred for 2 h at 80 °C. At 
this point reaction was analyzed by GC using an internal standard to calculate conversion 
as well as yield of various products.   





Entry 1, Table 5.1 
 To a 2.5 dram vial equipped with a stir bar were added 3.44 mg p-TsOH (0.0200 
mmol, 0.200 equiv.), 175.5 mg of N-H-indole (1.500 mmol, 15.00 equiv.) and 200 µL of 
standard solution of 137 (0.100 mmol, 1.00 equiv.) (standard solution: 21.5 mg of 137, 
and 10 µL of undecane as internal standard in 300 µL of DCM).  To this an additional 
800 µL of DCM was added.   The vial was capped and was stirred for 2 h at room 
temperature. At this point reaction was analyzed by GC using an internal standard to 
calculate conversion as well as yield of various products.   
Entry 2, Table 5.1 
The same procedure as described for entry 1 was used, except DCE was used as 
solvent. 
Entry 3, Table 5.1 
The same procedure as described for entry 1 was used, except toluene was used as 
solvent. 
Entry 4, Table 5.1 
 The same procedure as described for entry 1 was used, except DMA was used as 
solvent. 
Entry 5, Table 5.1 
To a 2.5 dram vial equipped with a stir bar were added 1.71 mg p-TsOH (0.0100 
mmol, 0.100 equiv.), 87.8 mg of N-H-indole (0.700 mmol, 7.000 equiv.) and 200 µL of 
standard solution of 137 (0.100 mmol, 1.00 equiv.) (standard solution: 21.5 mg of 137, 
and 10 µL of undecane as internal standard in 300 µL of DMA).  To this an additional 
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300 µL of DMA was added.   The vial was capped and was stirred for 16 h at room 
temperature. The crude mixture was purified with flash silica-gel column 
chromatography.  
Entry 6, Table 5.1: To a 2.5 dram vial equipped with a stir bar was added 1.71 
mg p-TsOH (0.0100 mmol, 0.100 equiv.), 117.1 mg of N-H-indole (1.00 mmol, 10.0 
equiv.) and 200 µL of standard solution of 137 (0.100 mmol, 1.00 equiv.) (standard 
solution: 21.5 mg of 137, and 10 µL of undecane as internal standard in 300 µL of 
DMA).  To this an additional 300 µL of DMA was added.   The vial was capped and was 
stirred for 16 h at room temperature. The crude mixture was purified with flash silica-gel 
column chromatography.  
Substrate Scope with 137 
General Procedure for Substrate Scope (Table 5.2) 
To a 2.5 dram vial equipped with a stir bar were added 5.13 mg of p-TsOH (0.030 
mmol, 0.100 equiv.), 351.3 mg of N-H-indole (3.00 mmol, 10.0 equiv.) and 42.9 mg of 
137 (0.300 mmol, 1.00 equiv.).  To this 1.5 mL of DMA was added via syringe.   The vial 
was capped and was stirred for given time at room temperature. The crude mixture was 
purified with flash silica-gel column chromatography. (Note: In case of liquid 
nucleophiles, p-TsOH was added last) 
Synthesis of 127 
The same procedure as the general procedure was followed.  Yield = 80% 
(average of two run).  
The 1H-NMR spectrum of product was matched with literature. 
200 
 
Synthesis of 138 
The same procedure as the general procedure was followed.  Yield = 81% 
(average of two run), Rf = 0.30 w/ 20% EtOAC/Hex, pale green solid, M.P. = 51-53 °C.  
1H-NMR (400 MHz, CDCl3) δ = 7.37 (s,1 H), 7.66 (d, J = 7.9 Hz, 2 H), 7.35 (dt, J = 7.2 
Hz, J = 0.9 Hz, 2 H), 7.30-7.22 (m, 2 H), 7.13 (ddd, J = 7.9 Hz, J = 7.0 Hz, J = 0.8 Hz, 2 
H), 6.91 (d, J = 2.3 Hz, 1 H), 6.82 (s, 1 H), 4.75 (q, J = 7.1 Hz, 1 H), 3.72 (s, 3 H), 1.88 
(d, J = 7.1 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 137.5, 136.8, 127.5, 127.1, 
126.2, 121.9, 121.5, 121.4, 120.3, 120.0, 119.9, 119.2, 118.6, 111.2, 109.3, 32.7, 28.3, 
22.2. IR 3411, 2967, 1455, 1335, 760 cm-1. HRMS C19H19N2 (M+H)+ calcd. 275.1543, 
obsvd. 275.1554. 
Synthesis of 139 
The same procedure as the general procedure was followed except 432.0 mg of 
indole (3.00 mmol, 10.0 equiv.) was added.  Yield = 85% (average of two run), Rf = 0.35 
w/ 20% EtOAC/Hex, colorless solid, M.P. = 52-54 °C,  1H-NMR (400 MHz, CDCl3) δ = 
7.81 (s, 1 H), 7.64 (d, J = 7.9 Hz, 1 H), 7.45 (d, J = 7.9 Hz, 1 H), 7.31 (dd, J = 12.4 Hz, J 
= 8.1 Hz, 2 H), 7.19-7.15 (m, 2 H), 7.06-7.00 (m, 3 H), 4.72 (qd, J = 7.2 Hz, J = 1.1 Hz, 1 
H), 3.67 (s, 3 H), 2.40 (s, 3 H), 1.89 (d, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 
136.9, 136.8, 131.2, 127.4, 127.1, 121.9, 121.8, 121.1, 120.3, 119.8, 119.5, 119.1, 118.5, 
115.2, 111.1, 108.7, 29.6, 29.3, 21.2, 10.7.  IR 3419, 1457, 1233, 765 cm-1. HRMS 
C20H21N2 (M+H)+ calcd. 289.1699, obsvd. 289.1701. 
Synthesis of 140 
The same procedure as the general procedure was followed except 616.8 mg of 1-
methyl-2-phenyl-1H-indole (3.00 mmol, 10.0 equiv.) and additional 1 mL of DMA were 
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added.  Yield = 55% (average of two run), Rf = 0.32 w/ 20% EtOAC/Hex, colorless solid, 
M.P. = 178-180 °C.  1H-NMR (400 MHz, CDCl3) δ = 7.80 (s,1 H), 7.67 (d, J = 7.9 Hz, 1 
H), 7.49-7.43 (m, 3 H), 7.39 (dd, J = 7.7 Hz, J = 1.6 Hz, 2 H), 7.34 (t, J = 8.6 Hz, 1 H), 
7.28 (t, J = 7.6 Hz, 1 H), 7.21 (td, J = 7.6 Hz, J = 1.1 Hz, 1 H), 7.13-7.09 (m, 1 H), 7.05-
6.94 (m 3 H), 4.55 (dq, J = 7.2 Hz, J = 0.8 Hz, 1 H), 3.60 (s, 3 H), 1.86 (d, J = 7.2 Hz, 3 
H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 137.7, 137.2, 136.7, 132.4, 130.9, 130.8, 
128.4, 128.1, 126.8, 121.8, 121.7, 121.4, 121.3, 120.9, 119.9, 118.9, 118.8, 117.4, 110.9, 
109.5, 30.9, 28.6, 21.7. IR 3414, 2969, 1466, 740 cm-1. HRMS C25H23N2 (M+H)+ calcd. 
351.1856, obsvd. 351.1843. 
Synthesis of 141 
The same procedure as the general procedure was followed except 588.1 mg of 5-
bromo-1H-indole (3.00 mmol, 10.0 equiv.) was used.  Yield = 46% (average of two run), 
Rf = 0.30 w/ 20% EtOAC/Hex, colorless solid, M.P. = 47-50 °C.  1H-NMR (400 MHz, 
CDCl3) δ = 7.88 (s, 2 H), 7.71-7.70 (m, 1 H), 7.54 (dd, J = 7.9 Hz, J = 0.7 Hz, 1 H), 7.36 
(dt, J = 8,1 Hz, J = 0.8 Hz, 1 H), 7.26-7.16 (m, 3 H), 7.06 (ddd, J = 7.9 Hz, J = 7.0 Hz, J 
= 0.9 Hz, 1 H), 6.91 (td, J = 2.2 Hz, J = 0.8 Hz, 2 H), 4.61 (q, J = 7.1 Hz, 1 H), 1.79 (d, J 
= 7.1 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 136.8, 135.3, 128.8, 126.9, 124.7, 
122.6, 122.3, 122.0, 121.5, 119.8, 119.2, 112.6, 112.5, 111.3, 28.2, 21.7. IR 3405, 1453, 
1092, 739 cm-1. HRMS C18H15BrN2 (M)+ calcd. 338.0429, obsvd. 338.0419. 
Synthesis of 142 
  The same procedure as the general procedure was followed except 588.1 mg of 5-
bromo-1H-indole (3.00 mmol, 10.0 equiv.) was used.  Yield = 76% (average of two run), 
Rf = 0.25 w/ 20% EtOAC/Hex, colorless solid, M.P. = 57-59 °C.  1H-NMR (400 MHz, 
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CDCl3) δ = 7.86 (s,1 H), 7.75 (s, 1 H), 7.63 (d, J = 7.9 Hz, 1 H), 7.32 (d, J = 8.1 Hz, 1 H), 
7.23-7.18 (m, 2 H), 7.11-7,06 (m, 2 H), 6.89-6.85 (m, 3 H), 4.66 (q, J = 7.1 Hz, 1 H), 
3.80 (s, 3 H), 1.83 (d, J = 7.1 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 153.7, 
136.8, 132.0, 127.4, 127.0, 122.2, 121.9, 121.6, 121.5, 121.4, 119.9, 119.1, 111.9, 102.0, 
56.0, 28.3, 21.8. IR 3403, 1452, 1206, 1091, 739 cm-1. HRMS C19H18N2O (M+H)+ calcd. 
291.1492, obsvd. 291.1489. 
Synthesis of 143 
The same procedure as the general procedure was followed except 435.6 mg of 7-
ethyl-1H-indole (3.00 mmol, 10.0 equiv.) was used.  Yield = 62% (average of two run), 
Rf = 0.35 w/ 20% EtOAC/Hex, pale green solid, M.P. = 50-52 °C.  1H-NMR (400 MHz, 
CDCl3) δ = 7.78-7.76 (m, 2 H), 7.61 (d, J = 7.9 Hz, 1 H), 7.49-7.47 (m, 1 H), 7.34 (d, J = 
8.1 Hz, 1 H), 7.19 (td, J = 7.6 Hz, J = 0.9 Hz, 1 H), 7.10-7.04 (m, 3 H), 6.90-6.86 (m, 2 
H), 4.69 (q, J = 7.1 Hz, 1 H), 2.85 (q, J = 7.6 Hz, 2 H), 1.83 (d, J = 7.1 Hz, 3 H), 1.38 (t, 
J = 7.6 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 136.8, 135.6, 127.1, 126.8, 
126.5, 122.3, 121.9, 121.8, 121.4, 121.0, 120.4, 119.9, 119.4, 119.1, 117.6, 111.2, 28.4, 
24.1, 21.9, 13.9. IR 3403, 1455, 1293, 1091, 739 cm-1. HRMS C20H21N2 (M+H)+ calcd. 
289.1699, obsvd. 289.1681. 
Synthesis of 144 
The same procedure as the general procedure was followed except 393.6 mg of 3-
methyl-1H-indole (3.00 mmol, 10.0 equiv.) was used.  Yield = 54% (average of two run), 
Rf = 0.41 w/ 20% EtOAC/Hex, colorless solid, M.P. = 64-66 °C.  1H-NMR (400 MHz, 
CDCl3) δ = 7.99 (m, 1 H), 7.59-7.56 (m, 2 H),  7.35 (t, J = 8.2 Hz, 2 H), 7.21-7.08 (m, 3 
H), 6.99 (t, J = 7.5 Hz, 1 H), 4.72 (q, J = 7.1 Hz, 1 H), 2.45 (s, 3 H), 1.76 (d, J = 7.1 Hz, 3 
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H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 138.7, 136.7, 135.0, 129.8, 126.9, 122.5, 
121.4, 120.9, 119.8, 119.7, 119.5, 119.0, 118.2, 111.2, 110.6, 105.9, 28.6, 20.6, 8.7. IR 
3412, 1455, 1335, 740 cm-1. HRMS C19H19N2 (M+H)+ calcd. 275.1543, obsvd. 275.1554. 
Synthesis of 145 
The same procedure as the general procedure was followed except 201.2 mg of 
1H-pyrrole (3.00 mmol, 10.0 equiv.) was added. Yield = 55% (average of two run), Rf = 
0.43 w/ 20% EtOAC/Hex, colorless liquid, 1H-NMR (400 MHz, CDCl3) δ = 7.94-7.78 
(m, 2 H), 7.48 (d, J = 7.9 Hz, 1 H), 7.37 (d, J = 8.2 Hz, 1 H), 7.22 (td, J = 7.6 Hz, J = 0.9 
Hz, 1 H), 7.11-7.07 (m, 1 H), 6.97 (d, J = 2.4 Hz, 1 H), 6.59 (q, J = 2.1 Hz, 1 H), 6.21 (q, 
J = 2.9 Hz, 1 H), 6.17-6.16 (m, 1 H), 4.45 (q, J = 7.1 Hz, 1 H), 1.74 (d, J = 7.1 Hz, 3 H).  
13C-NMR {1H} (100 MHz, CDCl3) δ = 136.7, 129.2, 126.7, 122.3, 121.4, 120.2, 119.7, 
119.6, 116.3, 111.3, 108.1, 104.3, 30.0, 21.3. IR 3401, 1291, 1091, 743 cm-1. HRMS 
C14H14N2 (M+H)+ calcd. 211.123, obsvd. 211.1224. 
Synthesis of 146 
The same procedure as the general procedure was followed except 525.5 mg of 
methyl indolizine-1-carboxylate (3.00 mmol, 10.0 equiv.) was used.  Yield = 68% 
(average of two run), Rf = 0.28 w/ 20% EtOAC/Hex, colorless solid, M.P. = 77-79 °C.  
1H-NMR (400 MHz, CDCl3) δ = 8.22 (d, J = 9.0 Hz, 1 H), 8.11 (s, 1 H), 7.68 (d, J = 7.1 
Hz, 1 H),  7.61 (d, J = 7.9 Hz, 1 H), 7.35 (d, J = 8.1 Hz, 1 H), 7.31 (s, 1 H), 7.23-7.19 (m, 
1 H), 7.12 (t, J = 7.5 Hz, 1 H), 6.98 (dd, J = 9.0 Hz, J = 6.6 Hz, 1 H), 6.59 (d, J = 2.4 Hz, 
1 H), 6.52 (td, J = 6.8 Hz, J =0.7 Hz, 1 H), 4.57 (q, J = 7.0 Hz, 1 H), 3.93 (s, 3 H), 1.85 
(d, J = 7.0 Hz, 3 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 165.7, 136.8, 136.3, 129.1, 
126.4, 124.0, 122.3, 121.8, 121.5, 119.8, 119.6, 118.8, 117.9, 113.6, 112.1, 111.6, 102.4, 
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51.0, 28.6, 20.8. IR 3314, 2966, 1662, 1214, 735 cm-1. HRMS C20H19N2O2 (M+H)+ calcd. 
319.1441, obsvd. 319.1453. 
Synthesis of 147 
The same procedure as the general procedure was followed except reaction was 
run at 70 °C.  Yield = 84% (average of two run), Rf = 0.40 w/ 20% EtOAC/Hex, colorless 
solid, M.P. = 88-90 °C.  1H-NMR (400 MHz, CDCl3) δ = 7.82 (s,1 H), 7.64 (dt, J = 7.9 
Hz, J = 0.9 Hz, 2 H), 7.33-7.29 (m, 2 H), 7.26-7.32 (m, 2 H), 7.07 (ddd, J = 8.0 Hz, J = 
7.0 Hz, J = 1.1 Hz, 2 H), 6.99 (d, J = 1.6 Hz, 1 H), 6.86 (s, 1 H), 4.41 (t, J = 7.4 Hz, 1 H), 
3.72 (s, 3 H), 2.27 (quintet, J = 7.4 Hz, 2 H) 1.05 (t, J = 7.4 Hz, 3 H).  13C-NMR {1H} 
(100 MHz, CDCl3) δ = 137.4, 136.7, 128.2., 127.8, 127.4, 126.5, 121.8, 121.6, 121.4, 
120.6, 120.0, 119.1, 119.0, 118.6, 111.2, 109.3, 36.0, 32.7, 29.1, 13.3. IR 3406, 2963, 
1584, 1451, 1335, 1095, 738 cm-1. HRMS C20H21N2 (M+H)+ calcd. 289.1699, obsvd. 
289.1705. 
Substrate Scope with 148 
General Procedure for Substrate Scope (Table 5.3) 
To a 2.5 dram vial equipped with a stir bar were added 3.44 mg of p-TsOH (0.020 
mmol, 0.100 equiv.), 262.4 mg of N-Me-indole (2.00 mmol, 10.0 equiv.) and 59.7 mg of 
148 (0.200 mmol, 1.00 equiv.).  To this 1.0 mL of DMA was added via syringe.   The vial 
was capped and was stirred for given time at 70 °C in oil bath. The crude mixture was 
purified with flash silica-gel column chromatography. (Note: In case of liquid 




Synthesis of 149 
The same procedure as the general procedure was followed.  Yield = 91% 
(average of two run), Rf = 0.35 w/ 66% EtOAC/Hex, colorless solid, M.P. = 133-135 °C. 
1H-NMR (400 MHz, CDCl3) δ = 8.14 (s, 1 H), 7.52 (dd, J = 12.1 Hz, J = 9.1 Hz, 2 H), 
7.31 (d, J = 8.1 Hz, 1 H), 7.26 (d, J = 8.2 Hz, 1 H), 7.16-7.08 (m, 2 H), 7.03 (d, J = 2.5 
Hz, 1 H), 6.96-6.90 (m, 3 H), 3.73 (s, 3 H), 3.65-3.55 (m, 4 H), 2.62 (t, J = 5.4 Hz, 4 H), 
1.52 (s, 9 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 155.4, 137.9, 137.3, 126.9, 126.5, 
126.1, 122.3, 121.8, 121.6, 121.4, 121.2, 120.4, 118.9, 118.4, 111.4, 109.4, 79.4, 38.1, 
35.9, 32.9, 28.7. IR 3303, 2947, 1667, 734 cm-1. HRMS C27H31N3O2 (M+Na)+ calcd. 
452.2308, obsvd. 452.2314. 
Synthesis of 150 
The same procedure as the general procedure was followed.  Yield = 90% 
(average of two run), Rf = 0.35 w/ 66% EtOAC/Hex, colorless solid, M.P. = 186-188 °C. 
1H-NMR (400 MHz, CDCl3) δ = 8.10 (d, J = 1.1 Hz, 1 H), 8.01 (d, J = 1.2 Hz, 1 H), 7.49 
(d, J = 8.0 Hz, 1 H), 7.29 (d, J = 8.1 Hz, 1 H), 7.18 (d, J = 8.8 Hz, 1 H), 7.10-7.02 (m, 3 
H), 6.90 (dd, J = 3.8 Hz, J = 1.7 Hz, 1 H), 6.75 (dd, J = 8.8 Hz, J = 2.4 Hz, 1 H), 3.66 (s, 
3 H), 3.58 (bs, 4 H), 2.63-2.52 (m, 4 H), 1.49 (s, 9 H).  13C-NMR {1H} (100 MHz, 
CDCl3) δ = 155.4, 153.1, 137.3, 132.5, 129.2, 126.6, 126.1, 123.0, 122.2, 121.7, 121.6, 
121.4, 121.2, 118.9, 111.8, 111.4, 11.2, 104.0, 79.5, 55.9, 37.9, 35.7, 20.7.  IR 3305,  
1524, 1425, 793 cm-1. HRMS C27H31N3O3 (M+Na)+ calcd. 468.2258, obsvd. 468.2267. 
Synthesis of 151 
The same procedure as the general procedure was followed.  Yield = 71% 
(average of two run), Rf = 0.30 w/ 66% EtOAC/Hex, colorless solid, M.P. = 266-268 °C, 
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1H-NMR (400 MHz, CDCl3) δ = 8.35 (d, J = 0.4 Hz, 1 H), 8.12 (d, J = 0.6 Hz, 1 H), 8.05 
(d, J = 0.9 Hz, 1 H), 7.56 (dd, J = 8.6 Hz, J = 1.5 Hz, 1 H), 7.45 (d, J = 8.6 Hz, 1 H), 7.40 
(d, J = 8.1 Hz, 1 H), 7.31 (d, J = 8.1 Hz, 1 H), 7.25 (d, J = 2.5 Hz, 1 H), 7.11-7.05 (m, 2 
H), 6.90-6.86 (m, 1 H), 3.87 (s, 3 H), 3.57 (bs, 4 H), 2.64-2.51 (m, 4 H), 1.48 (s, 9 H).  
13C-NMR {1H} (100 MHz, CDCl3) δ = 155.3, 137.2, 136.5, 129.7, 125.9, 125.2, 123.4, 
122.7, 122.0, 121.9, 121.4, 121.0, 120.6, 119.9, 119.0, 113.7, 111.4, 79.6, 52.0, 37.9, 
35.8, 28.6.  IR 3303, 1667, 1509, 734 cm-1. HRMS C28H32N3O4 (M+H)+ calcd. 474.2401, 
obsvd. 474.2401. 
Synthesis of 152 
The same procedure as the general procedure was followed.  Yield = 85% 
(average of two run), Rf = 0.32 w/ 66% EtOAC/Hex, colorless thick liquid,  1H-NMR 
(400 MHz, CDCl3) δ = 8.14 (s, 1 H), 7.70 (d, J = 0.6 Hz, 1 H), 7.35 (dt, J = 7.3 Hz, J = 
0.9 Hz, 1 H), 7.15 (td, J = 7.6 Hz, J = 1.1 Hz, 1 H), 7.01-6.96 (m, 2 H), 6.55 (td, J = 2.6 
Hz, J = 1.5 Hz, 1 H), 6.23-6.16 (m, 2 H), 3.60 (ddd, J = 13.3 Hz, J = 7.5 Hz, J = 3.9 Hz, 2 
H), 3.49-3.44 (m, 2 H), 2.47-2.41 (m, 2 H), 2.26 (ddd, J = 13.3 Hz, 8.5 Hz, J = 4.3 Hz, 2 
H), 1.47 (s, 9 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 155.2, 137.7, 137.1, 125.8, 
122.3, 122.1, 120.9, 120.8, 119.7, 116.6, 111.4, 108.0, 104.9, 79.5, 38.3, 36.6, 28.6.  IR 
3369, 2969, 2928, 1594, 1484, 1381, 789 cm-1. HRMS C22H28N3O2 (M+H)+ calcd. 
366.2176, obsvd. 366.2182. 
Synthesis of 153 
The same procedure as the general procedure was followed.  Yield = 90% 
(average of two run), Rf = 0.30 w/ 66% EtOAC/Hex, colorless solid, M.P. = 197-199 °C. 
1H-NMR (400 MHz, CDCl3) δ = 8.62 (d, J = 1.7 Hz, 1 H), 8.17 (dt, J = 9.0 Hz, J = 1.1 
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Hz, 1 H), 7.84 (d, J = 7.2 Hz, 1 H), 7.54 (s, 1 H), 7.30 (d, J = 8.2 Hz, 1 H), 7.21 (d, J = 
2.5 Hz, 1 H), 7.05 (ddd, J = 8.1 Hz, J = 7.1 Hz, J = 1.0 Hz, 1 H), 6.98 (d, J = 8.1 Hz, 1 
H), 6.85 (ddd, J = 9.0 Hz, 6.6 Hz, J = 0.9 Hz, 1 H), 6.78 (ddd, J = 8.1 Hz, 7.1 Hz, J = 0.9 
Hz, 1 H), 6.31 (td, J = 6.9 Hz, J = 1.3 Hz, 1 H), 3.95 (s, 3 H), 3.73 (bs, 2 H), 3.48 (bs, 2 
H), 2.5 (m, 4 H), 1.48 (s, 9 H).  13C-NMR {1H} (100 MHz, CDCl3) δ = 165.8, 155.1, 
137.1, 136.9, 129.2, 128.8, 125.4, 125.1, 122.3, 121.7, 121.6, 120.0, 119.9, 119.6, 119.3, 
115.7, 111.7, 111.4, 102.5, 79.8, 51.1, 37.9, 28.6. IR 3303, 1667, 1509, 734 cm-1. HRMS 
C28H32N3O4 (M+H)+ calcd. 474.2387, obsvd. 474.2397. 
Biological Evaluation 
General Culture Procedure 
MCF-10A and MCF-7 cells were cultured in monolayer in Dulbecco’s Modified 
Eagle’s Medium/Nutrient Mixture F-12 Ham (DME/F-12) containing HEPES buffer and 
L-glutamine  (HyClone) supplemented with 10% (v/v) fetal bovine serum (FBS, 
HyClone), 1% (v/v) penicillin/streptomycin (P/S), 1% (v/v) insulin-transferrin-selenium-
X (ITS, Gibco), and 2.5 nM human epidermal growth factor, recombinant (EFG, BD 
Biosciences).  Cells were maintained in a humidified incubator at 37 °C and 5% CO2. 
Initial 3-point Screening of Compounds 138-147, 149-153 
In a 96-well flat bottom plate, MCF-7 cells were seeded at 1,500 cells/well and 
MCF-10A cells were seeded at 9,000 cells/well using the 10% FBS medium described in 
the general culture procedure.  The cells were then incubated in a humidified incubator at 
37 °C and 5% CO2 for 18 hours.  From a 100 mM stock of each compound in molecular 
biology grade DMSO (Sigma) was made a 50 µM standard solution of each compound in 
DME/F-12 supplemented with 2% (v/v) FBS, 1% (v/v) P/S, 1% (v/v) ITS, and 2.5 nM 
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EFG.  From this 50 µM standard solution, serial dilutions of 10 µM and 1 µM were made.  
The media was aspirated from the cells in the 96-well plates after the initial incubation 
period and 100 µL of the appropriately diluted compound in media was added (day 0).  
The cells were incubated and on days 2, and 4, the media was aspirated and 100 µL of 
fresh compound-containing media was added.  On day 5, an MTS assay was performed 
using CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega).  The 
absorbance measurements were normalized to the DMSO control and these values were 
plotted against the ± standard deviation of 2 wells per condition. 
12-Point Dose Response Curve of Compounds 139 and 149 
In a 96-well flat bottom plate, MCF-7 cells were seeded at 1,500 cells/well and 
MCF-10A cells were seeded at 9,000 cells/well using the 10% FBS medium described in 
the general culture procedure.  The cells were then incubated in a humidified incubator at 
37 °C and 5% CO2 for 18 hours.  From a 100 mM stock of each compound in molecular 
biology grade DMSO (Sigma) was made a 100 µM standard solution of each compound 
in DME/F-12 supplemented with 2% (v/v) FBS, 1% (v/v) P/S, 1% (v/v) ITS, and 2.5 nM 
EFG.  From this 100 µM standard solution, an automated liquid handler (EP Motion 
5075, Eppendorf) was used to prepare the 12 necessary concentrations.  The media was 
aspirated from the cells in the 96-well plates after the initial incubation period and 100 µL 
of the appropriate compound in media was added (day 0).  The cells were incubated and 
on days 2 and 4, the media was aspirated and 100 µL of fresh compound-containing 
media was added.  On day 5, an MTS assay was performed using CellTiter 96 AQueous 
Non-Radioactive Cell Proliferation Assay (Promega).  The absorbance measurements 
were normalized to the DMSO control and these values were plotted against the ± 
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standard deviation of the 3 wells per condition.  The EC50 values were calculated using 
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